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"Believe me, my young friend", said the Water Rat to the Mole, "there 
is nothing - absolutely nothing - half so much worth doing as simply 
messing about in boats. Simply messing about in boats or with boats. 
In or out of 'em, nothing seems really to matter, that's the charm of it. 
Whether you get away, or whether you don't; whether you arrive at 
your destination or whether you reach somewhere else, or whether you 
never get anywhere at all, you're always busy, and you never do any-
thing in particular; and when you've done it there's always something 
else to do, and you can do it if you like but you'd much better not." 
(From: The Wind in the Willows by Kenneth Grahame, Methuen Chil-
dren's Books Ltd, Great Britain, originally published 8 October 1908) 
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Chapter I 
Introduction 
Joint replacement surgery has become the most widely accepted opera-
tion to treat a variety of disabling pathological conditions of the hip and, 
to a lesser extend, also of the knee joint. The procedure has now come 
closer to an industrial process than any other surgical form of surgery 
and in the Netherlands this operation is estimated to be performed 
more than 10.000 times annually12* 
The incidence of joint sepsis after hip replacement has decreased from 
10 percent in the late 1960s to around one percent nowadays' and 2-3 
% after knee replacement'. However, the consequences of joint sepsis 
after prosthesis implantation are still devastating. The prosthesis often 
has to be removed and for many patients the final result is resection 
arthroplasty or arthrodesis or even amputation. The functional outcome 
is nearly always much poorer than anticipated before the operation and 
many patients suffer from pain with these conditions. Reimplantation is 
only performed in a limited number of patients under favourable condi-
tions4. 
The majority of the infections are initiated during operation, and 
prospective randomized trials have documented the value of periopera-
tive antibiotics'7. Lidwcll et al.7 have clearly established that clean air 
systems are effective in reducing the incidence of joint sepsis. The cur-
rent literature on the etiology, prophylaxis and diagnosis of prosthesis 
related infections are summarized in chapter II. 
Most Dutch hospitals do not have clean-air facilities in their operating 
theatres. Therefore, systemic antibiotics are used routinely in joint 
replacement surgery. A one day (24 hour) antibiotic regimen is well-
accepted". In other surgical fields, a single perioperative dose of antibi-
otics is becoming an increasingly popular means of infection prophylax-
* These figures refer to the references at the end of each chapter 
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is9 and this trend is also being adopted in orthopaedic joint replacement 
surgery. 
As the efficacy of a single perioperative antibiotic dose has not been 
investigated in joint replacement surgery, we decided to start a prospec­
tive randomized controlled trial on this subject. Statistical calculations 
showed that a large study population was needed, comprising a group 
of approximately 1250 patients who would receive a single dose and a 
control group of 1250 patients who would receive three doses of an 
antibiotic (type I error 5% and type II error less than 20%, one-tail 
test)10. Cefuroxime was chosen as the prophylactic agent. 
Orthopaedic departments situated in the central provinces of the 
Netherlands were invited to participate in the study and 27 contributed 
to the trial which took place in the period from 1 July 1986 to 1 July 
1988. The follow-up was completed on 1 July 1989. The majority of the 
record forms were checked against the patient forms by the author, who 
visited the participating hospitals every two to three months. 
The most important results of the dose-defining study for hip and knee 
replacements are reported in Chapters III and VI. A separate analysis 
on hip and knee patients was performed because patient characteristics 
and incidence of joint sepsis differed considerably. 
As detailed preoperative, perioperative and postoperative data were 
documented prospectively for each patient, we were also able to per­
form an adequate risk factor analysis which enables the orthopaedic sur­
geon to identify patients who carry a high risk for joint sepsis. Chapters 
V and VI report on this subject. 
Further analysis of the relation of wound and urine cultures and later 
joint sepsis after joint replacement is reported in Chapter VII. The 
additional usage of antibiotics after single and three dose cefuroxime 
prophylaxis is described in Chapter VIII. 
It was not possible to present all simple data gathered in this study in 
the various chapters. Therefore, supplements with a general summary 
of all the used data from the dose defining study, the risk factor analysis 
and details on the 26 patients with joint sepsis, have been added. 
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Chapter II 
Prosthesis-related infection 
Etiology, prophylaxis and diagnosis (a review) 
A.B. Wymenga*, B.J. van Dijke", J.R. van Horn* and 
T J . J . H . SloofT 
Acta Orlhopaedua Belgica, Vol 50,2-1990 463-475 
Summary 
The recent literature on prosthesis-related infections was reviewed with respect to eti­
ology, prophylaxis and diagnosis. 
Most prosthesis-related infections are initiated during the operation by contamination 
with bactena-canying particles from the air as a result of the dispersion of skin scales 
from individuaL· in the operating theatre. A small number of infections are caused by 
the haematogenous seeding of bacteria. Glycocalyx, a slime layer produced by the bac­
teria, plays an important role in the pathogenesis of infections, especially in the pre­
sence ofbiomatenal 
Clean-air systems in combination with perioperative systemic antibiotics reduce pros­
thesis-related infections from 3 or 4 per cent to a few cases per thousand. The use of 
antibiotic-loaded bone cement is advised in high nsk patients although further evalua­
tion и needed. 
Physical examination of the patient, laboratory tests including the E.S.R. and C-
reactive prolan, serial radiograms, isotope scanning techniques and joint aspiration, 
can all help to diagnose prosthesis-related infection. However, definitive diagnosis и 
only possible by cultunng several samples of material obtained from the interface du­
ring revision surgery. A perioperative frozen section of interface tissue showing acute 
(more than 5 leucocytes per high power field, 500x) or severe chronic (more than 50 
lymphocytes) inflammation и highly suggestive of sepsis. 
Introduction 
Deep infection is the most severe complication of joint replacement, 
resulting in significant morbidity and considerable financial cost43 'n3. 
Most infected prostheses must be removed and the outcome for many 
= Department of Orthopaedic Surgery, = Department of Microbiology, St Radboud 
Hospital, University of Nijmegen 
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patients is resection arthroplasty or arthrodesis after multiple opera-
tions51 l03. 
The purpose of this study is to review the current literature with respect 
to: 
1. the etiology of prosthesis-related infections, 
2. the subsequent prophylactic measures and 
3. the efficacy of diagnostic procedures. 
The literature from 1975 to 1988 was selected using MEDLINE. 
Etiology 
Causative microorganisms 
Almost any microorganism can give rise to a prosthesis-related infec-
tion. Gram-positive, gram-negative, aerobic and anaerobic bacteria and 
even yeasts have been reported as causative agents60·"5. There is no 
obvious distinction between pathogens and nonpathogens in this type of 
infection68. Many of these agents are skin commensals or transient skin 
contaminants60. 
More than 50% of well-established prosthesis-related infections are 
caused by gram-positive organisms (Table I). In some series, Staphylococ-
cus epidermidis outnumbered S. aureus, indicating that this can be an 
important cause of prosthesis-related infection. Enteric gram-negative 
bacteria are responsible for 24% and anaerobic bacteria are responsible 
for the remaining 21 % of the infections. In this latter group, anaerobic 
skin commensals, such as Propionibacterium acnes and Peptococcus, are fre-
quently isolated60. 
Table I Causative agents of endoprosthesis infection (percentages of the number of isolates are given; 
species m mixed infections [mean 13%] are shown separately) 
Author (ref.) S. aur. S. epid. other gram anaerob. other no. of 
Carlsson " 
Whyte "' 
Lidwell w 
Inman 51 
Buchholz l2 
Mean 
% 
21 
8 
36 
18 
40 
34% 
% 
31 
45 
22 
37 
5 
13% 
gram + 
% 
10 
-
5 
13 
3 
4% 
-
% 
11 
10 
22 
22 
28 
24% 
% 
24 
37 
12 
10 
22 
21% 
% 
2 
-
. 
-
3 
2% 
iso-
lates 
98 
51 
74 
68 
695 
986 
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Deep infection initiated during surgery 
Deep infection can be initiated during an operation by the deposition of 
microorganisms in the open wound. Despite aseptic surgical techniques, 
there are three possible remaining sources of exogenous microbial con-
tamination: contaminated air, the patient's skin and the surgeon's hand 
through a punctured glove130. 
Air contamination is caused by the dispersion of fragmented desqua-
mated skin scales from individuals in the operating theatre. These parti-
cles are small enough to pass through the interstices of conventional 
woven cotton suits and gowns67. Dispersal values from an individual in a 
cotton scrub-suit vary between 1000-1500 colony-forming units (c.f.u.) 
per minute. Wearing an additional cotton gown reduces this by only 33 
per cent139. 
Thus both scrubbed and non-scrubbed operating theatre personnel 
contribute significantly to air contamination. The amount of air con-
tamination caused by non-scrubbed personnel may be substantially 
increased by movement in the operating theatre, which increases the 
dispersion of skin scales67·82. By limiting the number of persons in the 
operating theatre and avoiding any unnecessary activity, it is possible to 
significantly reduce bacterial dispersion65. 
There is an évadent relationship between the number of c.f.u./m3 in the 
air and the average number of bacteria washed out of the wound before 
closure. More bacteria are found in the wound washout in conventional 
operating theatres with a high degree of air contamination than in clean 
air conditions, where significantly fewer bacteria are recovered from the 
wound6"130. The bacterial contamination of instruments and drapes is 
also substantially reduced in clean air106. 
Whyte et al. (1982) concluded from their experiments that 30% of the 
airborne bacteria fall direcdy from the air into the wound. The remain-
ing 70% are indirectly transferred to the wound by the surgeons via the 
contaminated surrounding areas, such as drapes and instruments130. 
They calculated that in a conventionally-ventilated operating theatre, 
more than 95% of the bacteria found in the wound must have been 
transported by the airborne route. This was confirmed by Lidwell et al. 
during the Medical Research Council (MRC) trial61, in which a definite 
relationship was demonstrated between air contamination and deep 
sepsis. In the trial, more than 8000 patients were allocated at random to 
conventional or ultraclean-air operating theatres. Significantly fewer 
cases of infection were found in clean-air systems, independent of the 
use of antibiotics70. 
Infection of the postoperative wound was an important risk factor for 
later deep infection. Deep infection occurred in 30% of the patients 
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with major postoperative wound infection, in 3% with suspected post-
operative wound sepsis and in less than 1% without postoperative 
wound infection. Nevertheless, joint sepsis eventually developed in 60% 
of the patients without any postoperative woundhealing problems1'9. 
The incidence and type of bacteria found in operating theatre air, 
wounds and deep sepsis, were very similar, but some species, such as S. 
aureus and gram-negative bacteria, were more prevalent in deep sepsis. 
These bacteria are probably more virulent than others"''n6. 
There is evidence that the source of superficial postoperative wound 
infection differs from that which leads to deep joint sepsis. In 71% of the 
cases of deep joint sepsis, a possible source could be matched by phage 
typing with the theatre staff present at the time of the operation. In the 
case of postoperative wound infections which did not progress to deep 
sepsis, only 21 % of the theatre staff were implicated. Later contamina-
tion on the ward would seem to be the most likely cause of these super-
ficial postoperative wound infections66. 
Sometimes infection is present before the operation. Latent infection 
can persist for decades in previously septic areas, but this is rarely the 
cause of deep infection in primary joint replacement^. In revision 
surgery, however, undiagnosed latent infection can cause a high per-
centage of septic failures1'2. 
Deep infection initiated after the operation 
Deep infection initiated after surgery is caused by the haematogenous 
spread of bacteria from distant infections. The 'early' type of haema-
togenous infection occurs in the postoperative period\ It appears that 
there is increased susceptibility to haematogenous seeding from distant 
foci during the first 4 to 6 weeks after implantation24·'9·3'1·0"91^. Animal 
experiments have confirmed this postoperative susceptibility7,6. Concur-
rent infections should therefore be treated \igorously with antibiotics 
and other measures in order to prevent bacteraemia1. 
The 'late' type of haematogenous infection occurs in patients who have 
a long pain-free interval. After an intercurrent infection or an invasive 
procedure in a contaminated area, acute joint pain may develop with 
subsequent symptoms of deep infection''. 
Host factors as well as the amount and virulence of the bacteria play a 
role in the development of deep implant infection after bacteraemia, as 
not every bacteraemic episode leads to joint sepsis24,32·1"1. Patients with 
rheumatoid arthritis seem to be more susceptible to haematogenous 
infection23·'1'24·49. Hinged knee prostheses are also a risk factor for acquir-
ing haematogenous infection'. 
Transient, usually asymptomatic bacteraemia occurs in a wide variety 
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of procedures and manipulations, particularly those associated with 
trauma to the mucous membranes. Very high percentages of positive 
blood cultures are found following dental extractions, manipulation of 
the urogenital tract and septic foci18120. 
The most frequent sources of haematogenous spread are cutaneous 
lesions, the respiratory tract, the urinary tract and the oral cavity3,1', but 
the gut and other infected joints and prostheses have also been reported 
as sources'^
1
''
3
·
49
'"
8
·
133
. The most frequent isolate (50%) was S. aureus and 
in 25% a gram-negative organism was found30. 
The risk of haematogenous infection was calculated for eight (mostly re­
trospective) series, comprising more than 1000 arthroplasties2'7,34-40·'799109 
(Table II). The results showed that an average of 18% of all deep infec­
tions were presumed to be caused by haematogenous infection. The con­
tribution varied considerably within the different series, from 5 to 
49%. 
Table II Incidence of haematogenous infection 
Author (ref.) Type of No. of Tolal Haematogenous Percentage 
Poss1"1 
Joseffson57 
Glynn 4 " 
Fitzgerald 3 9 
Salvati 1 0 9 
Carlsson 1 7 
Ainscow2 
Total 
arthro­
plasty 
various 
tha 
tha 
tha 
tha/tka 
tha 
tha 
patients 
η 
4240 
1633 
1500 
3215 
3175 
1065 
1112 
15940 
infections 
η (%) 
53 (1.3) 
16 (1.0) 
14 (0.9) 
42 (1.3) 
57 (1.8) 
73 (6.9) 
22 (2.0) 
277 (1.7) 
infections 
η (%) 
26 (0.6) 
2 (0.1) 
2 (0.1) 
7 (0.2) 
7 (0.2) 
4 (0.4) 
3 (0.3) 
51 (0.3) 
of total 
% 
49 
13 
14 
17 
12 
5 
14 
18 
(tha = total hip arthroplasty, tka = total knee arthroplasty) 
Lidwell67 stated that the proportion of haematogenous infections must 
be very small, because his calculations on air contamination data re­
vealed that at least 90% of the infections which manifested themselves 
in the first two years after the operation were initiated in the opera­
ting theatre; thus the contribution of haematogenous infection in this 
period was 10% or less. The incidence in Table II is somewhat high­
er. 
Pathogenesis and the susceptibility to infection 
Biomaterials, such as orthopaedic prostheses, provide a good adhesive 
surface for bacteria. Immediately after a prosthesis has been implanted, 
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the surface is covered by a layer of glycoproteins. In this layer, receptors 
are available which facilitate the adherence of tissue cells and bacteria. 
Both tissue cells and bacteria 'compete in the race for the surface', but 
the bacteria may defeat the tissue cells because they adhere more easily. 
After adherence has taken place, the bacteria immediately start to pro­
duce a form of slime, the glycocalyx, which has various functions, 
including rendering adherence irreversible, permitting the optimal con­
centration of nutrients and providing protection against external ha­
zards, such as phagocytosis and antibiotics22,41. Glycocalyx formation is 
considered to be the natural mode of growth of bacteria, affording it the 
best chances for survival. 
The primary local immune defense system reacts within two to five 
hours after the initial invasion of bacteria into the tissue. During this 
time, the infection is either localized and suppressed, or spreads to adja­
cent tissuesl3·26·27·78·79. This phase also constitutes the decisive period in 
which antibiotics are likely to be successful in reducing the total number 
of bacteria and enhancing the immune system. After this time the effect 
is very limited8·'1·26'27·79 m . 
There are numerous factors which interfere with the optimal function­
ing of the local immune system. For example, poor blood flow and 
hypoxia reduce the efficacy of the immune defense reaction75·78 97'108, 
malnutrition may reduce the synthesis of humoral factors and humoral 
immunity is also reduced in agammaglobulinaemia and c3 deficiency. 
The cellular immune system may be impaired by neutropaenia, 
rheumatoid arthritis, diabetes, alcohol consumption and various drugs, 
such as steroids and іттигап Ч 7 1 0 я . 
The presence of a foreign body in itself may reduce the minimum 
infecting bacterial dose by up to a factor of 10.00034. The properties of 
biomaterials are important. Reactive material potentiates infection 
more seriously than non-reactive таіегіаГ1"4. 
The bone cement most frequendy used nowadays significandy reduces 
the minimum infecting dose. The monomer which leaks from the 
resorbable plastic interferes with complement factors, chemotactic fac­
tors, the migration and viability of the leukocytes and impairs intracellu­
lar killing9095. 
Certain metals used in implant surgery (nickel and cobalt) have a toxic 
effect on macrophages'01102. Leucocytes exposed to synovial fluid with 
metal wear debris from hinged knee prostheses show a depressed mito­
tic index, indicating cellular damage23. 
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Prophylaxis 
A considerable decrease in prosthesis-related infections can be achieved 
by reducing the bacterial inoculum during surgery. This can only be 
accomplished by preventing the deposition of bacteria into the wound, 
by means of asepsis and clean-air systems and by killing as many bacte-
ria as possible using secondary measures, such as suitable antibiotics gi-
ven perioperatively36. 
Ckan air systems 
The most effective method of preventing the deposition of bacteria into 
the wound is by reducing air contamination using clean-air systems, 
provided that asepsis and skin disinfection protocols are carefully fol-
lowed. Very low airborne bacterial counts must be achieved in order to 
reduce bacterial deposition into the wound and subsequent sepsis'31. 
Clean-air systems emit a rapid unidirectional flow of filtered sterile air 
over the operating area (100-300 times the operating theatre volume 
per hour). Full-walled downflow ventilation systems provide the lowest 
degree of air contamination, while partially-walled and horizontal sys-
tems arc less effective·*8. 
Air contamination can be further diminished by reducing the bacterial 
dispersion of the theatre staff. This can be achieved with body-exhaust 
gowns, made of tightly woven bacterial-occlusive cloth. Promising 
experiments with nonwoven conventional disposable gowns in combi-
nation with nonwoven suits have shown an equivalent reduction in dis-
persion, without hampering communication or movement and with the 
same comfort as cotton gowns6"fl2131. Mean values in modern operating 
theatres of 164 c.f.u./m3 are reduced to less than 1 c.f.u./m3 by full-
walled downflow systems in combination with body exhaust suits70. 
In the MRC trial, ultraclean-air systems reduced the number of cases of 
confirmed sepsis by half, compared to conventional ventilation. When 
body-exhaust suits were worn, the reduction was almost fivefold70. Simi-
lar results were reported by Nelson84, who also reviewed the literature. 
Penoperative systemic antibiotics 
Perioperative systemic antibiotics are a very efTcctive means of reducing 
the incidence of prosthesis-related sepsis. In a large randomized clinical 
trial using cefa/.olin antibiotic prophylaxis versus a placebo, Hill et al.47 
found a sevenfold reduction in prosthesis-related infection. These 
patients underwent surgery in a conventional operating theatre. 
Ericson37 also observed a sevenfold reduction using cloxacillin in a 
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smaller trial. In the treatment of hip fractures, a six to eightfold reduc-
tion has been reported'114 '-'-'. 
In the MRC trial, Lidwell et al. found a three to fourfold reduction, but 
the antibiotics were not administered at random. They also found that 
the effects of clean air were supplementary to those achieved by the 
administration of antibiotics, resulting in a more than eightfold reduc-
tion in sepsis (from 3.4 to 0.3 percent). Thus deep implant infection can 
be limited to a few per thousand operations70. 
The choice of prophylactic antibiotic should be based on the current 
causative agents and the sensitivity patterns at the hospital. Narrow spec-
trum antistaphylococcal prophylaxis does not prevent an infection with 
gram-negative bacteria. When Lidwell et al. administered antistaphylo-
coccal antibiotics, a greater incidence of gram-negative bacteria infec-
tions was observed than when broad spectrum antibiotics were used''6. 
Second generation cephalosporins, such as cefuroxime and 
cefamandole, have become popular in prophylaxis owing to their wide 
activity against gram-negative bacteria, without losing their effectiveness 
against staphylococci. However, the cefalosporin spectrum has its limita-
tions. These drugs are not suiïiciently active against P. aeruginosa, Enter-
obacter φ, S.faecalis and anaerobes''^. 
It is important that the antibiotics are given at the induction of anaes­
thesia and 10 minutes before the inflation of the tourniquet^'62. Intra­
venous injection is preferred, because this results in higher blood and 
tissue concentrations compared with intramuscular injection1"·74. 
Prophylaxis can be short of duration, because trials have shown that 
there is no difference in the incidence of deep infection between 14-day 
and 1-day 98 or 5-day and 1-day antibiotic prophylaxis8'. One-day pro­
phylaxis is the accepted practice nowadays. 
Λ further reduction to one perioperative dose is now being advocated 
for antibiotics with a sufficiently long half-life that provide high tissue 
concentrations during the operation4844. A single dose has already 
proven to be effective in cardiac21, abdominal41'"7 and gynaecological 
surgery44,77. We are currently investigating the safety of this approach in 
a controlled multicentre trial on joint replacement in more than 2500 
patients. The results after one dose of cefuroxime prophylaxis arc being 
compared to those after three doses. 
Antibiotics in bone cement 
After Buchholz and Engelbrecht reported on the effects of antibiotic-
loaded bone cement", this product has been employed for prophylaxis, 
with gentamicin as the most commonly used drug. After implantation, 
high bone and soft tissue concentrations are achieved in the first 48 
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hours. Thereafter gentamicin may be cluted for a long period (months) 
in low concentrations'135121,126. 
Wannske and Tscheme127 found that the infection rate was reduced 
from 5.9% to 1.2% when gentamicin-loaded cement was used, com-
pared to plain cement and no systemic antibiotics. Josefsson et al.8n com-
pared systemic antibiotics to gentamicin cement and found a reduction 
from 1.6% to 0.4%. In the gentamicin cement group, they found more 
superficial infections, which indicates that wound tissue distant from the 
gentamicin cement is not sufficiently protected. Additional systemic 
antibiotics should therefore be used124. 
In a retrospective study, Lynch et al.71 confirmed the efficacy of genta-
micin cement above plain cement in patients who had undergone previ-
ous hip surgery and revisions, but no difference was found in patients 
with primary arthroplasties without previous surgery. A combined 
approach with systemic antibiotics and antibiotic-loaded cement seems 
to be justified in high-risk patients, but further clinical trials are needed124. 
Animal studies have confirmed the protective action of antibiotic-loaded 
cement against perioperative bacterial contamination*107,114, but no 
comparison has been made with systemic antibiotics. Protection against 
haematogenous infection was found in one study"' in the immediate 
postoperative period but not after 6 weeks6,16. The intervening period 
was not evaluated, however. 
Diagnosis 
Clinical diagnoses 
Pain is a prominent feature in prosthesis-related infections, affecting 
more than 80-90% of the patients with deep infectionl,,5J·80. Constant 
pain at rest, aggravated on weight-bearing and gradually increasing 
after the operation, is suggestive of infection; a more sudden onset of 
pain suggests mechanical loosening6,,ln'^. Antibiotics may help to dimin-
ish the pain of infection, but do not cure chronic infection61. 
The symptoms of infection, such as increased temperature, warmth, 
redness and fislulization, are often less prominent4'',',3,8ü. Many patients 
with an infected arthroplasty admit that they were never entirely pain-
free after the operation. 
Laboratory investigations 
Laboratory investigations can be of help, but it should be realized that 
negative results do not exclude infection. An elevated ESR of more than 
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35 mm is suggestive of, but does not prove, infection14 "·55·10''. C-reactive 
protein is a more sensitive means for detecting infection"'61125. 
Radiography and isotope scanning techniques 
Serial radiographs showing periostial reactions, progressive radiolucent 
lines and cortical scalloping are suggestive of infection. These nonspeci-
fic signs can also be present in mechanical loosening, making differenti-
ation difficult416'87·1"- "2 ·1 2 0 . 
A technetium-99m (Tc-99m) bone scan may be helpful; intense uniform 
activity indicates infection, whereas mild local activity is more compati-
ble with mechanical loosening73,1"121. The Tc-99m scan can be com-
bined with a Gallium-67 scan. If an incongruent pattern is found, infec-
tion is likely, whereas congruent patterns favour mechanical 
failure73·87·128. Unfortunately, a number of scans fall into the gray zone 
between the extremes43·871"'"2·. 
Another scanning technique is the injection of Indium-Ill labelled 
autologous leucocytes, but this involves a very delicate technique for 
preparing the leucocyte-concentrates8"·100. (Addendum: The utility of 
Indium-111 labeled immunoglobulin G is a new promising technique 
for identifying the presence, location, extent and soft tissue involvement 
of acute and low-grade bone infections. The sensitivity appears to be at 
least as high as that of labeled leucocytes and labeled immunoglobelin 
can easily be prepared. Van Oyen W.J.G., Ciaessens R.A.MJ., Van 
Horn J.R., Van der Meer J.W.M., Corstens F.H.M., Scintigraphic 
Detection of Bone and Joint Infections with Indium-111-labeled Non-
specific Polyclonal Human Immunoglobelin G., The Journal of Nuclear 
Medicine, 31, 4: 403-412, 1990) 
Microbial diagnoses 
Aspiration of the joint before surgery can be performed, but false ne-
gative and false positive cultures do occur12·50'80,89·96. Local anaesthetics 
and contrast media should not be introduced into the joint before aspi-
ration because of their possible bactericidal and bacteriostatic propcr-
f;es25,30,76,ll0 
A definitive diagnosis can only be made after a revision operation. The 
diagnosis can then be based on the results of multiple biopsy cultures (at 
least 3) from interface tissue, each taken with a different pair of sterile 
forceps59. Preoperative antibiotic therapy should be stopped two to three 
days prior to the operation and perioperative antibiotics should be given 
only after the sampling has been completed66. Specimens should be sent 
to the laboratory immediately to preserve any anaerobes"5 and the cul-
tures should be incubated for 10 days42. Both solid and broth media 
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should be used, as broth encourages the growth of organisms present in 
small numbers2", while a solid medium gives an indication of the inocu-
lum size and the number of different species present. 
Frozen sections 
During a revision operation, a frozen section of interface tissue can pro-
vide reliable information as to whether or not sepsis is present20,33,81. 
Acute inflammatory changes of more than five polymorphonuclear 
leucocytes per high power field (x 500) or severe chronic (more than 50 
lymphocytes) inflammation are highly suspicious of sepsis20,81, but occa-
sional false positive20 and false negative results'04 have been reported81,104. 
Gram staining is of litde use in the diagnosis of subacute prosthesis-
related infection. It is very important to sample representative interface 
tissue. 
Conclusions 
Etiology 
Almost any type of microorganism can give rise to prosthesis-related 
infection. Aerobic and anaerobic skin commensals play an important 
role. Most infections are initiated during the opération by airborne con-
tamination with infectious skin scales originating from individuals in the 
operating theatre, although a small number are caused by the early 
(postoperative) and late haematogenous seeding of bacteria from distant 
foci. The glycocalyx, a slime layer produced by bacteria, plays a major 
role in the pathogenesis. Biomaterials and debris from wear, impair the 
local immune response in various ways. 
Prophylaxis 
Clean-air systems reduce the rate of infection by half; when used in 
combination with body-exhaust gowns an additional 25% reduction is 
achieved. Concurrent perioperative antibiotics result in a four to sixfold 
reduction. 
The above-mentioned measures in combination with clean air, produce 
a supplementary effect, resulting in a few infections per thousand opera-
tions. Antibiotic-loaded cement is advised in high-risk patients, but fur-
ther controlled trials are needed to evaluate the efficacy, especially in 
primary procedures. 
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Diagnosis 
In prosthesis-related infections, vanous tests including physical exami­
nation, preoperative laboratory tests e g ESR and C-reactive protein, 
serial radiography, isotope scanning techniques and aspiration cultures 
may be helpful, but they will never completely prove or exclude the 
existence of infection During a revision operation, a frozen section of 
the interface may assist with the diagnosis, but a definitive diagnosis can 
only be made on the basis of multiple biopsy cultures, for which special 
cultunng techniques should be used 
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Chapter III 
Joint sepsis after propylaxis with one or three 
doses of cefuroxime in 2651 hip replacements 
A randomized controlled multicentre trial 
A.B. Wymenga*, J.R. van Horn', A. Theeuwes**, 
H.L. Muytjens-, T.J.J.H. Slooff 
Summary 
The efficacy of infection prophylaxis in hip replacement with one penoperatwe dose of 
cefuroxime was evaluated in a randomized controlled multicentre study, using a three 
dose regimen as a control. All the operations were performed in conventionally-venti-
lated operating theatres. Of the 2796 hip replacements that entered in the study, 145 
replacements were excluded due to protocol deviations. The remaining 2651 hip 
replacement were analysed: 1327 and 1324 in the one and three dose group, respec-
tively. 
There were no differences between the one dose group and the three dose group regard-
ing the incidences of postoperative woundheahng problems, urinary tract or other dis-
tant infections. The use of additional antibiotics prescribed after the penoperatwe pro-
phylaxis, did not differ either between the treatment groups. 
After a meanfollow-up of 13 month, joint sepsis was diagnosed in 11 of the patients 
in the one dose group (0.83%, 95% confidence limits 0.33-1 32%) and in 6 of the 
patients in the control group (0.45%, 95% confidence limits 0.08-0.81%). This 
difference was not significant (one tailed chi-square test, p > 0.05). The estimated 
difference between the one dose and three dose groups was 0.38% (95% confidence 
upper limit 0.9%>). Therefore, it could not be confirmed that the efficacy of one dose 
was equal to that of three doses. However, the incidence of joint sepsis in this study was 
too small to draw definite conclusions. An extended follow-up, with probably more 
cases of joint sepsis, may provide more conclusive data. Until then a three dose regimen 
is recommended. 
= Department of Orthopaedic Surgery, = Medical Statistics Department, - Department of 
Microbiology, St Radboud Hospital, University of Nijmegen 
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Introduction 
Perioperative systemic antibiotics in hip replacement form a very effec-
tive means of reducing the incidence of joint sepsis14. There is, however, 
no consensus on the optimal duration of antibiotic prophylaxis in joint 
replacementJ"B. A duration of 24 hours is currently recommended in 
joint replacement surgery9, but there is a trend towards further reduc-
tion to a single dose in orthopaedics6810 as well as in other surgical 
fields1"2. 
In order to establish the efficacy of a single perioperative antibiotic dose 
for infection prophylaxis in joint replacement surgery, a randomized 
controlled multicentre study was performed. Cefuroxime, a second ge-
neration cephalosporin with a half-life of 70 minutes, was chosen 
because this antibiotic provides a broad spectrum of activity against the 
organisms which cause joint sepsis in orthopaedic implants'3. 
Patients and methods 
Assuming that the incidence of joint sepsis is 1 % with a three dose regi-
men, we estimated that at least 1250 patients were needed in each treat-
ment group to detect a difference of 1% joint sepsis, on the basis of a 
one-sided type I error of 5% and a type II error of less than 20% (one-
tail test). A difference of less than 1% (which is less than twice the inci-
dence in the three dose regimen) would mean that the single dose was 
equally effective. 
A study population of 1250 hip replacements per treatment group was 
sufficient to ensure that the upper 95% confidence limit (one-sided) for 
the difference between joint sepsis rates was almost certainly smaller 
than 1% (80% probability), given a joint sepsis rate of 1% in both 
groups14. 
Using these criteria, only rather large relative differences can be detec-
ted, but given the low incidence of joint sepsis, a detectable difference of 
1 % was considered to be adequate for estimating the efficacy of a single 
dose. If we were to employ a smaller detectable difference, the trial 
would require several thousands of operations more in each arm, which 
is impracticable. 
Twenty-seven Dutch hospitals participated in the study from 1 July 
1986 to 1 July 1988. Only centres with conventionally-ventilated oper-
ating theatres took part and local ethical committees approved the pro-
tocol. 
Patients undergoing total hip replacement, hemi-arthroplasty of the hip 
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or total knee replacement were eligible for inclusion in the study. The 
exclusion criteria were allergy to cephalosporin, penicillin anaphylaxis, 
the use of antibiotics less than 48 hours before the operation, the use of 
perioperative antibiotics other than cefuroxime, malignancy in the 
operated joint, former or current sepsis in the joint and the use of gen-
tamicin-impregnated bone cement for fixation of the prosthesis compo-
nents. 
Randomization of the prophylaxis regimen was performed using a com-
puterized list in blocks of ten numbers. For every eligible patient, an 
envelope containing a self-adhesive label with the prescribed dosage, 
was opened sequentially. The label was placed on the patient records 
and anaesthesia list. Thus the treatment was not blinded. For logistic 
reasons, a number of centres randomized all the patients and exclusions 
were performed after the operation. 
Cefuroxime at a dose of 1500 mg was administered intravenously to 
both groups at the induction of anaesthesia, 30 minutes before the first 
incision. In the three dose group, a second and third injection of 750 mg 
cefuroxime was given after 8 and 16 hours. Three centres rinsed the 
wound with a fluid containing an antibiotic; 2 centres used povidone 
iodine to rinse the wound. 
Definitions 
The clinical end point of the study was joint sepsis, reoperation or 
death. 
- Confirmed joint sepsis was defined as a positive bacteriological culture 
at reoperation or a draining binus. Strong evidence of sepsis was 
defined as four or more 'possible signs of infection'. These two groups 
of conditions were analysed together (category I). 
- In patients who only showed two or three possible signs of sepsis (ca-
tegory II) a definite diagnosis could not be made. Patients with one or 
no signs (category III) were not suspected of having joint sepsis. 
The conditions which were defined as being possible signs of infection 
at follow-up were: pain during weight-bearing and/or at rest, tender-
ness of the wound, fever, an abnormal X-ray (periostial reactions, pro-
gressive bone resorption), an increased ESR (more than 20 mm above 
the preoperative value or > 35 mm), positive culture in the joint fluid 
aspiration, a positive arthrogram, a bone scan showing the typical signs 
of infection or an increased C-reactive protein. 
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- Wound infection in the postoperative period, was defined as erythema 
more than one centimetre from the incision. 
- Minor postoperative woundhealing problems were defined as erythe-
ma of the wound less than one centimetre from the incision, pus 
suture, small wound dehiscence, necrosis of the wound edge and blis-
ters. 
- Distant infections were usually diagnosed on the basis of positive cul-
tures. A urinary tract infection was defined as bacteriuria of more 
than 101 bacteria/ml. Blood cultures of Staphylococcus epidermide were 
only considered positive when cultured at least twice. A few lung, skin 
and other infections were diagnosed clinically. 
Additional antibiotics prescribed after the perioperative period for 
wound and/or distant infections or other reasons, were also recorded. 
The amount of antibiotic was expressed in Defined Daily Doses which 
is based on the main indication and expressed as the weight of active 
substance15. 
Patients undergoing total knee replacement surgery were also eligible 
for inclusion in the study and were stratified by the randomization pro-
cedure. A total of 455 operations were registered, 58 of which were 
excluded (12.7%) and 35 withdrawn (8.8%), leaving 362 operations (328 
patients) for analysis. Joint sepsis was diagnosed by follow-up in 3 out of 
the 175 (1.7%) operations in the single dose group and in 6 out of the 
187 operations (3.2%) in the three dose group. As these data differed 
considerably from those obtained from the hip operations, the knee 
arthroplasties cohort was analysed separately. 
The primary variable was joint sepsis (category I). Confidence limits 
(one-sided) were calculated for the differences, i.e. the ratio of the crude 
rates in both groups. Other outcome variables were compared by using 
a chi-square test (two-sided) with continuity correction. 
Results 
From 1 July 1986 to 1 July 1988, 3074 operations were registered. A 
total of 278 (9%) operations did not meet the criteria in the protocol 
and were excluded. The most frequent reason for exclusion was the use 
of gentamicin bone cement, which was often used in high risk patients. 
A number of centres did not enter their high risk patients in the study or 
they used gentamicin bone cement whereas other hospitals entered all 
the consecutive patients. 
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From the remaining 2796 operations, 145 (5%) were withdrawn, lea-
ving 2651 operations (2547 patients) for analysis (Table I). A separate 
follow-up of all withdrawn patients showed that all were free from joint 
sepsis. Data on 15 patients were lost during follow-up. The mean fol-
low-up duration was 13 months for both prophylaxis groups. 
'Tabk 1 Inclusion entena, exclusions and withdrawab (hip replacements) 
RANDOMIZED 
OPERA I IONS registered # 
EXCLUSIONS protocol 
FOLLOW-UP 
WITHDRAWN FROM ANALYSIS 
other type of antibiotic 
died within 7 days 
wrong dose or administration 
second hip replacement # # 
Numbc 
one dose 
1600 
1540 
r of operations 
141 (9 2%) 
1399 
72(5 
17 
4 
42 
9 
1%) 
three doses 
1599 
1534 
137(8 9%) 
1397 
73 (5 2%) 
16 
8 
35 
14 
total 
3199 
3074 
278 (9%) 
2796 
145(5 2%) 
33 
12 
77 
23 
SUITABLE FOR ANALYSIS 1327 1324 2651 
(# = in some patients, the operation was cancelled or a different procedure 
was performed, # # = dunng one hospital admission) 
The two trial arms were well-matched with respect to the general and 
orthopaedic diagnoses (Table II). The incidence of rheumatoid arthritis, 
diabetes, use of steroids and prosthesis failure, was low. With respect to 
the data on the operative procedure, there were no relevant difTerences 
between the groups. 
Joint sepsis was recorded in 11 patients (0.83%, 95% confidence limits 
0.33-1.32) in the one dose group and in 6 patients (0.45%, 95% confi-
dence limits 0.08-0.81) in the three dose group (Table III). This differ-
ence was not significant (p < 0.05, one tailed chi-square test). The esti-
mated difference in incidence of sepsis between the one and three dose 
group was 0.38% (95% upper confidence limit 0.9%). The estimated 
ratio was 1.83 with an upper confidence limit of 4.2. 
Joint sepsis was confirmed by a positive culture at reoperation and/or a 
draining sinus in fourteen patients. Three patients showed strong evi-
dence of joint sepsis, of whom two underwent reoperation for infection, 
but their perioperative cultures were negative. The joint aspirate from 
the third padent was found to contain Staphylococcus aureus. 
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lable ¡I Ornerai and orthopaedic charactemhcs (hip replacemenls) 
mean age yr SDj 
sex - male/female 
opcrali'd side - leil/riçhl 
mean quetclet index kç/m2 (SD) fmv] 
physical condition (moderate/poor) 
steroid use 
diabetes # 
cardiac disease # 
pulmonary disease # 
preoperative mlections 
no concurrent diseases # 
DIAGNOSIS 
osteoarthritis 
rheumatoid arthritis 
fracture (recent) 
other 
failed prosthesis 
osteotomy 
fratture osteosynthesis 
other earlier operations 
one dose 
n=1327 
69 1 (10 7) 
287/1010 
649/678 
26 2Π8)[216] 
206/19 
36 
42 
191 
86 
64 
823 
959 
83 
138 
35 
2b 
42 
33 
11 
ΊΎΡΕ Ol· RLPLACEMEN'I AND USE OF BONE CEMENT 
total hip cement a+ f+ 
a- f+ 
a+f-
a- f-
hemiarthroplasty +/-
revisions ivanous procedures) 
approach -(anlero)lateral/posterolatcral 
surgeon status -stall/resident 
mean blood loss in ml
 VSD [mvj 
mean operation time in minutes SD)[m\] 
breakdown ofstenhly (>9ü0/o hole in glove) 
863 
164 
4 
183 
79/8 
26 
439/888 
1245/82 
686 (422) [55] 
88 (31) [28] 
75 
three doses 
n=1324 
69 1 ^10 5) 
266/1058 
611/713 
26 5 Í4 0)[ 220] 
184/17 
33 
58 
171 
87 
67 
843 
954 
77 
120 
31 
40 
56 
30 
16 
859 
152 
4 
188 
71/10 
40 
422/902 
1242/82 
705 482)137] 
89(32)[161 
82 
((SD) = Standard Deviation, [mv] = number of missing values, a = acetabular 
component, Γ= femoral component, + = fixation with bone cement, - = fixation with­
out bone cement, # - more than one concurrent illness possible) 
Nine patients were diagnosed as having joint sepsis within one month 
after surgery. Five of these patients underwent early reoperation, com­
prising the evacuation of an infected haematoma or the excision of a 
sinus; four of these patients were functioning well at one year follow-up 
without signs of joint sepsis. One case of joint sepsis was diagnosed after 
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four monlhs, one after five months, two after 11 months, two after 14 
months, one after 18 and one after 24 months. There were two sepsis-
related deaths, one in each prophylaxis group, after one month (one 
dose group) and after five months (three dose group). 
At the five centres where the wound was rinsed during the operation 
with a fluid containing an antibiotic or povidone iodine, the incidences 
of joint sepsis were similar. 
After reoperation for mechanical reasons (n=64), four additional 
patients developed joint sepsis, three in the one dose group and one in 
the three dose group. These cases of joint sepsis were omitted from 
analysis, because reoperation was defined as an end-point in the study. 
Table III Joint sepsts wound healing, distant infections (hip replacements) 
joint sepsis (cat I) 
some signs of possible sepsis (rat II) 
postoperative wound infection 
minor woundhcahng disiurbances 
haematoma light 
moderate 
severe 
any wound drainage 
postoperative distant infections 
unnary tract 
pulmonary tract 
skin 
septicaemia 
one dose 
n=1327(%i 
11 (0 8) 
7 (0 4) 
25 (1 9) 
169(12 7) 
127 (9 6) 
94 (7 5) 
28 (2 1) 
166(12 5) 
201 (15 2) 
18 (1 4) 
31 (2 3) 
5 (0 4) 
three doses 
n= 13241%) 
6 (0 5) 
9 [0 7) 
31 (2 3) 
166(12 5) 
145(11 0) 
82 (6 2) 
44 [3 2) 
178(13 4) 
194(14 7) 
20 (1 5) 
26 (2 0) 
4 (0 3) 
ρ value 
xMest 
0 17# 
0 3 7 # # 
0 50 
0 89 
0 09 
051 
0 72 
0 88 
0 59 
0 99 
(# = one-sided, # # = category I + II analysed together one-sided) 
No significant differences were found between the groups with respect 
to postoperative wound infection, minor woundhcaling problems, 
haematoma and wound drainage, the amount of additional antibiotics 
prescribed for wound problems and temperature e causa ignota (Table 
III). 
Distant infections were not influenced by the method of prophylaxis 
(Table III). Most postoperative distant infections occurred in the urinary 
tract. In nine patients, septicaemia was documented during hospital 
admission, but only one patient developed subsequently joint sepsis. 
The amount of additional antibiotics prescribed for distant infections in 
both prophylaxis groups did not differ significantly (Table IV). 
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Table IV Additional postoperative antibiotics usage expressed in DDD# with number of replace­
ments (n) 
indication 
wound infection 
temperature ex.i 
distant infection 
other reasons 
one 
DDD 
1241 
416 
2040 
164 
dose (n= 
η 
48 
18 
196 
35 
= 1327) 
(%) # # 
(3.6) 
(1.4) 
(14.8) 
(2.6) 
three 
DDD 
1281 
356 
2072 
57 
doses (n 
η 
40 
18 
198 
24 
i=1324) 
(%) ## 
(3.0) 
(1.4) 
(15.0) 
(1.8) 
ρ value 
x
2
-test 
0.45 
1.00 
0.94 
0.15 
(# = Defined Daily Doses, # # = % of replacements) 
The number of (non)orthopaedic complications was well-matched 
between the groups (Table V). The number of invasive diagnostic pro­
cedures, such as gastroscopy, cystoscopy as well as operations per­
formed for general complications, was slightly higher in the one dose 
group. There was no difference between the number of patients who 
died in the hospital. During follow-up, the number of patients who died 
due to cardio-respiratory disease was higher in the one dose group, but 
no relation with sepsis could be found. 
Only five of the patients in our study group (0.2%) suffered allergic 
reactions associated with cefuroxime of which two were withdrawn 
from the analysis because they did not receive the full three doses. Ana­
phylactic shock was not registered. 
Table V Complications, adverse effects and mortality (hip replacements) 
orthopaedic complications 
orthopaedic reoperation (also in f-up) 
non-orthopaedic complications 
non-orthopaedic operations 
invasive diagnostic procedures 
adverse reactions cefuroxime 
died in hospital 
died during follow-up < 1 year 
> 1 year 
one dose 
η (%) 
48 (3.6) 
33 (2.5) 
47 (3.5) 
18(1.4) 
12 (0.9) 
1 (0.1) 
11 (0.8)## 
43 (3.2) 
18(1.4) 
three doses 
η (%) 
46 (3.5) 
31 (2.3) 
45 (3.4) 
7 (0.5) 
5 (0.4) 
2 (0.2)# 
5 (0.4)## 
30 (2.3) 
13(1.0) 
ρ value 
x
2
-test 
0.92 
0.91 
0.92 
0.046 
0.15 
0.99 
0.21 
0.20 
(# — two additional patients in the three dose group suffered from adverse reactions 
[withdrawn from analysis]. # # = four additional patients in the one dose group and 
eight in the three dose group died within 7 days [withdrawn from analysis - Table Ц) 
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Discussion 
A low number of high risk patients were included in this series due to 
limited entry and exclusion because the use of gentamicin-impregnated 
bone cement. The follow-up was also relatively short and both factors 
may have influenced the sepsis rate, which was much lower than the 
expected 1%. Nevertheless, our overall incidence of 0.64% compares 
well with the 0.84% and 0.7% joint sepsis reported by Lidwell4 and Hill1 
in patients operated in conventionally-ventilated operating theatres 
receiving prophylactic antibiotics. 
The incidence of joint sepsis in the single dose group was almost double 
that in the three dose group (0.83 versus 0.45%); the numbers were 
small and the différence was not significant (p > 0.05). However, this 
negative chi-square test did not prove that the treatments were equally 
effective, since the confidence limits were so wide as that they included 
the possibility oflarge underlying differences. 
The one-sided 95% confidence limits of the difference between the sin-
gle dose group and the control group had a range of up to 0.9% and a 
ratio up 4.2 . Thus ultimately a more than doubled incidence could 
occur in the one dose group. This was, by the criteria set before the trial 
started, defined as unacceptable. The equal efficacy of the single dose of 
cefuroxime compared with three doses could therefore not be con-
firmed. Our trial sample with a low incidence of joint sepsis, was too 
small to draw definite conclusions. An extended follow-up, with proba-
bly more low grade infections diagnosed10, may provide more conclusive 
data. We are now planning a 3-year follow-up evaluation. 
The data on woundhcaling problems were comparable with other 
reported series1 " 1 β although the definitions varied to some extent. In 
this study, the incidence of postoperative minor woundhealing pro­
blems, wound drainage and wound infection as well as the amount of 
antibiotic prescribed for wound problems and temperature e causa 
ignota, was not influenced by one dose or three doses of antibiotic pro­
phylaxis. 
The urinary tract was the most frequent site of distant infection and the 
15% incidence was somewhat higher than the 4-9% reported in other 
studies'7'". This may be related to the large proportion of patients who 
received an urinary catheter postoperatively'9. In one study, in which a 
5-day regimen was compared to a placebo, the incidence of urinary 
tract infection was reported to be 5.8 and 9.9%, respectively3. In our 
series, no difference in the incidence of various postoperative distant 
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infections was found between the single and triple dose regimen. The 
amount of additional antibiotics prescribed for distant infections and 
other reasons was also similar in both groups. Adverse events associated 
with of cefuroximc were reported in only five patients (0.2%). 
We were unable to confirm that the efficacy of a single perioperative 
dose of cefuroxime was equal to that of a three dose regimen, since 
there remains a considerable possibility that more than twice the inci-
dence of sepsis could occur when more operations are performed The 
numbers of joint sepsis were too small to draw definite conclusions. A 
three dose regimen of cefuroxime is therefore recommended in hip 
replacement surgery until further data become available from an 
extended follow-up. 
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Chapter IV 
Joint sepsis after prophylaxis with one or three 
doses of cefuroxime in 362 knee replacements 
A randomized controlled multicentre study 
A.B. Wymenga", J .R. van Horn' , A. Theeuwes", 
H.L. Muytjens-, T J J . H . SloofF 
Summary 
The efficacy of infection prophylaxis in knee replacement using one penoperative dose 
of cefuroxime was evaluated in a randomized controlled multicentre study. A three 
dose cefuroxime regimen was used as a control. All the operations were performed m 
conventionally-ventilated operating theatres. From the 455 operations registered, 58 
were excluded and 35 were withdrawn, leaving 362 operations (345 patients) for 
analysis, 175 in the one dose group and 187 in the control group. 
There were no differences between the incidence ofhaematoma and minor postopera-
tive woundhealmg problems, but there were more wound infections in the three dose 
group. The incidence of unnary tract and other distant infections as well as the 
amount of additional antibiotics used after the prophylaxis were similar in both 
groups. 
During a mean follow-up of 12 months, joint sepsis was diagnosed in 3 out of the 
175 operations in the one dose group (1.7%, 95% confidence limits 0 09-3 33%) 
and in 6 out of the 187 operations in the control group (3.2%, 95% confidence li-
mits 0.63-5.77%). This différence was not significant (one tailed chi-square test, p 
> 0.05). Confidence limits of the difference between the one dose group and the three 
dose group revealed that with many more operations performed, the incidence of joint 
sepsis in the one dose group may ultimately be 1.78% higher. The trial sample of the 
present study however, is too small to draw definitive conclusions about the efficacy of 
a single dose m hrge patient populations. 
7he mean incidence of joint sepsis in knee replacements (2.45%) was nearly four 
times higher than the incidence in hip rephcements performed at the same hospitab 
and using the same infection prophylaxis. The use ofgentamicin bone cement is re-
commended in high nsk patients. 
— Department of Orthopaedic Surçcry, = Medical Statistics Department, = Department of 
Medical Microbiology, St Radboud Hospital, Lmversity of Nijmegen 
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Introduction 
Joint sepsis in total knee arthroplasty remains a major clinical problem' 
and it is the second most common reason for failure'. Perioperative sys-
temic antibiotics are very effective in reducing the incidence of joint sep-
sis1 and a 24-hour prophylaxis regimen is currently advised in joint 
replacement surgery4. In the past decade, a trend towards further reduc-
tion to a single dose has been noted in orthopaedic surgeryJ 7 as well as 
in other surgical fields"0. 
In order to establish the efficacy of a single perioperative dose for infec-
tion prophylaxis, a randomized controlled multicentre study was per-
formed on hip and knee replacements10. The two operations could not 
be analyzed together, because the patient characteristics and the results 
of the knee replacements differed considerably from the hip replace-
ments. 
The purpose of this chapter is to report on a separate analysis of the 
knee replacements in relation to the incidence of joint sepsis, wound-
healing problems and distant infections, after the application of infec-
tion prophylaxis using one dose or three doses of cefuroxime. 
Patients and methods 
The study population in this trial comprised the total knee replacements 
performed at twenty-two hospitals in the period from 1 July 1986 to 1 
July 1988. Only hospitals with conventionally-ventilated operating the-
atres were invited to participate; the local ethics committees approved 
the protocol. Before the trial started, the assumed incidence of joint sep-
sis was 1% and the detectable difference was set at 1%'°. An increased 
incidence of joint sepsis of less than 1% in the one dose group (which is 
less than twice the incidence found in the three dose group) was consi-
dered to be acceptable. As knee replacements are performed fairly infre-
quently, the number of replacements in this separate analysis was too 
small to meet the statistical requirements for the evaluation of conserva-
tive therapy". 
Patients who underwent total knee arthroplasty were eligible for inclu-
sion in the study. The exclusion criteria were cephalosporin allergy, 
penicillin anaphylaxis, the use of antibiotics less than forty-eight hours 
before operation, the use of perioperative antibiotics other than cefuro-
xime, malignancy in the operated joint, former or current sepsis in the 
joint and the use of gentamicin-impregnated bone cement for fixation of 
the prosthesis components. In one patient, tuberculous joint sepsis was 
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diagnosed. She was excluded retrospectively, because she had acquired 
this joint infection before the operation. 
Randomization of the prophylaxis regimen was performed with a com-
puterized list in blocks of ten numbers. For every eligible patient, an 
envelope was opened sequentially. From the envelope a self-adhesive 
label with the prescribed dosage on it was entered on the patient's 
records and anaesthesia records. Thus the treatment was not blinded. 
For logistic reasons, a number of centres randomized all the patients 
and exclusions were performed after the operation. 
Cefuroxime is a second generation cefalosporine which provides a 
broad spectrum of activity against the organisms which cause joint sep-
sis in orthopaedic implants'^. Both prophylaxis groups received an intra-
venous injection of 1500 mg cefuroxime at the induction of anaesthesia, 
thirty minutes before the incision and at least 20 minutes before the 
inflation of the tourniquet. This ensured adequate bone and soft tissue 
concentrations throughout the operation13. In the three dose group, a 
second and third dose of 750 mg cefuroxime was administered intra-
venously after 8 and 16 hours, respectively. Three centres rinsed the 
wound with a fluid containing an antibiotic and two centres used povi-
done iodine. 
Definitions 
The clinical end point of the study was joint sepsis, reoperation or 
death. 
- Confirmed joint sepsis was defined as a positive culture at reoperation 
or a draining sinus. Strong evidence of sepsis was defined as four or 
more 'possible signs of infection'. These two groups were analysed 
together (category I). 
- In patients who only showed two or three possible signs of sepsis (cate-
gory II) a definite diagnosis could not be made. Patients with one or no 
signs (category III) were not suspected of having joint sepsis. 
The conditions which were defined as being possible signs of infection 
at follow-up were: pain during weight-bearing and/or at rest, tender-
ness of the wound, fever, an abnormal X-ray (periostial reactions, pro-
gressive bone resorption), an increased ESR (20 mm above the preoper-
ative value or > 35 mm), positive culture in the joint fluid aspiration, a 
positive arthrogram, a bone scan showing the typical signs of infection 
or an increased CRP. 
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- Wound infection in the postoperative period, was defined as erythema 
more than one centimetre from the incision. 
- Minor postoperative woundhealing problems were defined as erythe-
ma of the wound less than one centimetre from the incision, pus 
suture, small wound dehiscence, necrosis of the wound edge and blis-
ters. 
- Distant infections were usually diagnosed on the basis of positive cul-
tures. A urinary tract infection was defined as bacteriuria of more 
than 105 bacteria/ml. Blood cultures of Staphylococcus epidermidis were 
only considered positive when cultured at least twice. A few lung, skin 
and other infections were diagnosed on a clinical basis. 
Additional antibiotics prescribed after the perioperative period for 
wound and/or distant infections or other reasons, were also recorded. 
The amount of antibiotic was expressed in Defined Daily Doses, which 
is based on the main indication and expressed as the weight of active 
substance11. 
The primary variable in the statistical analysis was joint sepsis (category 
I). Confidence limits (one-sided) were calculated for the difference and 
for the ratio of the crude rates in both groups. Other outcome variables 
were compared by using the chi-square test (two-sided) with a continuity 
correction. 
Results 
From 1 July 1986 to 1 July 1988, 455 operations were registered (Table 
I). On the basis of the criteria laid down in the protocol, 58 operations 
were excluded, the main reason being the use of gentamicin bone 
cement. From the remaining 397 knee replacements, 35 were with-
drawn owing to protocol deviations, leaving 362 replacements (345 
patients) for analysis. 
A separate follow-up (not included in the analysis) was performed on all 
the withdrawn patients. One patient in the one dose group had devel-
oped joint sepsis (Table III) and was also found to have received an 
incorrect dose. 
At many of the hospitals, knee replacement, unlike hip replacement, 
was not a routine procedure. Nine hospitals contributed less than 10 
replacements to the trial and only eight contributed more than 20. The 
mean follow-up period was twelve months in both groups. None of the 
patients were lost to follow-up. 
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Tabk I Entrance entena, exclusions and imthéawab (knee replacements) 
Number of operations 
one dose three doses total 
RANDOMIZED 
OPERAI IONS repstcred # 
EXCLUSIONS protocol 
FOLLOW-UP 
246 
225 
249 
230 
"ЮЗ 
455 
3 3 ( 1 4 7%) 25 ( 10 9%) 5 8 ( 1 2 7%) 
192 205 397 
W I T H D R A W N F R O M ANALYSIS 
other type of antibiotic 
died within 7 days 
wrong dose or administration 
second replacement # # 
17 
4 
-
11 
2 
(8 9%) 18 
1 
-
13 
4 
(8 8%) 35 (8 8%) 
5 
-
24 
6 
SUITABLE F O R ANALYSIS 175 187 362 
(# = in some patients, the operation was cancelled or a different procedure was 
performed, # # = during one hospital admission) 
The general and orthopaedic characteristics (Table II) of the prophylax­
is groups were well-matched, except for the increased incidence of car­
diac disease in the three dose group. The number of previous operations 
was also slightly increased in the three dose group. The peroperative 
data were well-matched in both trial arms. 
Table II General and orthopaedic characteristics (knee replacements) 
mean age yr (SD) 
sex - male/female 
operated side - left/nght 
mean quetelet index (SD) 
physical condition (moderate) 
steroid use 
diabetic # 
cardiac disease # 
pulmonary disease # 
preoperative infections 
no other concurrent illness # 
DIAGNOSIS 
osteoarthritis 
rheumatoid arthritis 
prosthesis failure 
other previous operations 
one dose 
n=175 
70 6 (9 6) 
23/152 
80/95 
27 2 kg/m2 (4 5) 
36 
17 
9 
9 
6 
16 
95 
101 
41 
2 
31 
three doses 
n=187 
71 1 (9 3) 
23/164 
89/98 
27 4 kg/m2 (4 5) 
39 
17 
8 
24 
6 
23 
95 
89 
51 
5 
42 
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Table II continued 
ΊΎΡΕ OF REPLACEMENT 
bone cement used 
non-constrdined prosthe4is## 
status of surgeon staiT/resident 
mean blood loss (SD)[mv] 
mean operation time (SD)[mv] 
breakdown of sterility 
(> 90% hole in glove) 
one dose 
η=17τ 
m 
145 
167/8 
361(310)[89] 
105(26)[3] 
5 
three doses 
n=187 
141 
148 
177/10 
322(248) [79] 
107(29) [-] 
10 
i4(SDi = standard deviation, fmv] = number of missing values, # = more than one 
concurrent illness per patient possible, # # = majority of other prosthesis were 
semiconstrained except one constrained prosthesis in each group) 
No significant differences were found between the two prophylaxis 
groups with respect to haematoma, minor woundhealing problems, 
wound drainage and the amount of antibiotics (in DDD) prescribed for 
wound problems and temperature e.c.i. (Table III). The incidence of 
wound infections was higher in the three dose group, but the numbers 
were very small (9 versus 4). 
Joint sepsis was diagnosed in three patients in the one dose group 
(1.71%, 95% confidence limits 0.09-3.33%) and in six patients in the 
three dose group (3.20%, 95% confidence limits 0.63-5.77%). The esti­
mated difference between the incidence of joint sepsis in the one dose 
group minus the three dose group was -1.49% (95% upper confidence 
limit 1.78%). The estimated ratio was 0.53 with an 95% upper confi­
dence limit of 1.69. 
Joint sepsis was confirmed by a positive culture at reoperation and/or a 
draining sinus in eight patients; in the remaining patient, there was 
strong evidence of joint sepsis. Joint sepsis was diagnosed in three cases 
within one month, in three more cases after three months, in one case 
after four months, in one after five months and a further one after ten 
months. 
Six of the nine patients with joint sepsis were also found to be suffering 
from rheumatoid arthritis: two in the one dose group and four in the 
three dose group. There were two joint sepsis-related deaths, one in 
each prophylaxis group; both were suffering from rheumatoid arthritis. 
The final outcome in three other patients with joint sepsis was arthrode­
sis, resection arthroplasty and amputation, respectively. In two cases, 
reimplantation was performed. 
50 
Three out of the 26 patients who underwent 'mechanical' reoperation 
subsequently developed joint sepsis. They were not included in the ana­
lysis because reoperation was defined as an end-point in the study. 
Table III Joint sepsu, woundhealmg, distant infection (knee replacements) 
joint sepsis (cat. I) 
signs οΓ possible sepsis (cat. II) 
postoperative wound infection 
minor woundhealing disturbances 
any wound drainage 
haematoma: slight 
moderate 
severe 
postoperative distant infections: 
urinary tract 
pulmonary tract 
other 
septicaemia 
one dose 
η (%) 
3 (1.7)S 
1 (0.6) 
4 (2.3) 
33 (18.9) 
30(17.1) 
19(10.9) 
23(13.1) 
5 (2.9) 
32 (18.3) 
3 (1.7) 
2 (1.1) 
-
three doses 
η (%) 
6 (3.2) 
5 (2.7) 
9 (4.8) 
35 (18.7) 
38 (20.3) 
13 (7.0) 
26(13.9) 
9 (4.8) 
34(18.8) 
4 (2.1) 
1 (0.5) 
2 (1.1) 
p-valuc 
xMest 
0.89 # 
0.98 # # 
0.31 
0.92 
0.52 
0.47 
0.91 
0.79 
0.95 
0.51 
($ = one withdrawn patient in the one dose group developed joint sepsis, 
# = one-sided, # # = category I + II analysed together one-sided) 
The incidence of distant infections was not influenced by the one dose 
or three dose regimen (Table III). Most distant infections occurred in 
the urinary tract. There were two patients with documented septi­
caemia (positive blood culture). The amount of antibiotics (in DDD) 
prescribed for distant infections and other reasons in both treatment 
groups did not differ (Table IV). 
Table IV Amount of additional postoperative antibiotics used (expressed in DDIM with number of 
knee replacements (n)) 
indication 
wound 
temperature cci 
distant infection 
other reasons 
one 
DDD 
387 
99 
382 
6 
dose (n: 
η 
11 
8 
30 
7 
= 175) 
(%;## 
(6.3) 
(4.6) 
(17.1) 
(4.0) 
three doses ( 
DDD 
389 
140 
355 
6 
η 
15 
7 
38 
5 
n=187) 
(%)## 
(8.0) 
(3.7) 
(20.3) 
(2.7) 
ρ value 
x^-test 
0.66 
0.90 
0.52 
0.94 
(# = Defined Daily Doses, # # = percentage of knee replacements) 
There was no difference in the number of orthopaedic and non-
orthopaedic complications between the groups (Table V). In the three 
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dose group, the number of orthopaedic reoperations more than doubled 
that in the one dose group. This was mainly due to reoperations per­
formed for patellofcmoral problems, without any relation to sepsis. The 
incidence of adverse events associated with cefuroxime was low (0.5%). 
Table V Complwatwns, adverse effects and mortality 
orthopaedic complications 
orthopaedic reoperation (also f-up) 
non-orthopaedic complications 
non-orthopaedic operations 
adverse events cefuroxime# 
death in hospital 
death during follow-up 
one dose 
η (%) 
4 (2.3) 
8 (4.6) 
6 (3.4) 
3(1.7) 
2(1.1) 
1 (0.6) 
5 (2.9) 
three doses 
η ел.) 
5 (2.7) 
18 (9.6) 
5 (2.7) 
5 (2.7) 
-
-
9 (3.2) 
ρ value 
x
2
-tcst 
0.92 
0.097 
0.91 
0.79 
-
0.69 
(# - no anaphylactic shock was registered) 
Discussion 
In this series of total knee replacements, the number of high risk 
patients was reduced due to their limited entry and the exclusion criteri­
on regarding the use of gentamicin bone cement. These factors in addi­
tion to the relatively short period of follow-up, may have reduced the 
sepsis rate in the trial. The fact that knee replacement, unlike hip 
replacement, was not a routine procedure at several hospitals, may also 
have influenced the incidence. 
The overall incidence in this trial of 2.45% is well-matched with the 
incidences mentioned in other series, which vary from a minimum of 
1.3% up to a maximum of 4.4% using systemic antibiotics and, in the 
majority of cases, a two or three compartmental prostheses1,2,15'10. 
The incidence of joint sepsis in the three dose group was double that in 
the one dose group, as was the number of wound infections. This differ­
ence was most unexpected, because more antibiotics were given in the 
three dose group and the groups were reasonably well-balanced with 
respect to patient characteristics (Table II). The difference between the 
treatment groups was not statistically significant (p > 0.05). This did not 
prove that the treatments were equally effective, since the confidence 
limits were so wide that they included the possibility of large underlying 
differences, from very low percentages to an extreme of more than 5% 
in the three dose group. The confidence limits of the difference between 
the one dose and the three dose group showed that an even higher inci-
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dence (max. 1.78% more joint sepsis) may be possible in the one dose 
group with more operations performed. These wide margins indicate 
that the number of patients is too small to be able to draw definitive 
conclusions regarding the efficacy of a one dose regimen of cefuroxime. 
Apart from joint sepsis and postoperative wound infection, no differ­
ences were found between the one dose and three dose group with 
respect to minor woundhealing problems, wound drainage, haematoma 
and the amount of antibiotics (in DDD) prescribed for wound problems. 
The overall incidence of woundhealing problems was high, but lay 
within the range of 5-25% reported in other series15·17·'9,20. Perioperative 
wound rinsing with povidone iodine or a fluid containing an antibiotic, 
did not influence the incidence of joint sepsis. 
We did not find any difference between the two prophylaxis groups 
regarding the incidence of urinary tract and other postoperative distant 
infections, nor in the amount of antibiotics (in DDD) used to treat these 
infections. It is not likely that a short course of perioperative antibiotics 
would exert any influence on urinary tract infections. The incidence is 
probably more determined by the rate and duration of catheteri­
zation21·22. 
Bearing in mind that all the total knee replacements and hip replace­
ments were operated on by the same surgeons, using the same prophy­
laxis regimen, at the same hospitals, it is quite remarkable that there 
was such a difference between the incidence of joint sepsis (2.45% and 
0.65%, respectively)10. Rheumatoid arthritis may have been partly 
responsible for this difference, as it has proved to be an important risk 
factor for joint sepsis in other series1,2'"'"18·23. In this series of total knee 
replacements, 6 out of the 107 patients with rheumatoid arthritis devel­
oped joint sepsis (5.9%), whereas only 3 out of the 255 (1.18%) without 
rheumatoid arthritis developed joint sepsis24. 
In order to find methods for reducing the higher incidence of joint sep­
sis in knee replacements performed in conventionally-ventilated operat­
ing theatres, trials with additional prophylactic measures, such as gen-
tamicin bone cement23, should be performed on patients undergoing 
cemented knee replacement. The routine use of gentamicin bone 
cement is certainly recommended in patients with rheumatoid arthritis 
and/or other risk factors. 
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Chapter V 
Risk factors for joint sepsis in hip replacement 
An analysis of 2651 operations 
A.B. Wymenga*, J.R. van Horn*, A. Theeuwes**, 
H.L. Muytjens-, TJ.J.H. Slooff 
Summary 
Ruk factors associated with joint sepsis were investigated in 2547 patients with 
2651 hip replacements who were examined m a prospective multicentre trial. The 
operations were performed in the period from 1 July 1986 to 1 July 1988 at 27 
hospitaL· with conventionally-ventilated operating theatres. All the patients received a 
short course of penoperative cefuroxime. After a mean follow-up of 13 months, joint 
sepsis was diagnosed in 17 patients(0.64%). 
The following factors were found to be associated with an increased nsk ratio (RR) 
for joint sepsis: diabetes(RR=3.7), failedfracture osteosynthesis(RR—5.4), a break­
down ofstmlity(RR=3.4) and surgical reintervention (RR=9.5). 
Patients who siifferedfrom wound infection offer the operation ran a very high nsk of 
developing joint sepsis (RR-62.2). In patients for whom it was indicated to perform 
wound or blood cultures, it was 11.6 and 7.3 times as high as in patients without 
these signs and symptoms, respectively. In patients with a unnary tract infection, the 
nsk was 4.9 times increased. Risk factors at discharge from hospital were an 
unhealed wound (IIR=22.2) and a slow reconvalescence penod (RR—5.2). 
The use of gentamicin bone cement as an additional prophylactic measure might 
reduce the incidence of joint sepsis in high nsk patients and its application и therefore 
recommended in these patients. Patients with diabetes should be carefully prepared 
and monitored dunng the penod of hospitalization. 
If patients develop a wound infection, adequate antibiotic therapy should be instiga­
ted, with its course guided by the wound culture results. Minor woundhealing pro­
blems do not form an indication for antibiotic treatment. In patients with a wound 
infection and a draining haematoma, surgical evacuation might salvage the joint as 
we found in 3 out of our 4 patients. Patients who are discharged from hospital with 
an unhealed wound or a slow rate of reconvalescence, should receive adjunctive follow-
up care. 
- Department of Orthopaedic Surgery, = Medical Statistics Department, = Department 
of Medica] Microbiology, St Radboud Hospital, University of Nijmegen 
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Introduction 
Joint sepsis after hip replacement is a devastating complication. The 
incidence is related to environmental factors, such as air contamination 
and the use of perioperative antibiotics612'6 From the data obtained 
during a large multicentre study, Lidwell et al." calculated that in con­
ventionally-ventilated operating theatres, approximately 90-95% of the 
cases of joint sepsis were initiated during the operation. The application 
of perioperative antibiotics has been reported to achieve a four to six­
fold reduction in the incidence of joint sepsis'' ' ' 2\ 
Besides environmental factors, individual patient characteristics also 
play an important role in the development of joint sepsis. For example, 
the preoperative medical and orthopaedic diagnoses, characteristics of 
the operative procedure and postoperative events all demonstrate a 
relationship with joint sepsis. The importance of any particular risk fac­
tor may vary at the various levels of joint sepsis. 
The purpose of this study was to investigate the risk factors which are 
associated with joint sepsis in 2651 hip replacements in 2547 patients, 
all operated on in conventionally-ventilated operating theatres, with a 
short course of perioperative antibiotic prophylaxis. 
Patients and methods 
From July 1986 to July 1988, a prospective randomized controlled trial 
was performed at 27 hospitals with conventionally-ventilated operating 
theatres, in order to investigate the efficacy of one dose of cefuroxime 
(1500 mg i.v. at the induction of anaesthesia) in hip replacement. 
Patients receiving a three dose cefuroxime regimen (perioperative dose 
1500 mg, subsequent doses of 750 mg i.v. after 8 and 16 hrs., respec­
tively) served as a control. 
Λ relevant summary is given in this section, as details were reported 
elsewhere'6. A total of 3074 hip replacements were eligible for entry into 
the trial, of which 278 were excluded. The most frequent reason for 
exclusion was the use of gentamicin-impregnated bone cement, which 
was used in high risk patients. This series therefore represents a rather 
homogeneous group of patients who underwent hip replacement proce­
dures, as a number of high risk patients were excluded. Further impor­
tant exclusion criteria were the use of other antibiotics and former or 
current sepsis in the joint. 
From the remaining 2796 hip replacements, 145 were withdrawn for 
the following reasons: the wrong type and/or dose of antibiotics had 
been administered, the patient died (not sepsis-related) within 7 days of 
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the operation or a second replacement had to be performed during the 
same period of hospitalization. This left 2651 hip replacements (2547 
patients) for analysis. 
In the analysis, the end point of participation in the follow-up was 
defined as reoperation or death, but a separate analysis was done on the 
reoperations (performed for mechanical reasons). The mean follow-up 
was 13 months. In the one dose group (n=1327), 11 patients suffered 
from joint sepsis (0.83%, 95% confidence limits 0.33-1.32) and in the 
three dose group, 6 patients (0.45%, 95% confidence limits 0.08-0.81). 
The estimated difference between the one dose group and the three 
dose group was 0.38% (95% confidence limits 0-0.9%). Therefore, we 
could not confirm that one dose of cefuroxime has the same prophylac­
tic efficacy as a three dose regimen in hip replacement. Λ longer follow-
up, which will probably lead to more diagnoses of joint sepsis, is needed 
to provide more conclusive data*6. 
Definitions 
- Confirmed joint sepsis was defined as a positive culture at reoperation 
or a draining sinus. 
- Strong evidence of joint sepsis was defined as four or more possible 
signs of sepsis (pain during weight-bearing and/or at rest, tenderness 
of the wound, fever, an abnormal X-ray with periostial reactions, pro­
gressive bone resorption, an increased ESR (20 mm above the preop­
erative value or > 35 mm), a positive culture in the joint fluid aspira­
tion, a positive arthrogram, a bone scan showing the typical signs of 
infection or an increased C-rcactive protein. 
- Wound infection in the postoperative period, was simply defined as 
erythema of the wound more than one centimetre from the incision. 
- Minor postoperative woundhealing problems were defined as erythe­
ma of the wound lesss than one centimetre from the incision, pus 
suture, small wound dehiscence, necrosis of the wound edge and blis­
ters. 
- Distant infections were usually diagnosed on the basis of positive cul­
tures. Urine cultures were considered positive if bacteriuria was pre­
sent with more than IO5 bacteria per ml. A few lung, skin and other 
infections were also diagnosed on a clinical basis. 
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Statistical analysis 
Joint sepsis rates within subgroups were estimated as crude rates. Uni­
variate analysis of all the potential risk factors was performed with the 
chi-square test. From all the risk factors tested, only those with a p-valuc 
of ρ < = 0.1 were considered significant. These, and a few other inter­
esting risk factors, are summarized in Tables la-d. 
The number of times the risk for joint sepsis is increased, can be 
expressed as the risk ratio (RR). 
% JOINT SEPSIS WITH RISK FACTOR 
RISK RATIO = 
% JOINT SEPSIS WITHOUT RISK FACTOR 
As it is possible for risk factors to be related to each other, their impor­
tance can be overestimated in a univariate analysis. To overcome this 
problem, a multiple logistic regression analysis was carried out. This 
method identifies the risk factors whose influence is independent of any 
other simultaneously occurring risk factor(s). In this way wc identified 
separate risk factors which have an additive effect on the risk of joint 
sepsis, i.e. the more factors a patient has, the higher the risk of joint sep­
sis. 
Four separate groups of risk factors were analysed: perioperative factors 
(la), postoperative factors (lb), cultures (1c) and risk factors at discharge 
from hospital (Id). Within each section, a regression analysis was per­
formed (Tables Ila-d). 
Results 
Joint sepsis 
Confirmed joint sepsis was diagnosed in fourteen patients. Three 
patients had strong evidence of joint sepsis, of whom two underwent 
reoperation for joint sepsis, but demonstrated negative cultures despite 
the clinical evidence. From the third patients, the joint aspirate grew 
Staphylococcus aureus. 
Preoperative and perioperative risk factors (Table la) 
In the univariate analysis, the following preoperative risk factors were 
not found to be associated (p > 0.1) with joint sepsis: sex, age, the 
cefuroxime dose (one dose or three doses), the quetelet index (kg/m2), 
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physical condition, number of days in hospital before the operation, 
preoperative infections of the urinary tract, lung or skin, a urine sedi­
ment with more than 5 leucocytes per field (400x), the use of steroids 
and the orthopaedic diagnosis. 
Patients with diabetes had an increased risk for joint sepsis. Patients who 
had previous surgery were also at risk. One revision of a failed cup 
arthroplasty out of 66 revisions became infected and for patients with 
failed fracture osteosynthesis the risk was even higher. In the group with 
other previous procedures (80% being osteotomies) no joint sepsis was 
diagnosed. 
From the perioperative risk factors, the surgical approach (lateral or 
posterolateral), the use of bone cement versus fixation without cement, 
the degree of difficulty of the operation, the operation time, the amount 
of blood loss and the status of the surgeon (staff or resident), did not dis­
play a significant relationship with joint sepsis. The results of routine 
cultures of the joint, sampled during the operation at several hospitals, 
were not related to joint sepsis either. 
During 6% of the operations, a breakdown of sterility occurred. In 
more than 90% of the cases, this was caused by a hole in the inner sur­
gical glove. Three patients (1.91%) in this group suffered from joint sep­
sis. During two operations, a glove ruptured and during another opera­
tion the close contact between the glove and the sleeve of the gown was 
lost. In one patient Staphyloccus epidermidis was cultured at reoperation, in 
two other patients joint cultures were not available. 
Tabk la Univariate nsk factor analysis: preoperative and penoperative data 
Risk factor 
diabetes 
no diabetes 
rheumatoid arthritis 
fracture (fresh/old) 
other diagnosis 
arthrosis 
prosthesis 
fracture osteosynth. 
other 
no previous surgery 
break in sterility 
complete sterility 
η 
100 
2551 
168 
334 
78 
2071 
66 
63 
125 
2397 
157 
2494 
Joint sepsis 
η (%) 
2 
15 
1 
4 
0 
12 
1 
2 
0 
14 
3 
14 
(2.00) 
(0.59) 
(0 60) 
(1.20) 
(0.00) 
(0.58) 
(1.52) 
(3.17) 
(0.00) 
(0.58) 
(1.91) 
(0.56) 
risk ratio 
3.4 
1.0 
2.1 
2.6 
5.5 
0 
3.4 
ρ value # 
0.08 
0.52 
0.05 
0.04 
(# = chi-squarc test, ρ < = 0.1 is significant) 
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Further analysis of the most important preoperative and perioperative 
risk factors derived from the multiple logistic regression analysis, showed 
that diabetes, failed fracture treatment and a breakdown of sterility, 
each acted as a separate risk factor for joint sepsis (Table Ha). This was 
validated by the observation that 6 out of the 291 patients with one or 
more of these three factors developed joint sepsis (1.9%), versus 11 out 
of the 2343 patients who did not display these factors (0.5%). 
Postoperative woundheahng and other factors (Table lb) 
Univariate analysis showed that the presence of minor woundhealing 
problems, the day of vacuum-drain removal and the use of an 
indwelling urinary catheter, were not related to joint sepsis. Moreover, 
orthopaedic complications (n=94), such as nerve damage, dislocations 
and fractures which were treated conservatively, were not related to 
joint sepsis, nor were non-orthopaedic complications (n=88) which 
mainly occurred in the cardiovascular and gastrointestinal tract. 
Patients who underwent additional non-orthopaedic surgery on the 
urinary tract (n=7), the gastrointestinal tract (n=10), pacemaker implan-
tation (n=3), skin necrotomy (n=4) and lower leg amputation (n=l) 
during the period of hospitalization, did not develop joint sepsis either. 
Moderate and severe hacmatomas were clearly related to joint sepsis in 
univariate analysis. Patients with early postoperative wound drainage 
were also more at risk or joint sepsis. The risk for patients with serous 
drainage was 4.5 times higher and the risk for patients with blood or pus 
draining from the wound was even higher. Discharge from the orifice 
arising more than 24 hours after the removal of the drain occurred fair-
ly often, but was less strongly related to joint sepsis. Postoperative 
wound infection was highly related to joint sepsis, 16% of these patients 
developed joint sepsis. Patients who had antibiotics prescribed for 
wound problems were also very much at risk for joint sepsis. 
The multiple logistic regression analysis of the postoperative data 
revealed that wound infection was the only factor which acted indepen-
dently (estimated RR = 62.2, Table lib). The other (univariate) risk fac-
tors for postoperative sepsis, such as wound drainage and antibiotics, 
were apparently only acting in association with wound infection. 
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Table lb Univariate nsk factor analysis postoperative woundheahng 
Risk factor 
haemaloma light 
moderate 
severe 
none 
wound drainage- serous 
blood 
pus 
none 
discharge drain onfice 
no discharge 
wound infection present 
no wound infection 
antibiotics for wound 
no antibiotics 
Joint sepsis 
η η (%) 
272 
181 
72 
2126 
295 
29 
20 
2307 
374 
2277 
56 
2595 
88 
2563 
1 
3 
2 
11 
4 
2 
4 
7 
5 
12 
9 
8 
8 
9 
(0 37) 
(166) 
(2 78) 
(0 52) 
(136) 
(6 90) 
(20 00) 
(0 30) 
(134) 
(0 53) 
(16 07) 
(0 31) 
(9 76) 
(0 35) 
nsk ratio 
0 7 
3 2 
5 3 
4 5 
23 0 
66 6 
2 5 
51 8 
27 9 
ρ value # 
0 03 
0 00 
0 07 
0 00 
0 00 
(# = chi-square test, ρ < = 0 1 is significant) 
Cultures of the wound and other sites (Table Ic) 
The number of postoperative gastrointestinal and lung cultures performed 
was small (n=42) and there was no relationship with laterjoint sepsis. 
Patients in whom there was an indication for performing a 
postoperative wound culture, were clearly at risk for joint sepsis and the 
risk was higher for patients with a positive culture. Patients with positive 
vacuum-drain cultures were also more at risk. 
The urinary tract was the most frequent site of distant postoperative 
infection (15%). Patients with this complication had an increased nsk of 
developing joint sepsis. Patients with skin infections (mainly skin ulcers 
and decubital sores on the sacrum and calcaneus) were also more at risk 
for joint sepsis. In the four patients with joint sepsis and sores, the sores 
developed after the operation. 
Patients in whom a blood culture was performed for elevated tempera­
ture and/or signs of infection, were at risk for joint sepsis. Nine patients 
had documented septicaemia (positive blood cultures) and one of them 
developed joint sepsis. She was not reoperated on and blood cultures 
could not be matched with the causative bacteria of joint sepsis. 
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The multiple logistic regression analysis (Table lie) showed that wound 
cultures (positive or negative), positive postoperative urine cultures and 
blood cultures (either positive or negative) were risk factors which acted 
independently in relation to joint sepsis. Validation showed that in the 
patients with one or more of these factors (n=533), 14 (2.62%) suffered 
from joint sepsis, whereas there were only three cases (0.14%) in the 
patients without these factors (n=2118). 
Table Ic Univariate ruk factor analysis wound and other cultures 
Risk factor 
wound culture 
drain culture 
unne culture-
skin infection 
blood culture 
negative 
positive 
not done 
negative 
positive 
not done 
negative 
positive 
not done 
present 
no infection 
negative 
positive 
not done 
Joini 
η 
50 
77 
2524 
684 
122 
1845 
274 
395 
1982 
57 
2594 
72 
9 
2570 
: sepsis 
η (%) 
1 
5 
11 
3 
5 
9 
9 
8 
4 
13 
3 
1 
13 
(2 00) 
(6 49) 
(0 44) 
(0 44) 
(4 10) 
(0 49) 
(0 00) 
(2 28) 
(0 40) 
(7 02) 
(0 50) 
(4 71) 
(11 1) 
(0 51) 
nsk ratio 
4 5 
14.8 
0 9 
8 4 
0 0 
5 7 
140 
9 2 
21 8 
ρ value # 
0 00 
0 00 
0 00 
0 00 
0 00 
(# = chi-square test, ρ < = 0 1 is significant) 
Situation at discharge from hospital (Table Id) 
Patients with an unhealed wound or an elevated temperature at dis­
charge from hospital were at risk for joint sepsis. A prolonged and diffi­
cult postoperative reconvalescence period during hospitalization and a 
painful and limited function of the hip joint were also significant risk 
factors. 
Multiple logistic regression analysis revealed that an unhealed wound at 
discharge from hospital and a prolonged and difficult period of reconva­
lescence acted as two independent risk factors (Table lid). Validation 
showed that in the patients with one or more of these factors (n=206), 8 
(3.9%) developed joint sepsis, versus 9 out of the 2445 patients (0.36%) 
without these factors. 
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TabL· Id Unwanate nsk/actor analysis: situation at discharge 
Risk factor 
Joint sepsis 
η η (%) risk ratio ρ value # 
wound not healed 
healed 
temperature elevated 
normal 
function limited, pain 
pain-free 
reconvalescence slow 
normal 
38 
2613 
29 
2622 
95 
2556 
172 
2479 
4 
13 
1 
16 
2 
15 
5 
12 
(10.53) 
(0.50) 
(3.45) 
(0.61) 
(2.11) 
(0.59) 
(2.91) 
(0.48) 
21.6 0.00 
5.6 0.06 
3.6 0.07 
6.1 0.00 
(# = chi-square test, ρ < = 0.1 is significant) 
TabL· II α-d Multivariate analysis of nsk factors 
a Diabetes 
Failed fracture ostcosynth. 
Breakdown of sterility 
b Wound infection 
с Wound culture done 
Postop. urine culture pos. 
Blood culture done 
d Wound not healed 
Slow reconvalescence 
beta 
1.3 
1.7 
1.2 
4.1 
2.5 
1.6 
2.0 
3.1 
1.8 
SE 
0.8 
0.8 
0.6 
0.5 
0.5 
0.5 
0.6 
0.6 
0.6 
risk ratio # 
3.7 
5.4 
3.4 
62.2 
11.6 
4.9 
7.3 
22.2 
5.2 
(a = preoperative and peroperative risk factors, b = woundhealing problems, 
с = cultures, d = situation at discharge from hospital, beta = regression 
coefficient, SE = standard error, # = estimated risk ratio = ehcl'1) 
Mechanical reoperation 
The patients who underwent mechanical reoperation were included in 
the analysis up to the time of reoperation. A separate follow-up was per­
formed on this group after the surgery. The most frequent indications 
for reintervention were femoral loosening of a prosthesis which had 
been applied without cement, and dislocation. Four out of the 64 
(6.3%) patients with these complications developed joint sepsis versus 17 
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out of 2587 without reintervention (0.7%, RR=9.5). 
Two patients with joint sepsis after reoperation needed surgical inter-
vention for an irreducible dislocation, one on the day of the index oper-
ation and one after three weeks. In one patient, a non-cemented 
femoral component used in a revision procedure, was revised after six 
months. In one patient, a segment ring was added to the acetabular cup 
for recurrent dislocations after seven months. All of these four patients 
developed early wound infection and joint sepsis after reintervention, 
despite the administration of perioperative antibiotics. 
Discussion 
A number of independently acting risk factors were identified in 2547 
patients who underwent 2651 hip replacements in conventionally-venti-
lated operating theatres and received a short course of perioperative 
antibiotics. 
Diabetes is a well-recognized risk factor18, although it is not always 
found to influence the postoperative course of recovery4. The cellular 
immune system may be weakened by the disease21. Rheumatoid arthritis 
was not related to joint sepsis in this series, perhaps due to the limited 
numbers or the relatively short follow-up; Poss19 found an increased sep-
sis rate in rheumatoid arthritis only after a longer follow-up. The 
increased susceptibility of patients with rheumatoid arthritis has been 
confirmed by others1'4·13·22. 
Patients with failed fracture osteosynthesis in addition to prosthesis fail-
ure were at risk for joint sepsis in this study. In many other studies1·4·17,19· 
23
, an increased risk was found after previous surgery, except in two 
large series11,22. Reintervention soon after the index operation is also 
known to be an important risk factor for joint sepsis23. 
The significance of increased joint sepsis in relation to a breakdown of 
sterility in this study is evident and it is logical to theorize that contami-
nation with skin flora from the surgeon's hand may enhance joint sepsis. 
Especially the isolation of S. epidemidis from the joint of one of our 
patients supports this theory. McCue15 found perforations in 15% of the 
inner gloves used in total hip replacements, but none of the gloves grew 
bacteria colonies. The size of the glove perforations in our study were 
probably fairly large, as they were discovered macroscopically, but the 
consequences of this on the extent of contamination is unknown. 
In patients who are known to have risk factors preoperatively or periop-
eratively, such as diabetes, rheumatoid arthritis and previous surgery, 
the use of gentamicin bone cement is recommended, because there is 
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some evidence that the use of gentamicin bone cement in combination 
with systemic antibiotics reduces joint sepsis in high risk groups8·14·24 Per-
haps paüents with a breakdown of sterility during the operation would 
also benefit. In patients who have undergone previous surgery, it is 
obvious that low-grade sepsis should always be excluded419 using all the 
necessary diagnostic efforts, including culturing of multiple biopsies 
from periprosthetic tissue0,9. 
Postoperative wound infection (erythema of the wound more than one 
centimetre from the incision), was a very strong predictor of joint sepsis; 
this complication was often accompanied by haematoma and discharge 
from the wound. An attempt should be made to reduce the incidence of 
joint sepsis in these high risk patients4·10 by early diagnosis and treatment 
with adequate antibiotics. Treating minor woundhealing problems 
with antibiotics is not recommended, because the risk of joint sepsis is 
low. 
We agree with Fitzgerald4 that in the case of wound infection in combi-
nation with a draining haematoma, surgical evacuation of the infected 
haematoma is indicated and the patient should be treated with addi-
tional antibiotics. This procedure salvaged three out of the four hip 
replacements with these complications in our series. 
Antibiotic treatment should be guided by the results of the wound cul-
ture, because when joint sepsis is preceded by wound infection, the 
organisms isolated from the joint are the same as those isolated from the 
postoperative wound in the large majority of cases13. We found this in 
four out of six patients with joint sepsis. 
Not all cases of joint sepsis are preceded by wound infection. In five out 
of the 17 paüents with joint sepsis in this series, the postoperative wound 
healed uneventfully. Lidwell11 et al. calculated that two-thirds of the ca-
ses of joint sepsis were not preceded by any indication of wound sepsis 
and Surin21 et al. found that the wound had healed uneventfully in 18 
out of the 34 patients with joint sepsis. 
The patients with positive urinary tract cultures in this study were at risk 
for joint sepsis, as has also been reported in other series4,23, although one 
other study did not find a significant relationship6. Usually no clear cor-
relation can be found between the pathogens of urinary tract infections 
and hip joint sepsis, so a causal relationship cannot be established. 
There are, however, a number of case reports in which early postopera-
tive haematogenous seeding from the urinary tract is documented2·3·7·25. 
We found only one patient with similar microorganisms in the urine 
postoperatively who later developed joint sepsis, but haematogenous 
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seeding did not occur until 5 months after surgery and not in the early 
postoperative period. 
An unhealed wound at discharge from hospital was another strong risk 
factor and undoubtedly mirrors the influence of wound infection. A 
prolonged and difficult rcconvalescence period was also related to joint 
sepsis as can be expected, because many patients with low-grade joint 
sepsis stated that they were suffering from pain immediately after the 
operation 2 0. Such patients who are also at risk should have frequent 
check-ups at the outpatient department. 
In conclusion, the identification of several risk factors for joint sepsis 
enables the orthopaedic surgeon to trace high risk patients. Patients 
with diabetes, a history of previous operations (especially fracture 
osteosynthesis), a breakdown of sterility and surgical reintervention and 
probably also reumatoid arthritis, are at risk for joint sepsis. There is 
some evidence that the application of gentamicin bone cement might 
reduce the incidence of joint sepsis8 and it is therefore recommended in 
high risk patients. Patients with diabetes should be carefully prepared 
and monitored during the period of hospitalization. 
If patients suffer from wound infection after the operation, they carry a 
very high risk of developing joint sepsis and should be given adequate 
antibiotic therapy. Antibiotic therapy should be guided by the results of 
wound cultures. Minor woundhealing problems do not form an indica­
tion for treatment. In the case of wound infection with a draining 
haematoma, surgical evacuation is indicated. Patients with an unhealed 
wound or a slow reconvalescencc period should undergo frequent fol­
low-up examinations after discharge from hospital. 
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Chapter VI 
Risk factors for joint sepsis in total knee 
replacement 
A analysis of 362 operations 
A.B. Wymenga*, J.R. van Hom*, A. Theeuwes**, 
H.L. Muytjens***, T.JJ.H. Slooff 
Summary 
Ruk factors associated with joint sepsis were investigated in 345 patients who under-
went 362 knee replacements in a prospective multicentre trial. The operations were 
performed at 22 hospitah with conventionally-ventilated operating theatres and all the 
patients received a short course of penoperative cefuroxime. After a mean of follow-up 
of 12 months, joint sepsis was diagnosed in 9 patients (2.5%). 
The nsk ratio (RR) for joint sepsis in patients imth rheumatoid arthntis was 5.0 
times higher and in patients who had undergone surgical mntervention 4.7 times 
higher than in patients without these conditions. 
Patients with a woundinfection were 17.2 times more at nsk for joint sepsis and 
patients who received antibiotics for woundproblems 20.8 times more. The nsk was 
abo higher in the presence of <¡hn necrosis (RR=14.7) and wound dehiscence 
(RR=4.5), especially in combination with an additional woundhealing problem. 
Patients from whom a wound or blood culture was taken were 10.7 and 3.9 times 
more at nsk, respectively Patients who were discharged from hospital with an 
unhealed wound earned a high nsk (RR=20.3) as well as patients with a painful 
and limited function at discharge (RR=7.0) 
The application ofgentamicin bone cement is recommended in high nsk patients. It is 
abo possible that this approach would be beneficial for all Ыее replacement patients, 
in view of the relative high joint sepsis rate, but further tnah are needed to confirm 
this. 
Early diagnosis and adequate antibiotic therapy и indicated in patients with high 
nsk wound problems. Antibiotic treatment is not neccesary in the presence of a single 
minor woundproblem, drainage or hematoma. Significant skin defects should be 
closed by sfangrqfiing or musculocutaneous flaps. Patients who are discharged from 
hospital with an unhealed wound or painful and limited Ыее function should undergo 
frequent follow-up examinations at the outpatients clinic. 
*= Department of Orthopaedic Surgery, **= Medical Statistics Department, ***= Department of 
Microbiology, St Radboud Hospital, Lmversity of Nijmegen 
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Introduction 
Joint sepsis after total knee arthroplasty is still a major complication and 
it has devastating consequences'". It is the second most frequent reason 
for failure14. The operating theatre environment plays an important role 
in the incidence of joint sepsis. In conventionally-ventilated operating 
theatres, the incidence of joint sepsis is two to four times higher than in 
clean air. Moreover, 90-95% of all the cases of joint sepsis arc initiated 
during the operation. It is possible to achieve a fourfold reduction by 
using perioperative antibiotics '\ 
The individual patient characteristics also play an important role. The 
medical and orthopaedic diagnoses, previous operations, the type of 
prosthesis and the surgical techniques, all exert an influence on the risk 
of acquiring joint sepsis3·17 IB. 
The purpose of this study was to investigate the risk factors which are 
associated with joint sepsis in 345 patients with 362 total knee replace­
ments, all operated on in conventionally-ventilated operating theatres, 
with a short course of perioperative antibiotics. 
Patients and methods 
From July 1986 to July 1988, a prospective randomized controlled trial 
was performed at 22 hospitals with conventionally-ventilated operating 
theatres, in order to investigate the efficacy of one dose of cefuroxime 
(1500 mg i.v. at the induction of anaesthesia) in knee replacement. 
Patients receiving a three dose cefuroxime regimen (perioperative dose 
1500 mg, subsequent doses of 750 mg i.v. after 8 and 16 hrs., respec­
tively) served as a control. Λ relevant summary is given in this section, 
as details were reported elsewhere2\ 
A total of 455 total knee replacements were eligible for entry into the 
trial, of which 58 were excluded. The most frequent reason for exclu­
sion was the use of gentamicin-impregnated bone cement. This series 
therefore represents a rather homogeneous group of patients who 
underwent knee replacement procedures, as a number of high risk 
patients were excluded. Further exclusion criteria were the use of other 
antibiotics and former or current sepsis in the joint. 
From the remaining 397 total knee hip replacements, 35 were with­
drawn for the following reasons: the wrong type and/or dose of antibi­
otics had been administered, death (not sepsis-related) within 7 days of 
the operation or a second replacement, performed during the same 
period of hospitalization. This left 362 knee replacements (345 patients) 
for analysis. 
72 
In the analysis, the end point of participation in the follow-up was 
defined as reoperation or death, but a separate analysis was done on the 
reoperations (not for infection). The mean follow-up was 12 months and 
no patients were lost to follow-up. 
In the one dose group (n= 175), 3 patients suffered from joint sepsis 
(1.71%, 95% confidence limits 0.09-3.33) and in the three dose group 6 
patients (3.20%, 95% confidence limits 0.63-5.77). The difference 
between the one dose group and the three dose group was -1.49% (95% 
confidence upper limit 1.78%). Definite conclusions about the equal 
efficacy of one dose of ccfuroxime in knee replacement could therefore 
not be drawn, because the trial sample was too small. 
The incidence in a simultaneous performed trial with 2651 hip replace-
ments treated with the same prophylactic regimen was 0.64% 24. 
Definitions 
- Confirmed joint sepsis was defined as a positive culture at reoperation 
or a draining sinus. 
- Strong evidence of joint sepsis was defined as four or more possible 
signs of sepsis (pain during weight-bearing and/or at rest, tenderness 
of the wound, fever, an abnormal X-ray with periostial reactions, pro-
gressive bone resorption, an increased ESR (20 mm above the preop-
erative value or > 35 mm), positive culture in the joint fluid aspira-
tion, a positive arthrogram, a bone scan showing the typical signs of 
infection or an increased CRP. 
- Wound infection in the postoperative period, was simply defined as 
erythema more than one centimetre from the incision. 
- Minor postoperative woundhealing problems were defined as erythe-
ma of the wound less than one centimetre from the incision, pus 
suture, small wound dehiscence, necrosis of the wound edge and blis-
ters. 
- Distant infections were usually diagnosed on the basis of positive cul-
tures. Urine cultures were considered positive if bacteriuria was pre-
sent with more than 101 bacteria per ml. A few lung and skin infec-
tions were also diagnosed on a clinical basis. 
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Statistical analysis 
Joint sepsis rates within subgroups were estimated as crude ratios. Uni­
variate analysis of all the potential risk factors was performed with a chi-
square test. From all the risk factors tested, only those with a p-value of 
ρ <= 0.1 were considered to be significant. These, and a few other 
interesting risk factors, are summarized in Tables la-d. 
The number of times the risk for joint sepsis is increased can be 
expressed as the risk ratio (RR): 
% JOINT SEPSIS WITH RISK FACTOR 
RISK RATIO = 
% JOINT SEPSIS WITHOUT RISK FACTOR 
As is it possible for risk factors to be related to each other, their impor­
tance can be overestimated in an univariate analysis. To overcome this 
problem, a multiple logistic regression analysis was used. This method 
identifies the risk factors whose influence is independent of any other 
simultaneously occurring risk factor(s) (Tables Ila-d). In this way, we 
identified separate risk factors which have an additive effect on the risk 
of joint sepsis, i.e. the more factors a patient has, the higher the risk of 
joint sepsis. 
Four separate groups of risk factors were analysed: preoperative and 
perioperative risk factors (la), postoperative factors (lb), culture results 
(Ic) and risk factors at discharge from hospital (Id). Within each section, 
a regression analysis was performed (Tables Ila-d). 
Results 
Joint sepsis 
Joint sepsis was confirmed by a positive culture at reoperation or a 
draining sinus in 8 patients. Strong evidence was found in one. All these 
patients underwent reoperation for joint sepsis. 
Preoperative and peroperatiue risk factors (Table la) 
In the univariate analysis, the following preoperative factors were not 
found to be associated (p >0.1) with joint sepsis: sex, age, the cefurox-
ime dose (one dose or three doses), the quetelet index (kg/m2), physical 
condition, number of days in hospital before the operation, preoperative 
infections of the urinary tract, lung or skin, a urine sediment with more 
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than 5 leucocytes per field (400x) and the use of steroids. 
Diabetes and previous surgery showed increased risk ratios but the dif­
ferences did not reach significance (p <= 0.1). The orthopaedic diagno­
sis was clearly related to joint sepsis; patients with rheumatoid arthritis 
were much more at risk for joint sepsis than patients with arthrosis. 
Analysis of the perioperative data showed that the use of (plain) bone 
cement, a breakdown of sterility, the degree of difficulty, the operation 
time, the amount of blood loss, the status of the surgeon (staff or resi­
dent) and the type of prosthesis (semi or non-constrained), were not 
related to joint sepsis. 
The multiple logistic regression analysis of the most important preoper­
ative and perioperative data identified rheumatoid arthritis as the only 
risk factor which acted independently. The risk was approximately five 
times increased (Table Ha). 
Table la Unwariale nsk factor analysis: preoperative and peroperatwe data 
Joint sepsis 
Risk factor η η (%) risk ratio ρ value # 
0.36 
0.05 
0.21 
(# = chi-square test, ρ < = 0.1 is significant) 
Woundhealing and other postoperative factors (Table lb) 
The following factors were not found to be related to joint sepsis: the 
postoperative day of vacuum-drain removal, discharge from the vacu­
um-drain wound after removal of the drain and indwelling urinary 
catheters. Orthopaedic complications (n=9), such as nerve damage and 
fractures which were treated conservatively, did not relate to joint sep­
sis. Non-orthopaedic complications (n=ll), the majority being cardio­
vascular, did not relate either. Five patients had non-orthopaedic opera­
tions (urinary and gastrointestinal tract), but none of them developed 
joint sepsis. 
diabetes 
no diabetes 
rheumatoid arthritis 
other 
arthrosis 
prosthesis 
osteotomy 
other 
no previous operation 
17 
342 
107 
7 
248 
7 
23 
49 
282 
1 (5.88) 
8 (2.32) 
6 (5.94) 
0 (0.00) 
3 (1.29) 
1 (14.29) 
1 (4.17) 
1 (2.04) 
6 (2.13) 
2.3 
4.3 
0.0 
6.7 
2.0 
1.0 
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Patients with severe haematoma had an increased risk for joint sepsis. 
Minor woundhealing problems analysed as a group, were also related to 
joint sepsis. Further analysis of this group showed that particularly 
patients with skin necrosis at the wound edge and (to a lesser extend) 
wound dehiscence carried a high risk for joint sepsis. Only those 
patients with skin necrosis or wound dehiscence, who also had an addi­
tional wound problem, developed joint sepsis. Skin necrosis was not 
related to previous operations or rheumatoid arthritis. Single minor 
wound problems, such as erythema less than 1 cm from the incision, pus 
suture or blisters, did not relate to joint sepsis. 
In the group of 12 patients with skin necrosis, 3 patients underwent 
additional attempts to close the skin defect, which succeeded in two and 
failed in one patient who developed joint sepsis. 
Table lb Univariate risk factor analysL·: woundhealing and other postoperative factors 
Risk factor 
haematoma: light 
moderate 
severe 
none 
minor woundhealing problems: 
absent: 
present: 
erythema < 1 cm 
pus suture 
dehiscence 
blisters 
skin necrosis 
wound drainage: 
absent : 
present: 
serous 
blood 
pus 
wound infection 
no wound infection 
antibiotics (wound) 
no antibiotics 
η 
32 
49 
12 
267 
294 
68 
35 
2 
26 
3 
12 
294 
68 
51 
13 
4 
13 
349 
26 
336 
Joint sepsis 
η 
2 
1 
2 
5 
5 
4 
1 
-
2 
-
3 
5 
4 
3 
1 
1 
3 
6 
5 
4 
(%) 
(3.13) 
(2.04) 
(14.29) 
(1.87) 
(1.70) 
(5.88) 
(2.86) 
-
(7.69) 
(25.00) 
(1.70) 
(5.88) 
(3.92) 
(7.69) 
(25.00) 
(23.08) 
(1.72) 
(19.23) 
(1.17) 
risk ratio 
1.7 
1.1 
7.6 
-
-
3.5 
1.7 
0 
4.5 
0 
14.7 
-
3.5 
2.3 
4.5 
14.7 
13.4 
-
16.4 
-
ρ value # 
0.04 
0.05 
0.05 
0.00 
0.00 
(# = chi-square test, ρ < — 0.1 is significant) 
Patients with wound drainage were also more at risk. The presence of 
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serous drainage or blood, meant a moderate increase, but patients with 
pus had a very high risk. 
Wound infection was a strong predictor of joint sepsis and often accom­
panied by other woundhealing problems. Patients who received antibi­
otics for woundhealing problems were even more at risk. 
Multiple logistic regression analysis showed that an antibiotic adminis­
tered for wound problems, was the strongest variable which acted inde­
pendently (Table ІІЫ). When regression analysis was done without 
antibiotics, wound infection was identified as the strongest independent 
factor (Table IIb2). The other woundhealing problems such as 
haematoma and drainage exerted their influence largely in combination 
with prescription of antibiotics or wound infection. 
Cultures of the wound and other sites (Table Ic) 
Drain cultures did not relate to joint sepsis, whereas positive and (to a 
lesser extend) negative wound cultures did. 
The most frequent site of distant infection was the urinary tract (18.2%) 
but there was no relation with joint sepsis. Patients with skin infections 
and patients from whom a blood culture was taken for high temperature 
or wound problems, were also at risk. Two patients with septicaemia 
(positive blood culture) did not develop joint sepsis. 
Table Ic Umvanale mkfactor analysis wound and other cultures 
Risk factor 
wound culture. 
skin infection 
blood culture 
. negative 
positive 
not done 
present 
absent 
negative 
positive 
not done 
η 
17 
18 
327 
6 
356 
22 
2 
338 
Joint sepsis 
η (%) 
1 (5 88) 
3(16 67) 
5 (153) 
1 (16 67) 
8 (2 25) 
2 (9 52) 
0 (0 00) 
7 (2 07) 
nsk ratio 
3 8 
109 
7 4 
5 0 
0.0 
ρ value # 
0 00 
0 02 
0 10 
(# = с hi-square test, ρ < = 0 1 is significant) 
The multiple logistic regression analysis revealed that the wound culture 
and the blood culture both acted as independent risk factors (Table He). 
Validation showed that in the patients from whom a wound culture 
and/or a blood culture was taken (n=54), five (9.3%) suffered from joint 
77 
sepsis, whereas there were only four cases (1.3%) in the patients who did 
not undergo these tests. 
Situation at discharge fiom hospital (Table Id) 
An unhealed wound at discharge from hospital was a strong risk factor. 
An elevated temperature at discharge was less strongly related to joint 
sepsis. Patients with a painful knee and limited function at discharge 
carried an increased risk for joint sepsis. A prolonged and difficult 
reconvalescence period was also a meaningful predictive factor for joint 
sepsis. 
The multiple logistic regression analysis revealed that an unhealed 
wound and, to a lesser extend, a painful knee with limited function, 
were risk factors which acted independently (Table lid). Validation of 
the data showed that in patients with these factors, five out of the 36 
(10.2%) developed joint sepsis, versus only four out of the 326 (1.2%) 
without these factors. 
Table Id Univariate risk factor analysis: situation at discharge 
Joint sepsis 
Risk factor η η (%) risk ratio ρ value # 
21.5 0.00 
7.4 0.02 
wound not healed 
healed 
temperature elevated 
normal 
function limited, pain 
pain-free 
reconvalescencc slow 
norma] 
13 
349 
13 
356 
27 
335 
42 
320 
4 
5 
1 
8 
4 
5 
4 
5 
(30.77) 
(1.43) 
(16.67) 
(2.25) 
(14.81) 
(1.49) 
(9.52) 
(1.56) 
9.9 0.00 
6.1 0.00 
(# = chi-square test, ρ < = 0.1 is significant) 
Mechanical reoperations 
During the period of hospitalization and follow-up, 24 "mechanical" 
reoperations were performed for various reasons: 15 for patellofemoral 
problems (the majority being dislocations), two for fractures of the adja­
cent bone, one for prosthesis fracture, one for medial collateral ligament 
rupture, two arthrotomies for limited function, one haematoma evacua­
tion, one revision for instability and one neurinoma excision. 
Joint sepsis was diagnosed in nine of 338 patients (2.7%) without rein-
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tervention versus three of 24 patients (12.5%, RR = 4.7) in this group 
after the second operation. In one of these patients, a tuberositas trans­
fer for patellar dislocation was performed, after which a large haema-
toma with wound infection and subsequent joint sepsis developed. No 
perioperative antibiotics were given at reoperation. In the second 
patient, skin necrosis, wound infection and joint sepsis developed after 
two repair operations for traumatic patellar tendon rupture. In the third 
patient, adhesiolysis was performed for limited function five months 
after the index operation and subsequent wound and joint infection 
developed. 
Table II Multwanate analysis of risk factors 
a Rheumatoid arthritis 
Ы Antibiotics for wound 
b2 Wound infection 
с Wound culture done 
Blood culture done 
d Wound not healed 
Pain + limited function 
Beta 
1.6 
3.0 
2.8 
2.4 
1.4 
3.0 
2.0 
SE 
0.7 
0.7 
0.8 
0.8 
0.9 
0.8 
0.8 
risk ratio# 
5.0 
20.8 
17.2 
10.7 
3.9 
20.3 
7.0 
(a = preoperative/perioperative risk factor, b = postoperative wound problems, 
с = cultures, d = situation at hospital discharge, beta = regression coeflicient, 
SE = standard error, # estimate of risk ratio = e1*") 
Discussion 
In a prospective trial, 345 patients underwent 362 total knee replace­
ments in conventionally-ventilated operating theatres, with a short 
course of systemic antibiotics. A number of risk factors were identified 
which acted independently in relation to joint sepsis, especially in the 
postoperative period. 
Rheumatoid arthritis was an important risk factor for joint sepsis, which 
has also been found by other authors5'6'815'16'8. Diabetes and previous 
operations were not identified as being significant risk factors in this 
study contrary to others5'8·14,18, but this may be due to the limited num­
ber that entered the study (Table la). Patients who underwent reopera­
tion after the index arthroplasty ran approximately five times more risk, 
as 12.5% of these patients ended up with joint sepsis. In previously 
operated knees, low-grade sepsis must always be excluded, especially 
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with hardware in situ and multiple biopsies from interface tissue should 
be sent for culture as described by Kamme and Lindberg". 
There is some evidence that gentamicin bone cement in combination 
with systemic antibiotics, reduces joint sepsis in hip replacement'016,21. 
We therefore propose to use it in cemented knee replacement proce-
dures in all risk patients with rheumatoid arthritis, diabetes and previ-
ous operations. But in view of the relative high incidence of joint sepsis 
in knee replacement as compared with hip replacement, even without 
risk factors, it might be beneficial for all cemented knee replacements. 
Further trials with gentamicin bone cement are needed to confirm this, 
in order to find methods of reducing joint sepsis when clean air opera-
ting theatre facilities are not available. 
The 18% incidence of minor wound problems in our series was high 
but comparable with the rates mentioned in other reports (varying from 
5% up to 25%)7 4'u. From the minor wound problems, only wound edge 
necrosis and wound dehiscence were clearly related to joint sepsis and 
only those patients who also suffered from other wound problems such 
as erythema or drainage developed joint sepsis. Secondary infection 
may have been initiated through these skin defects. Other papers24·'3 
have reported 10-33% joint sepsis in patients with these wound pro-
blems. We could not confirm the relationship between necrosis and 
rheumatoid arthritis or previous surgery1''''1''20. 
Insali6 advised immobilizing the knee in the case of skin necrosis and 
awaiting spontaneous separation of the eschar, because early debride-
ment might lead to the spread of infection to the deep fascial layers and 
the prosthesis. After that, skin grafting can be performed or, in the case 
of wound dehiscence, secondary closure can be performed. Vascula-
rized musculocutaneous skin flaps should be used to salvage the joint if 
the necrosis is progressive'1920. 
Many authors have reported that delayed woundhealing is related to 
joint sepsis in knee replacement2"48·1217·'8, but the relative importance of 
various woundhealing problems was not clear. In this study wound infec-
tion as well as skin necrosis or wound dehiscence in combination with 
other wound problems were found to be important postoperative riskfac-
tors. Orthopaedic surgeons were correct in considering these latter 
patients without wound infection to be at risk for joint sepsis, because 
their prescription of antibiotics was more strongly related to joint sepsis 
than wound infection. Patients with single minor woundhealing pro-
blems, wound drainage or hematoma were not at risk for joint sepsis. 
Early diagnosis and adequate antibiotic treatment is indicated in patients 
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with high risk wound problems in order to reduce the incidence of joint 
sepsis'3. The antibiotic course should be guided by the results of wound 
cultures, because it is very likely that the pathogens cultured from the 
wound will also be present in the joint when reoperation is performed for 
joint sepsis'1. There is no indication for antibiotic treatment in patients 
with a single minor wound problem, drainage or haematoma. 
The increased risk for joint sepsis in patients who are discharged from 
hospital with an unhealed wound or with a painful knee with limited 
function, is also obvious and these patients should be followcd-up by fre­
quent outpatient visits. 
In this study we were able to identify a number of important risk factors 
for joint sepsis in knee replacement. Patients with rheumatoid arthritis, 
a history of surgical reinterventions and probably also diabetes and pre­
vious surgery, carry a higher risk for joint sepsis. Additional gentamicin 
bone cement is recommended in (high) risk patients who undergo a 
cemented replacement and this may, in view of the relatively high rate 
of joint sepsis without risk factors, be beneficial for all patients. 
Risk factors in the postoperative period were mostly related to wound-
healing problems. Patients with wound infection and also patients who 
developed skin necrosis or wound dehiscence in combination with other 
woundhealing problems were very much at risk. Antibiotics should be 
prescribed for these patients and the course be guided by the wound 
culture results. There is no indication for antibiotic treatment in patients 
with a single minor woundhealing problem, wounddrainage or haema­
toma. Significant skin defects should be closed with skingrafting or mus­
culocutaneous flaps. 
Patients who are discharged from hospital with a painful and limited 
knee function or an unhealed wound should receive special adjunctive 
follow-up care. 
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Chapter VII 
The relation between wound, urine cultures and 
joint sepsis after hip and knee replacement 
A.B. Wymenga', H.L. Muytjens**, J.R. van Horn*, 
A. Theeuwes***, T.J.J.H. Slooff 
Summary 
The relation between wound and unne cultures was analysed in 2651 hip replace-
ments (2547 patients) and 362 knee replacements (345 patients), operated on in 
conventionally-ventilated operating theatres, with penoperative infection prophylaxis 
of one dose or three doses of cefuroxime. 
In 26 patients with joint sepsis (17 hip replacements and 9 knee replacements) S. 
aureus (42%), S. epidermidis (12%), gram-negative bacteria (24%) and anaerobic 
bacteria (4%) were identißed as the causative agents. The bacterial spectrum was 
covered suffiaently by cefuroxime. 
Joint sepsis was preceded by wound infection in 12 out of the 26 patients with this 
complication. When, in hip replacement, S. aureus, Gram-negative and other organ-
isms were cultured fiom the postoperative wound, the risk for joint sepsis was 
increased 24, 17 and 10 times, respectively. S. epidermidis was not related to joint 
sepsis. In knee replacement there was no relation with S.aureus and S.epidermidis but 
the risk was 17 times inaeased with gram-negative organisms and 15 times 
inaeased with other organisms in the wound culture. 
Perioperative joint cultures were positive in 4.2% but were not related to joint sepsis. 
Drain cultures were positive in 75% and related to joint sepsis, but the wound cul-
ture was considered to befar more reliable. Routine perioperative and drain cultures 
are therefore not indicated in primary joint replacement. 
Postoperative urinary tract infections occurred in 15% of the patients. There was an 
inaeased risk for joint sepsis in hip replacement, but this could not be explained by 
early postoperative haematogenous bacterial seeding. Urinary tract infections were 
strongly related to the use of indwelling catheters and the incidence increased with 
time. Removal before the third day is recommended, because five patients in this study 
developed septicaemia with a catheter which had been in situ for more than 72 hours. 
*= Department of Orthopaedic Surgery, **= Department of Medical Microbiology, ***= Medi-
cal Statistics Department; St. Radboud Hospital, University of Nijmegen. 
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Introduction 
Systemic perioperative antibiotics are a very effective means of reducing 
the incidence of joint sepsis in conventionally-ventilated operating the-
atres, by a factor of 4 to 6 times'2J. No differences were found between 
14 days and 1 day of antibiotic prophylaxis and 5 days and 1 day4 J. 
In a recent multicentre trial, the efficacy of one dose of perioperative 
cefuroxime in hip and knee replacement was compared to a three dose 
regimen''7. The purpose of this study was to analyse the relation 
between wound and urine cultures and later joint sepsis in the patient 
population of this trial. 
Patients and methods 
From July 1986 to July 1988, a prospective randomized controlled trial 
was performed at 27 hospitals with conventionally-ventilated operating 
theatres, in order to evaluate the efficacy of a single perioperative dose 
of cefuroxime ( 1500 mg i.v. at the induction of anaesthesia) in hip and 
knee replacement. A three dose cefuroxime regimen, comprising an 
additional 750 mg i.v. after 8 and 16 hours, respectively, served as a 
control. 
As a detailed report has been published elsewhere67, only a relevant 
summary is presented in this section. A total of 3074 hip replacements 
and 455 knee replacements entered the trial, of which 278 hips and 58 
knees were excluded. The most frequent reason for exclusion was the 
use of gentamicin-impregnated bone cement. From the remaining 2796 
hip and 397 knee replacements, 145 and 35 were withdrawn, respec-
tively. The main reasons were the administration of the wrong type 
and/or dose of antibiotics, death within 7 days of the operation or a se-
cond operation within the same period of hospitalization. This left 2651 
hip replacements (2547 patients) and 362 knee replacements (345 
patients) for analysis. This series represents a rather homogeneous 
group of patients who underwent replacement surgery, as a number of 
high risk patients were excluded. 
The follow-up ended with joint sepsis, reoperation or death. The mean 
follow-up was 13 months for the hip group and 12 months for the knee 
group. 
Definitions 
- Joint sepsis was defined as a positive culture at reoperation or a drain-
ing sinus. 
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Strong evidence of joint sepsis was defined as four or more possible 
signs of sepsis at follow-up (pain on weight-bearing and/or at rest, ten­
derness of the wound, fever, an X-ray with periostial reactions or pro­
gressive bone resorption, an increased ESR (20 mm above the preop­
erative value or > 35 mm), positive joint aspiration, a positive 
arthrogram, a bone scan indicating infection or an increased CRP). 
Wound infection in the postoperative period was defined as erythema 
of more than one centimetre measured from the incision. 
Minor woundhealing problems were defined as erythema of less than 
1 cm measured from the incision, pus suture, small wound dehiscence, 
necrosis of the wound edge and blisters. 
Distant infections were diagnosed on the basis of positive cultures. A 
urinary tract infection was defined as bacteriuria of more than 105 
bacteria/ml. Blood cultures of Staphylococcus epidermidis were only con­
sidered to be positive when cultured at least twice. A few skin, pul­
monary and other infections were also diagnosed on a clinical basis. 
Results 
The most important results of the trial are summarized in Table I. 
Tabk I Wound infection, wound cultures and distant infections in the one dose and three dose group 
(hip and knee replacements) 
HIP REPLACEMENT KNEE REPLACEMENT 
1 dose 3 doses total (%) 1 dose 3 doses total {%) 
n-1324 n=1327 n=2651 n=175 n=187 n=362 
haematoma 
(l/mA)# 127/99/28 
minor wound probi. 
wound drainage 
wound infection 
joint sepsis 
positive wound cult. 
positive drain cult. 
urinary tract inf. 
skin inf. 
pulmonary inf. 
169 
166 
25 
11 
43 
65 
201 
31 
18 
145/82/44 
166 
178 
31 
6 
48 
57 
194 
26 
20 
525 
335 
344 
56 
17 
91 
122 
395 
57 
38 
(20.0)## 
(12.6) 
(13.0) 
(2.1) 
(0.64) 
(3.4) 
(4.6) 
(14.9) 
(2.2) 
(1.4) 
19/23/5 
33 
30 
4 
3 
10 
12 
32 
2 
3 
13/26/9 
35 
38 
9 
6 
8 
6 
34 
4 
5 
97 
68 
68 
13 
9 
18 
18 
66 
6 
8 
(26.8) 
(18.8) 
(18.8) 
(3.6) 
(2.5) 
(5.0) 
(5.0) 
(18.2) 
(1.7) 
(2.2) 
{# = light/moderate/severe, # # = 0.05 < ρ < 0.10, no other significant différences) 
There were no significant differences between the one dose groups and 
the three dose groups with respect to woundhealing problems and 
wound infections. The number of positive wound cultures and drains 
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did not differ significantly. The incidence of remote infections was not 
influenced by one dose or three doses. 
Joint sepsis and wound infections 
Joint sepsis was diagnosed in twenty-six patients, 17 (0.64%) in the hip 
and 9 (2.45%) in the knee group. Cultures of the joint at reoperation for 
joint sepsis were taken in 22 patients and in one patient joint fluid from 
an aspiration was cultured Staphylococcus aureus. Most causative microor-
ganisms were gram-positive microorganisms. S. aureus was isolated in 
42%, S. epidermidis in 12%, gram-negative species in 24% and anaerobe 
species in 4% (Table V). 
Early postoperative wound infection preceded joint sepsis in 12 out of 
the 26 patients with this complication, minor woundhealing problems 
preceded joint sepsis in six and light haematoma in two patients. In six 
patients, postoperative woundhealing was uneventful (Table II). 
Table II Preceding postoperative woundhealing problems in joint sepsis 
Woundhealing problem HIP (n= 17) KNEE (n=9) 
wound infection 9 (4)# 3 (1)# 
minor woundhealing problems 3 (2)# 3 (2)# 
slight haematoma 1 1 
uneventful woundhealing 4 2 
(# = number of patients who also had haematoma) 
The incidence of joint sepsis after a positive wound culture was greatly 
increased and was found to be related to the species of microorganism 
isolated from the postoperative wound (Table III). The risk of joint sep-
sis in hip replacement after the isolation of S. aureus, gram-negative and 
other species was increased 24, 17 and 10 times when compared to 
patients without wound cultures, respectively. This relationship was not 
found with S. epidermidis. 
The risk of sepsis in knee replacement was not increased after the isola-
tion of S. aureus and S. epidermidis, but the risk was 17 times increased 
with gram-negative species and 15 times with other species. 
The same bacterial species were isolated at reoperation from four out of 
the six postoperative wound cultures of patients who later developed 
joint sepsis of the hip and in one out of the three knee patients. 
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TabL· III Risk ofjoinl sepsis after mktwn of S aureus and other mtcroorgamsms from the 
postoperative wound, calculated per isolate 
POSITIVE CULTURE 
S aureus 
S epidermidis 
Gram-negative 
other 
NEGATIVE CULTURE 
NO CULTURE 
HIP REPLACEMENT 
cultures joint sepsis 
η η 
92 6 
38 4 
35 0 
27 2 
44 2 
67 0 
2492 11 
(%) 
(6 5) 
(10 5) 
(0 0) 
(7 4)# 
(4 6)## 
(0 0) 
(0 4) 
KNEE REPLACEMENT 
cultures joint sepsis 
η 
18 
4 
7 
4 
9 
17 
327 
η 
3 
0 
0 
1 
2 
1 
5 
(%) 
(16 6) 
(0 0) 
(0 0) 
(25 0)S 
(22 0)S$ 
(5 9) 
(15) 
(# = E coli and Proteus, Pseudomonas sp and Proteus, # # = group D 
streptococcus and S vmdans, S = Enterobacter, SS = Peptococcus, 
Bacillus sp and Corynebactenum sp ) 
At follow-up, the majority of patients with joint sepsis presented with a 
draining wound or a sinus; only four had a normal wound. Most 
patients were diagnosed within three months of hospital admission 
(Table IV). 
Table IV Presentation atfolhw-up and lime of diagnosis 
Presentation at follow-
sinus 
draining wound 
erythema/ tenderness 
normal wound 
•up 
hip 
n=17 
9 
3 
1 
4 
knee 
n=9 
4 
2 
3 
Time definite 
1 month 
3 months 
4 months 
5 months 
10 months 
14 months 
18 months 
24 months 
diagnosis 
hip 
n=17 
9 
-
1 
2 
2 
1 
1 
knee 
n=9 
3 
3 
Penoperative cultures 
The microorganisms grown in perioperative joint cultures are presented 
in Table V. Only 26 out of the 622 cultures (4.2%) were positive. None 
of the patients with positive perioperative cultures developed joint sep­
sis. The majority of the bactenal species belonged to the skin flora. 
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Table V AlicToorgamsms grown in penoperative cultures fiom postoperative wound, drain, urine and 
joint sepsu 
SKIN ORGANISMS: 
S. aureus 
S. epidermidis 
Corynebacterium spp. 
S. viridans 
Bacillus spp. 
Pcptococcus spp. 
P. acnes 
Haemolytic streptococci 
Group В streptococci 
Branhamclla cattharalis 
Moraxella 
Fungus 
pen-
operative 
2 
17 
1 
1 
-
-
1 
-
-
-
-
2 
wound 
42 
42 
12 
3 
2 
-
INTESTINAL AND OTHER ORGANISMS: 
Group D streptococci 
E. coli 
Proteus spp. 
Klebsiella spp. 
Pseudomonas spp. 
Enterobacter spp. 
Citrobacter spp. 
Gram-negative rods 
Bacteroidfs spp. 
Acinctobacter spp. 
Mixed infcctions# 
no full data available 
positive cultures: 
number of cultures 
-
-
1 
-
1 
-
-
-
-
-
-
-
26 
622 
23 
4 
8 
1 
6 
j 
1 
2 
1 
4 
4 
-
109 
194 
drain 
12 
96 
2 
5 
4 
-
-
-
-
-
-
-
16 
-
3 
-
3 
2 
-
2 
-
4 
1 
-
140 
939 
urine 
6 
17 
4 
4 
-
-
-
-
4 
-
-
-
102 
285 
53 
30 
24 
12 
3 
5 
-
2 
17 
18 
455 
766 
joint 
sepsis 
11 
3 
-
-
-
1 
-
-
-
-
-
-
-
2 
1 
-
-
3 
20 
23 
(# = more than 3 species) 
Vacuum-drain cultures 
At a number of hospitals, drain cultures were performed routinely and 
15.3% of 806 cultures were positive in hip replacement. In knee 
replacement, 18 out of 133 (13.5%) were positive. The majority of the 
cultured microorganisms belonged to the flora of the skin. There was a 
significant relationship between positive drain cultures and joint sepsis 
in hip replacement but not in knee replacement (Table Via). In three 
cases in the hip replacement group, the same species were recovered 
from the postoperative drain culture and in later joint sepsis at reopera­
tion (Tabic VIb). 
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The incidence of positive cultures was higher when the drains remained 
in situ for several days. There were 14.7% (132/909) positive cultures 
from drains removed in the first three days, versus 31.0% (9/29) from 
drains removed after the third day (x2-test: p=0.03). 
Table VI Vacuum-drain cultures 
Table Via Relahonship between drain cultures and hier joint sepsis 
Pseudomonas + Proteus 
S. aureus + Streptococ D 
Enterobacter 
Gram ncg rods 
S epidermidis 
negative 
negative (2x) 
Proteus 
S aureus 
Enterobacter 
S. aureus 
Enterobacter 
S. epidermidis 
negative (2 χ) 
positive 
negative 
not done 
(* x'-test = 
Table VIb 
 0.00 ) 
Isolates from 
HIP REPLACEMENT 
cultures joint sepsis 
η η (%) 
122 
684 
1845 
5 
3 
9 
(4.10)* 
(0 44) 
(0.49) 
dram cultures and later joint sepsis 
VACUUM-DRAIN CULTURE 
(kip 
JOINT 
KNEE REPIACEMENT 
cultures joint sepsis 
η η (%) 
18 
115 
228 
replacement) 
SEPSIS 
0 
4 
5 
(0 00) 
(3.48) 
(2.18) 
Urinary tract infections 
The incidence of postoperative urinary tract infections did not differ in 
the one dose groups and the three dose groups and was fairly similar in 
both hip and knee replacements (15% and 18%, respectively; Table I). 
The microorganisms are shown in Table V. The relationship between 
the presence and duration of urinary catheters and urinary tract infec­
tion (UTI) was significant, the incidence rose to 48% after more than 
three days (Table VII). The incidence of postoperative UTI was more 
than double in female patients (17%) when compared to males (7%). 
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TabL· VII Relationship between иппату catheters and postoperative иппату tract infection (replacements) 
no catheter 
< 24 hrs 
24-48 hrs 
48-72 hrs 
> 72 hrs 
no UTI 
1367 
430 
394 
156 
211 
UTI (%) 
81 (5.6) 
80 (15.7) 
73 (15.6) 
30 (16.1) 
191 (47.6) 
TOTAL 
1448 
510 
467 
186 
402 
total 2558 455 (15.1) 3014 
(x2-tcst: ρ < 0.001) 
Hip replacement patients with postoperative UTI were significandy 
more at risk for joint sepsis614. From the 395 hip replacements with a 
positive urine culture, nine (2.28%) developed joint sepsis, versus eight 
out of the 2256 replacements without a positive culture (0.36%). 
Microorganisms cultured from the urine did not match those cultured 
from the infected joint, except in one patient. From this patient, we iso­
lated E. coli in the urine postoperatively and later in the joint, but do­
cumented haematogenous seeding of E. coli from the urinary tract 
occurred five months after the operation and not in the early postopera­
tive period. The relationship in hip replacement, between positive urine 
cultures in the postoperative period and later joint sepsis, is therefore 
not a causal one. 
Enterobacter was cultured from a draining wound of a patient who 
underwent knee replacement. The wound did not heal and at reopera­
tion Enterobacter and E. coli were isolated. E. coli may have invaded the 
wound secondarily after a urinary tract infection with this microorgan­
ism. 
Septicaemia 
In 11 patients (0.4%) blood cultures were positive during the period of 
hospitalization. Only one patient with postoperative S. aureus septi­
caemia from an unidentified origin later developed joint sepsis. The uri­
nary tract was the origin of septicaemia in five patients, all of whom had 
tin indwelling urinary catheter for longer than 72 hours. In the remain­
ing cases, septicaemia originated from infected packed cells, pneumo­
nia, an infected cardiac catheter tip, sacral decubitus and the biliary 
tract. 
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Discussion 
We were unable to establish that a single dose of cefuroxime was as 
equally effective as a three dose regimen, because the incidence of joint 
sepsis was low and possible range of incidences was too wide. A longer 
follow-up, with more diagnoses of joint sepsis is needed to draw definite 
conclusions. The results have been discussed elsewhere6,7. The prophy-
laxis regimen did not significantly influence the incidence of wound-
healing problems, wound infection and distant infections during the 
period of hospitalization. 
Joint sepsis and wound infection 
The identified causative agents in joint sepsis, S. aureus, S. epidermidis, E. 
coli, Proteus mirabilis, Peptococcus and Enterobacter, were usually sensitive to 
cefuroxime. The sensitivity of Enterobacter strains has been known to 
vary, but those isolated from three patients with joint sepsis were sus-
ceptible to cefuroxime. The bacterial spectrum was therefore consid-
ered to be sufficient. 
The incidence of Gram-positive, Gram-negative and anaerobe microor-
ganisms isolated from patients with joint sepsis was well within the 
range of other studies8"12, although we isolated relatively few S. epidermidis 
and anaerobes. This may be due the follow-up period of one year, 
because joint sepsis with these organisms often runs a subclinical 
course13,14. 
From the postoperative wound we often cultured skin flora. The isola-
tion of S. epidermidis in wound cultures was not related to joint sepsis. 
However, the isolation of 5. aureus, Gram-negative and other bacteria 
considerably increased the risk of joint sepsis in hip replacement and 
gram-negative and other bacteria in knee replacement. 
The number of isolates with S. aureus and group D streptococci was rela-
tively high. The latter organism might be enhanced by cefuroxime 
because it is resistant to the drug, but short antibiotic prophylaxis is 
unlikely to exert much influence on microbial wound flora, especially as 
a significant percentage of postoperative (superficial) wound infection is 
later acquired on the hospital ward15. 
In 77% of the patients, joint sepsis was preceded by wound infection or 
other wound problems. In a large multicentre study, Lidwell et al. found 
woundhealing problems in 40% of the patients with joint sepsis15. As 
patients with wound infection are very much at risk for later joint sep-
sis15,33,34 and the organisms found in postoperative wound infection and 
later joint sepsis are often similar, they should receive bactericidal 
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antibiotic treatment which is guided by the wound cultures. 
Operative cultures 
The percentage of positive perioperative joint cultures is known to 
depend on the culture technique, the level of air contamination16, the 
use of antibiotics17, previous surgery18 and the time of sampling during 
the operation. In primary joint replacement, there is an inconsistent 
relationship between positive cultures and joint sepsis11814"2-. We did not 
find a relationship with joint sepsis and we agree with Rand" that cul-
tures performed in primary replacement are of limited value. 
In revision surgery, the risk of joint sepsis is increased after positive peri-
operative cultures182224. However, one culture does not provide conclu-
sive evidence, because false positive results frequently occur. It is only 
possible to differentiate between sepsis and loosening by taking five or 
more periprosthetic tissue biopsies for culturing (each taken with a dif-
ferent pair of sterile forceps). Growth in one or two samples is a strong 
indication of contamination, whereas growth in all five biopsies is a 
strong indication of joint sepsis. Systemic perioperative antibiotics 
should not be administered until all the biopsies have been taken10,2-'. 
Drain cultures 
The incidence of positive vacuum-drain cultures in this series was about 
15% for hip and knee replacements. Other authors have reported per-
centages from 5.8% to 9.2%2'2627 and most of the microorganisms 
belonged to the skin flora group. Our results confirmed that there were 
more positive cultures if the drains were left in situ longer2126. 
In a few patients, similar pathogens were cultured from the drains and 
the joint in the case of sepsis. In many others, skin flora was cultured 
because it is difficult to keep the drain tip sterile during removal from 
the drain wound. 
When a surgeon requires information on the microbiology of the surgi-
cal wound, the wound culture is a far more reliable indicator of the risk 
for joint sepsis. Routine drain cultures can therefore be abandoned. 
Urinary tract infection 
We found a 15 to 18% postoperative incidence of urinary tract infec-
tion. This is well within the range of those reported by other authors, 
who found a rate of 4 to 26% in joint replacement1,20'21'27. Lower inci-
dences have been found in series in which the antibiotic prophylaxis was 
prolonged over several days1,28. With our short prophylaxis, we did not 
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find an increased incidence of Pseudomonas and Enterobacter as other 
authors did2" after the prolonged use of cefalosporin. 
We could confirm that most urinary tract infections are catheter- rela­
ted and that the incidence increases with time2e24. Catheter removal 
before the third day is advised, as five patients developed septicaemia 
from the urinary tract after the catheter had been left in situ for longer 
than 72 hours. 
Haematogenous seeding in the early postoperative period did not occur, 
although several other authors have reported this complication2"№ и . 
The relationship between postoperative urinary tract infection and joint 
sepsis in this series 33 was therefore not a causal one. In one patient who 
underwent knee replacement and developed an infected draining 
wound, secondary contamination may have originated from the urinary 
tract. 
In 26 patients with joint sepsis, S. aureus (42%), S. epidermidiî (12%), 
gram-negative bacteria (24%) and anaerobic bacteria (4%) were identi-
fied as causative agents. Cefuroxime provided adequate coverage of this 
bacterial spectrum. 
Wound infection preceded later joint sepsis in 12 out of the 26 patients 
with this complication. If S. aureus, gram-negative and other organisms 
were cultured from the postoperative wound, the risk for joint sepsis 
increased 23, 17 and 10 times, respectively. S. epidermidis was not related 
to joint sepsis. In knee replacement the risk was 17 times increased after 
isolation of gram-negative organisms and 15 times after other speciae 
and there was no relation with S. aureus and S. epidermidis. 
Perioperative cultures were positive in 4.2% but were not related to 
joint sepsis. Positive drain cultures did relate, but the wound culture was 
considered to be far more reliable. Routine perioperative and vacuum-
drain cultures do not provide any useful additional information. 
Postoperative urinary tract infections occurred in 15% of the patients. 
There was an increased risk for joint sepsis, but this could not be 
explained by early postoperative haematogenous bacterial seeding. The 
urinary tract infections were strongly related to the use of indwelling 
catheters. Removal of the catheter before the third day is recommend-
ed, as five of the patients in this study developed septicaemia after the 
catheter had been in situ for more than 72 hours. 
Acknowledgements The authors wish to thank the orthopaedic surgeons and all personnel of the par-
ticipating orthopaedic departments for the contribution to the study, Dr О M LidwcU (MRC 
Common Cold Unit, Harvard Hospital, Salisbury, \Viltshirc,L* К ) for advice on interpretation of 
the trial results, Glaxo В V 1 he Netherlands, who supplied the cefuroxime and financially sup­
ported the study and mrs J M Abma-Hill who corrected the English language 
93 
References 
1 Hill С , Mazas F , Flamant R , Evrard J , Prophylactic cefazolin versus placebo in 
totaJ hip replacement lariceti 795-797, 1981 
2 Encsson С , Lidgren L , Cloxacilhn in the prophylaxis of postoperative infections 
of the hip J Bone and Joint Surg 55A 808-813, 1973 
3 bdwell Ο M , Lowbury EJ L , Whyte W , Blowers R , Stanley S J , Lowe D , 
EITecl of ultraclean air in operating rooms on deep sepsis m the joint after total 
hip or knee replacement A randomized study Br Med J 285 10-14, 1982 
4 Pollard Ρ , Hughes S Ρ F , Scott J E , Evans Μ J , Benson Μ Κ D , Anübiotics 
prophylaxis in total hip replacement Br Med J 1 708-709,1979 
5 Heydemann J S , Nelson С L , Short-term preventive antibiotics Clin Orthop 205 
184-187, 1986 
6 Wymenga Α Β , Van Horn J R , Theeuwes A , Muytjens H L, SloofT T J J Η , 
Joint sepsis after infection prophylaxis with one or three doses of cefuroxime in 
2651 hip replacements A randomized controlled multicentre study Submitted 
for publication 
7 Wymenga Λ Β , Van Horn J R , Theeuwes A , Muytjens H L , Slooff T J J Η , 
Joint sepsis after infection prophylaxis with one or three doses of cefuroxime in 
362 knee replacements A randomized controlled multicentre study Submitted 
for publication 
8 Carlsson A S, Josefsson G , Lindberg L , Revisions with gentamicin-impregnated 
cement for deep infections in total hip arthroplasties J Bone and Joint Surg 60A 
1059-1064, 1978 
9 Whyte W , Hodgson R , Tinkler J , Graham J , The isolation of bactena of low 
pathogenicity from faulty orthopaedic implants J Hasp Inf 2 219-230, 1981 
10 Lidwell Ο Μ , Lowbury E J L , Whyte W , Blowers R , Stanley S J , Lowe D , 
Bactena isolated from deep joint sepsis after operation for total hip or knee 
replacement and the sources of the infections with staphyloccus aureus J Hasp 
Inf 4 19-29, 1983 
11 Inman R D , Gallegos К V , Brause В D , Redecha Ρ В , Chnstian С L , Clinical 
and microbial features of prosthetic joint infection Am J Med 77 47-53,1984 
12 Buchholz H W , Elson R A A , Wegelbrech E , Lodenkamper Η , Rottger J , 
Siegel J , Management of deep infection of total hip replacement J Bone and Joint 
Surg 63В 342-353, 1981 
13 Blomgren G , Hematogenous infection of total joint replacement Acta Orthop 
Scand (Suppl 187)52 7-63, 1981 
14 Sanderson Ρ J , The choice between prophylactic agents for orthopaedic surgery 
J Hasp Inf Π (suppl С) 57-67, 1988 
15 Lidwell О M , Lowbury Ε J L , Whvte W , Blowers R , Stanley SJ , Lowe D , 
Infection and sepsis after operations for total hip or knee joint replacement Influ­
ence of ultraclean air, prophylactic antibiotics and other factors J Hyg Cambr 93 
504-529, 1984 
16 Nelson J Ρ , Operating room environment clean rooms and personnel-isolator 
systems In Infection in joint replacement surgery Prevention and management Ed N S 
Eftekhar, С V Mosby, 166-178, 1984 
17 Lidwell О M , Lowbury E J L , Whyte W , Blowers R , Stanley S J , Lowe D , Air­
borne contamination of wounds in joint replacement operations the relationship 
to sepsis rates J Hasp Inf 4 111-131, 1983 
18 fieljen R , Stinchfield F Ε , Michelsen С В , The significance of intracapsular cul­
tures in total hip operations Smg Gyn Obst 144 699-702, 1977 
19 Fitzgerald R H , Nolan D R , llstrup D M , Van Scoy R Ε , Washington I I J Α., 
94 
Coventry M.В., Deep wound sepsis following total hip arthroplasty. J . Bone and 
Joint Surg. 59A: 847-855, 1977. 
20. Surin V.V., Sundholm К., Backman L, Infection after total hip replacement with 
special reference to a discharge from the wound. J . Bone and Joint Surg. 65B: 412-
418, 1983. 
21. Muiier J.C., Cheng N., van Toumhout В., Vandepitte J., Debryune H., Eifect of 
combined use of a clean air system and one day prophylactic administration of 
cefamandole in total hip replacement. Arch. Orthop. Ттаит. Surg. 98: 29-33, 1981. 
22. Rand J.Α., Fitzgerald Rr.H., Diagnosis and management of the infected total 
knee arthroplasty. Orthop. Clin. NAm. 20(2): 201-210, 1989. 
23. Dupont J.A., Significance of operative cultures in total hip arthroplasty. Clin. 
Orthop.211: 122-127,1986. 
24. Ritter M.A., Stringer E.A., Intraoperative wound cultures: Their value and long-
term effect on the patient. Clin. Orthop. 155: 180-185, 1981. 
25. Kamme CK., Lindberg L, Aerobic and anaerobic bacteria in deep infections 
after total hip arthroplasty. Clm. Orthop. 154: 201-207, 1981. 
26. Willet K.M., Simmons CD., Bendey G., The effect of suction drains after total 
hip replacement. J . Bone and Joint Surg. 7 0B: 607-610, 1988. 
27. Evrard J., Doyon F., AcarJ.F., Salord J.C., Mazas F., Flamant R., Two-day 
cefamandole versus five-day cephazolin in 965 total hip replacements. Int. Orthop. 
12: 69-73, 1988. 
28. Donovan Τ L., Gordon R.O., Nagel D.A., Urinary tract infections in total hip 
arthroplasty. J. Bone and Joint Surg. 58A: 1134-1137, 1976. 
29. Stamm W.E., Nosocomial urinary tract infections. In: Hospital infections, Eds. 
Benett J.V and Brachman P.S., Little, Brown and Co., Boston/Toronto, 375-384, 
1986. 
30. Wroblewski B.M., Del Sei HJ., Urethral instrumentation and deep sepsis in total 
hip replacement. Clin. Orthop 146: 208-212, 1980. 
31. Benson M.K.D., Hughes SP.F., Infection following total hip arthroplasty in a 
genera] hospital without special orthopaedic facilities. Acta Orthop. Scand. 46: 968-
978, 1975. 
32. Irvine R., Johnson B.L., Amstutz H . C , The relationship of genitourinary tract 
procedures and deep sepsis after total hip replacement. Surg. Gyn. Obttet. 139: 701-
706, 1974. 
33. Wymenga A.B., Van HomJ.R., Theeuwes Α., Muytjens H.L., SloolT T.J.J.H., 
Risk factors for joint sepsis in hip replacement. Submitted for publication 
34. Wymenga A.B., Van Hom J R . , Theeuwes Α., Muytjens H.L., Slooff T.J.J.H., 
Risk factors for joint sepsis in knee replacement. Submitted for publication. 
95 

Chapter Vili 
The use of additional antibiotics after a single 
dose or three doses of perioperative cefuroxime 
prophylaxis in hip and knee replacement 
A report on 2651 hip and 362 knee replacements 
A.B. Wymenga*, Y.A. Hekster**, A. Theeuwes***, 
H.L. Muytjens****,J.R. van Horn* and T J J . H . SloofT 
Summary 
We analysed the amount of additional antibiotics prescribed afler hip and knee 
replacement surgery during which penoperatwe infection prophylaxis had been admin-
istered either as one dose or three doses of cefuroxime. The Defined Daily Dose 
(DDD) methodology for measuring drug use was employed. A total of 2651 hip and 
362 knee replacements were performed: 1502 patients received a single perioperative 
dose of ce/uroxime and 1511 received three penoperatwe doses of cefuroxime. 
No relevant differences were observed between the groups who received a single dose 
and the groups who recewed three penoperatwe doses of cefuroxime with respect to the 
total amount, the type, the indication and duration of additional antibiotic therapy 
Additional antibiotics were used in 21% of the patients after hip replacement and in 
31% after knee replacement. An amount of 11.4 DDD per 100 bed days was 
administered in hip replacement and 15.7 DDD per 100 bed days in knee replace-
ment. For wound problems, 3.8 and 6.9 DDD per 100 bed days were given in the 
hip and knee replacement groups, respectwely. For distant infection, such as in the 
unnary tract, 6 5 DDD per 100 bed days were administered in both the hip and the 
knee group. The duration of antibiotic therapy varied only in relation to the indica-
tion The antibiotics most frequently prescnbed were penicillin (43-50%), sulfon-
amides (18%), cephalosponns (10-16%) and nitrofurantoin (8-13%); drug use 
was found to be related to the type of infection. 
*= Department of Orthopaedic Surgery, **= Department of Clinical Pharmacy, ***= Medical 
Statistics Department, ****= Department of Medical Microbiology, St Radboud Hospital, Um-
vcrsilv of Nijmegen 
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Introduction 
During the past decades, various trials have demonstrated that a short 
perioperative course of antibiotics for the prevention of infection is 
effective in several surgical procedures and even a single dose has been 
advocated in selected cases'2. In joint replacement surgery, no differ-
ence was found between 14, 7 and 1 dayM and 5 and 2 days of prophy-
laxis1. Recently, a prospective randomized controlled trial was per-
formed in order to compare the efficacy of a single perioperative dose of 
ccfuroxime in hip and knee joint replacement surgery, to a three dose 
regimen which also served as a control'17. 
The purpose of this study was to uncover details concerning the total 
amount, type, indication and duration of additional antimicrobial treat-
ment used after a single dose or three doses of perioperative cefuroxime 
prophylaxis in hip and knee replacement surgery. 
Patients and methods 
From July 1986 to July 1988, a prospective randomized controlled trial 
was performed at 27 Dutch hospitals with conventionally-ventilated 
operating theatres. In the single dose group and the three dose group, 
1500 mg of cefuroxime were administered intravenously at the induc-
tion of anaesthesia. In the three dose group, the patients also received 
750 mg of cefuroxime i.v. after 8 and 16 hours, respectively. 
Patients who underwent total hip replacement, hemiarthroplasty of the 
hip or total knee replacement, were eligible for participation in the 
study. The most important exclusion criteria were the use of antibiotics 
less than 48 hours before the operation, the administration of other 
perioperative antibiotics than cefuroxime, former or current infections 
in the joint and the use of gentamicin-impregnated bone cement; the 
latter was often used in high risk patients. The study was approved by 
the ethics committees at all the hospitals. 
Definitions 
- Joint sepsis was defined as a positive culture from the joint at reopera-
tion or a draining sinus. 
- Strong evidence of joint sepsis was defined as four or more possible 
signs of sepsis present at follow-up (pain on weight-bearing and/or at 
rest, tenderness of the wound, fever, an X-ray with pcriostial reactions 
or progressive bone resorption, an increased erythrocyte sedimenta-
tion rate (20 mm above the preoperative value or > 35 mm), a posi-
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tive joint aspiration, a positive arthrogram, a bone scan showing typi­
cal signs of infection or an increased C-reactive protein). 
- Wound infection was simply defined as an area of erythema of more 
than one centimetre measured from the incision. 
- Minor woundhealing problems were defined as an area of erythema 
of less than 1 cm measured from the incision, pus suture, small wound 
dehiscence, necrosis of the wound edge and blisters. 
- Distant infections were diagnosed on the basis of positive cultures. In 
the urine, more than 105 bacteria/ml was defined as a positive culture. 
Blood cultures of Staphylococcus epidermidis were only regarded as posi­
tive if cultured twice or more. Only a few skin, pulmonary and other 
infections were diagnosed on a clinical basis. 
Patients 
A total of 3074 hip and 455 knee operations entered the trial, of which 
278 hip and 58 knee operations were excluded. The most frequent rea­
son for exclusion was the use of gentamicin-impregnated bone cement. 
From the remaining 2796 hip and 397 knee replacements, 145 and 35 
were withdrawn, respectively. The major reasons were the administra­
tion of the wrong type and/or dose of antibiotics, death (not sepsis-rela­
ted) within 7 days of the operation or a second operation within the 
same period of hospitalization. This left 2651 hip replacements (2547 
patients) and 362 knee replacements (345 patients) for analysis. This 
series therefore represents a rather homogeneous group of patients who 
underwent replacements, from which a number of high risk patients 
were eliminated due to the use of gentamicin bone cement. The hip and 
knee replacements were analysed separately; the patient characteristics 
and trial results are shown in Table I. 
The incidence of joint sepsis in hip replacements was 0.83% in the sin­
gle dose group (95% confidence limits 0.33-1.32) and 0.45% in the 
three dose group (95% confidence limits 0.08-0.81). In the knee replace­
ments, the incidence was 1.71% in the single dose group (95% confi­
dence limits 0.09-3.33%) and 3.20% in the three dose group (95% con­
fidence limits 0.63-5.77). These incidences are comparable with those 
reported in other large series on hip and knee replacements 1β"11. 
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Table I Summary of patient charactmstics and tnal results 
HIP REPIACEMbN Γ KNEb REPLACEMENT 
charactenstics & 1 dose 3 doses total 1 dose 3 doses total 
results n=1327 n=1324 n=2651 (%) n=175 n=187 n=362 (%) 
mean age (years) 
male/female 
DIAGNOSIS 
arthrosis 
rheumatoid arthr 
fracture (fresh) 
other 
previous operations 
joint sepsis 
wound infection 
69 1 
287/1040 
959 
83 
138 
35 
112 
11 
25 
minor wound problems 169 
hacmatoma (l/m/s)# 
wound drainage 
urinary tract infection 
skin infcLtion 
pulmonary infection 
septicaemia 
bed days (mean; 
total 
127/99/28 
166 
201 
31 
18 
5 
26 3 
34919 3 
69 1 
266/1058 
954 
77 
120 
31 
142 
6 
31 
166 
145/82/44 
178 
194 
26 
20 
4 
24 0 
31863 2 
69 1 
553/2098 
1913(72 3) 
160 (6 0) 
258 (9 7) 
66 (2 5) 
254 (9 6) 
17 (0 6) 
56 (2 1) 
335(12 6) 
525 Í20 0) 
344(13 0) 
395(14 9) 
57 (2 2) 
38 (1 4) 
9 (0 3) 
25 2 
66782 5 
70 6 
23/152 
100 
41 
-
1 
33 
3$ 
4 
33 
19/23/5 
30 
32 
2 
3 
-
32 1 
5623 5 
71 1 
23/164 
83 
51 
-
5 
47 
6 
9 
35 
13/26/9 
38 
34 
4 
5 
2 
30 0 
5610 0 
70 9 
46/316 
183(50 6) 
92 (25 4) 
-
6 (2 7) 
80 (22 0) 
9 (2 5) 
13 (3 6) 
68(18 8) 
97 (26 8) 
68(18 8) 
68v18 8) 
6 (17) 
8 (2 2) 
2 (0 6) 
310 
11233 5 
(# = light/moderatc/scvere, $ — one other infection was diagnosed in a withdrawn 
patient who received three doses instead of a single dose ) 
Defined daily dose 
To enable comparisons between the two groups of patients regarding 
their overall antibiotic drug use, the methodology of the Defined Daily 
Dose (DDD) was used14. The level of the DDD is based on the main 
indication for the drug and is expressed -where possible- as the weight 
of active substance. For each individual antibiotic drug, the total 
amount in grams was calculated and divided by its DDD value (depend-
ing on the route of administration) to give the total amount of DDDs. 
By adding the DDD values for the drugs, group DDDs and the total 
amount of DDDs was assessed. The DDD values were taken from the 
Nordic Statisdcs on Medicines'5. 
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DDD per 100 bed days 
To make comparisons possible, the total value of DDDs was analysed in 
relation to the total number of bed days. For the hospitals, this relation-
ship was expressed as DDD per 100 bed days. This unit provides a 
rough estimate of the proportion of patients that would receive antibio-
tic drug treatment. The total number of bed days was calculated from 
the data of individual patients. The number of bed days in hospital was 
missing in 45 patients and a correction was performed by adding the 
mean number of bed days from the patient group concerned for each 
missing value (Table I). 
Results 
Additional antibiotics 
Additional antibiotics were prescribed in 20.7% of the hip replace-
ments, versus 31.2% of the knee replacements. The percentage of 
patients on poly-therapy was also somewhat higher in the knee group 
than in the hip replacement group. There was no difference between 
the use of antibiotics in the single and three dose groups for either oper-
ation (Table II). 
Table II Number of replacements with no therapy, mono therapy and poly-antibiotic therapy 
HIP REPLACEMENT KNEE REPIACEMENT 
1 dose (%) 3 doses (%) total (%) 1 dose (%) 3 doses (%) total (%) 
no 
antibiotics 1047 (78 9) 1054 (79 6) 2101 (79 3) 123 (70 3) 126 (67 4)249(68 8) 
mono-
therapy 224 (16 9) 222 (16 8) 446 (16 8) 40 (22 9) 49 (26 2) 89(24 6) 
poly-
therapy 56 (4 2) 48 (3 6) 104 (3 9) 12 (6 9) 12 (6 4) 24 (6 6) 
Total 1327 1324 2651 175 187 362 
Indication for additional antibiotics 
The amount of additional antibiotics, with the indication for which they 
were prescribed, is shown in Table III, expressed as DDD per 100 bed 
days. No large differences were observed between the single and three 
dose groups in hip and knee replacements. 
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The total amount of antibiotics prescribed was higher in the knee 
replacement group: nearly twice the amount of antibiotics were pre­
scribed for wound problems and temperature e.c.i. The amount of 
antibiotics administered for distant infections in hip and knee replace­
ment was fairly similar (around 6.5 DDD per 100 bed days). In the hip 
replacement group, the largest amount of antibiotics was administered 
for distant infections (53%) and somewhat less for wound problems 
(33%). In knee replacement, the amount of antibiotics administered for 
wound problems (44%) and distant infections (42%) was similar. 
Tabk III Amount of additional antibiotics presabed per indication in DDD per 100 bed days 
HIP REPIWCEMENT KNEE REPLACEMENT 
Indication 
antibiotics 
wound 
distant infection 
temperature e с ι 
other 
totals 
1 dose 
n=1327 
3 56 
5 84 
I 19 
0 47 
1105 
(%) 
(32 2) 
(52 9) 
(iom 
(4 3) 
(100) 
3 doses 
η=Π24(%) 
3 81 (32 3) 
6 51 (55 1) 
1 12 (9 5) 
0 18 (1 5) 
1182 (100) 
total 
n=2651 (%) 
3 77 (33 0) 
6 15 (53 9) 
I 15 (10 1) 
0 33 (2 9) 
1143 (100) 
Idose 
n=175 (%) 
6 88 (44 2) 
6 81 (43 8) 
176 (113) 
O i l (07) 
15 56 (100) 
3 doses 
n=187(%) 
6 94 (43 2) 
6 34 (39 5) 
2 50 (15 6) 
0 12 (ПЯ) 
16 05 (100, 
total 
n=362 
691 
6 57 
2 12 
0 13 
15 71 
(«/„) 
(44 0) 
Í418) 
(13 5) 
(0 7) 
(100) 
Duration of treatment 
The length of antibiotic treatment in days is shown in Table IV. In hip 
replacement, no large differences were observed between the single and 
three dose groups although the number of patients in the single dose 
group with wound problems was somewhat higher than in hip replace-
ment. The differences observed in the knee replacement group can be 
explained by the smaller number of patients and the large range of 
treatment days between the patients. 
The overall length of antibiotic therapy for hip and knee replacement 
was fairly similar and depended mainly on the indication for antibiotic 
therapy and not on the type of operation. In this trial, orthopaedic sur-
geons prescribed antibiotics for wound problems for an average period 
of 18 days, for distant infections 10 days and for temperature e.c.i. 12 
days. 
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Table ¡V Mean duration of additional anhbwtx therapy per indication (m days) in combination with 
the number of patients recewing antibiotics (n) 
Indication 
wound 
distant infection 
temperature e с ι 
other 
days 
(η) 
days 
(η) 
days 
(η) 
days 
(π) 
H I P R E P L A C E M E N T 
1 dose 
n=1327 
169 
(48) 
9 7 
(196) 
127 
(18) 
3 3 
(35) 
3 doses 
n=1324 
18 7 
(40) 
1 1 0 
(198) 
1 2 6 
(18) 
2 3 
(24) 
total 
• n = 2 6 5 1 
1 7 7 
(88) 
9 6 
(394) 
127 
(36) 
3 0 
(59) 
K N E E R E P L A C E M E N T 
1 dose 
n = 1 7 5 
23 8 
( Π ) 
1 1 0 
(30) 
9 6 
(8) 
1 0 
(7) 
3 doses 
n = 1 8 7 
15 3 
(15) 
8 6 
(38) 
1 4 3 
(7) 
1 0 
(5) 
total 
n = 3 6 2 
18 8 
(26) 
9 7 
(68) 
1 1 8 
(15) 
1 0 
(12) 
Types of antibiotic 
In Table V, the DDD per 100 bed days for the several groups of anti­
biotics is shown. The antibiotics prescribed most often were (in descend­
ing order): the penicillin, the sulfonamides, the cephalosponnes and 
nitrofurantoin. The only striking difference between the two types of 
operation was a higher DDD per 100 bed days for the penicillin group 
in knee replacements. Within the cephalosporin group, first generation 
cephalosporins, such as cefazolin, were prescribed in 85%, second ge­
neration cephalosporins in 14% and third generation in only 1%. 
Table V Types of additional antibiotic presabed in DDD per 100 bed days 
Type of 
antibiotic 
penicillin 
sulfonamides 
cefalosporms 
nitrofurantoin 
aminoglycosides 
quinolones 
tetracyclines 
metronidazole 
miconazols 
erythromycine 
isomazid 
hncosamidcs 
fusidic acid 
HIP REPLACEMENT 
1 dose 
n=1327 
4 767 
1990 
1 787 
1638 
0 424 
0 136 
0 195 
0 060 
0014 
0 043 
-
-
-
3 doses 
η=Ι324 
5 115 
2 224 
1 958 
1480 
0 224 
0 260 
0 191 
0 099 
0 024 
0 220 
0 020 
-
-
total 
n=2651 
4931 
2 101 
1 873 
1 562 
0 329 
0 199 
0 193 
0 078 
0 021 
0013 
0010 
-
-
(%) 
(43 1) 
(18 4) 
(16 4) 
(13 7) 
(2 9) 
(17) 
(17) 
(0 7) 
(0 2) 
(0 1) 
(0 1) 
-
-
KNEE REPLACEMENT 
1 dose 
n=175 
7 499 
2916 
1095 
0 871 
0 320 
0 402 
0 089 
0 024 
-
-
-
0 551 
1 280 
3 doses 
n=187 
7 747 
2 754 
2 060 
1640 
0 184 
0 378 
0 335 
-
-
0 285 
-
0 281 
-
total 
n=362 
7 890 
2 835 
1582 
1 255 
0 249 
0 381 
0316 
0012 
-
0 142 
-
0 416 
0 641 
(%) 
(50 2) 
(18 0) 
(10 1) 
(8 0) 
(16) 
(2 4) 
(2 0) 
(0 1) 
-
(0 9) 
-
(2 7) 
(4 1) 
Total 1105 1182 1143 (100) 15 56 16 05 15 71 (100) 
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Type of antibiotic and indication 
More detailed information on the type of antibiotic prescribed for a par-
ticular indication, is presented in Table VI. Penicillins were the drug of 
choice for wound problems in both hip and knee replacement in more 
than two-thirds of the cases. Within this group, flucloxacillin was pre-
scribed in 89%. 
For distant infections (the majority being urinary tract infection -Table 
I), sulfonamides were the most popular (33-35%); the amount of nitrofu-
rantoin (19-25%) and penicillin (25-28%) was fairly similar. For distant 
infections in the penicillin group, amoxycillin was prescribed in 54% 
and flucloxacillin in 29%. 
Tabk VI Types of additional antibiotic prescribed for wound problems and distant infection in DDD 
per 100 bed days 
HIP REPLACEMENT KNEE REPIACEMENT 
Type of wound 
antibiotic problems 
sulfonamides 
nitrofurantoin 
penicillin 
cephalosporins 
tetracyclines 
quinolones 
aminoglycosides 
metronidazole 
crythromicine 
miconazole 
lincosamides 
isoniazid 
fusidic acid 
'total 
0 043 
-
2 522 
0 885 
0 031 
0 048 
0 127 
0015 
0 103 
-
-
-
-
3 770 
(%) 
(12) 
-
(66 7) 
(23 3) 
(0 8) 
(13) 
(3 4) 
(0 4) 
(2 7) 
-
-
-
-
(100) 
distant 
infecuon 
2 033 
1 550 
1 534 
0 527 
0 147 
0 147 
0 122 
0 052 
0 024 
0015 
-
-
-
6 148 
(%) 
(33 0) 
(25 2) 
(24 9) 
(8 6) 
(2 4) 
(2 4) 
(2 0) 
(0 8) 
(0 4) 
(0 2) 
-
-
-
(100) 
wound 
problems 
0 249 
-
4 781 
0 356 
0312 
-
0 230 
-
-
-
0 320 
-
0 641 
6911 
(%) 
(3 6) 
-
(69 2) 
(5 2) 
(4 5) 
-
(3 5) 
-
-
-
(4 6) 
-
(9 3) 
(100) 
distant 
infecüon 
2 328 
1 255 
1855 
0 595 
-
0 381 
-
0012 
0 142 
-
-
-
-
6 568 
(%) 
(35 4) 
(19 1) 
(28 2) 
(9 1) 
(5 8) 
-
(0 2) 
(2 7) 
-
-
-
(100) 
Discussion 
Joint sepsis 
In hip replacement, the difference in joint sepsis between the single and 
three dose group was 0.38% with an upper confidence limit of 0.90%. 
We could therefore not confirm that a single dose of cefuroxime was as 
equally effective as a three dose regimen6. The trial sample in the knee 
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replacement group was too small to draw definite conclusions'. A longer 
follow-up (with probably more cases of joint sepsis) is presently under-
way. 
Use of additional antibiotics 
In this study, data are presented on the use of additional antibiotics after 
a short course of perioperative prophylaxis, using a single dose or three 
doses of cefuroxime. In 20% of the hip and in 30% of the knee replace-
ments, additional antimicrobial therapy was given. This use of antibi-
otics could partly be seen as a consequence of hospital-acquired infec-
tions. The prevalence of such infections varies widely between the 
hospitals (3.2% to 20%)lfi. 
Mono-therapy was employed in the majority of cases requiring antibio-
tic treatment. By using the DDD per 100 bed days methodology, it was 
possible to compare the use of antibiotics between groups. The analysis 
showed that the prescription of antibiotics was parallel in both groups 
and did not detect any difference per indication for antibiotic treatment. 
The use of antibiotics in knee replacement was higher than in hip 
replacement. This phenomenon can be explained by the higher inci-
dence of postoperative wound problems and joint sepsis (Table I), as has 
also been found by several other authors'^'3. Therefore, orthopaedic 
surgeons are inclined to administer antibiotics more often after knee 
replacement surgery, even for less serious woundhealing problems. 
The duration of treatment for the different kinds of infection did not dif-
fer between the knee and the hip group. This confirms the idea that 
irrespective of the type of operation, wound problems and distant infec-
tions are treated in a similar way. 
Wound infections were caused by the staphylococcus species in 51% of 
our patients". It therefore seems worthwhile to choose a drug which 
covers these strains. For wound problems, penicillin and cephalosporins 
were prescribed for more than 60% of the cases (Table VI). Within the 
penicillin group, flucloxacillin was indeed chosen, as were the first gen-
eration cephalosporins, such as cefazolin. These drugs have broad cov-
erage against staphylococci. Penicillin and cephalosporins were used 
mainly for wound infections. 
For distant infections, mosdy comprising urinary tract infections, sulfon-
amides in combination with trimethoprim were the drugs of choice. 
Nitrofurantoin was also popular. These drugs provide good coverage 
against the common causative microorganisms which can be found in 
these infections. 
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This study shows that using the DDD methodology, no relevant differ­
ences were found between a single dose and three doses of penoperative 
cefuroxime in hip and knee replacements, with respect to the amount, 
type, indication and duration of additional antibiotic therapy 
The number of patients who received additional antibiotics was consi­
derable and the main indications were distant infection (usually urinary 
tract infections) and woundhealmg problems In the knee replacement 
group, more antibiotics were used than in the hip group, mainly for 
woundhealing problems. 
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Chapter IX 
Summary 
Joint sepsis after prosthesis implantation still is one of the most severe 
complications after replacement surgery, although the incidence has 
fallen from 10% to 1-3% during the past decades. A review of the cur-
rent literature (chapter II) revealed that most prosthesis-related infec-
tions are initiated during operation by contamination with bacteria-car-
rying particles from the air as a result of dispersion of skin scales from 
individuals in the operating room. A small number of infections is 
caused by hematogenous seeding of bacteria. Glycocalyx, a slime layer 
produced by bacteria, plays an important role in the pathogenesis of 
infections, especially in the presence of biomaterial. 
Clean-air systems in combination with perioperative systemic antibiotics 
reduce prosthesis-related infections from 3 or 4 per cent to a few per 
thousand. The use of antibiotic-loaded bone cement is advised in high 
risk patients although further evaluation is needed. 
Physical examination of the patient, laboratory tests such as the E.S.R. 
and C-reactive protein, serial radiograms, isotope scanning techniques 
and joint aspiration can all help diagnose prosthesis-related infection. 
However a definitive diagnosis is possible only by culturing several sam-
ples of material obtained from the interface during revision operation. A 
perioperative frozen section of interface tissue showing acute (more than 
5 leucocytes per field, 500 x) or severe chronic inflammation (more than 
50 lymphocytes) is higly suggestive of sepsis. 
A single perioperative antibiotic dose is increasingly used in orthopaedic 
surgery and since there were no studies available about the efficacy of a 
single dose prophylaxis in joint replacement we performed a random-
ized controlled trial, stratified for hip and knee replacement. The expe-
rimental arm recieved one dose of cefuroxime and the control group 
received three doses (24 hours). All operations were performed in con-
ventionally ventilated operating rooms. Hip and knee replacements 
were separately analysed after the trial because patient characteristics 
and incidence of joint sepsis differed considerably in both groups. 
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In chapter III, 2651 hip replacements were analyzed, 1327 patients 
recieved a single dose and 1324 patients three doses of cefuroxime. There 
were no differences between the incidence of postoperative woundheal-
ing problems, urinary tract and other distant infections in the one and 
three dose group and the usage of antibiotics after prophylaxis did not 
differ either. 
After a mean follow-up of 13 months, joint sepsis was diagnosed in 17 
patients (0.64%); 11 in the one dose group (0.83%, 95% confidence li­
mits 0.33 - 1.32%) and in б in the three dose group (0.45%, 95% con­
fidence limits 0.08 - 0.81%). This difference is not significant (one tailed 
chi-square test, ρ > 0.05). The estimated difference between the one 
and three dose group was 0.38% (95% confidence limits 0-0.9%). 
The equal efficacy of the one dose cefuroxime compared with the three 
dose regimen could, with these low numbers of joint sepsis not be con­
firmed. An extended follow-up, with probably more cases of joint sepsis 
diagnosed, may provide more conclusive data and a three dose regimen 
is recommended untili further data become available. 
The trial results of the knee cohort were reported in chapter IV. 362 
operations were analysed, 175 in the one dose group and 187 in the 
three dose group. There were no differences between the incidences of 
hematoma and minor postoperative woundhealing problems but there 
were more woundinfections in the three dose group. There were also 
no differences between the groups with respect to urinary tract and oth­
er distant infections and antibiotic usage after prophylaxis. 
Alter a mean follow-up of 12 months joint sepsis was diagnosed in 9 
patients (2.45%). Three cases were identified after 175 operations in the 
one dose group (1.7%, 95% confidence limits 0.09-3.33%) and in 6 
after 187 operations in the three dose group (3.2%, 95% confidence 
limits 0.63-5.77%). This difference is not significant (one tailed chi-
square test, ρ > 0.05). The numbers of the operations were too small to 
draw definitive conclusions about the equal efficacy of the single dose in 
large numbers of operations. 
With the prospective data of the dose-defining studies, we were able to 
identify a number of independent acting riskfactors, associated with 
joint sepsis after hip and knee replacement. 
In hip replacement (chapter V) the risk ratio (RR) for joint sepsis was 
increased in patients with diabetes (RR=3.7), failed fracture treatment 
(RR=5.4), and a break in sterility during operation (RR=3.4). Patients 
with a woundinfection were 62.2 times more at risk. 
Patients from whom a woundculture or bloodculture was taken were 11.6 
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and 7.3 times more at risk, patients with a positive urine culture 4.9 times, 
respectively. Also at risk for joint sepsis were patients who left the hospital 
with an unhealed wound at hospital discharge (RR=22.2) or after a dif-
ficult and prolonged reconvalescence period (RR=5.2). A reoperation for 
mechanical complications was another major riskfactor; 4 out of 64 
patients developed joint sepsis after this second operation (RR=9.5). 
Gentamicin bone cement is recommended in high risk patients in order 
to reduce the incidence of joint sepsis. Diabetes patients should be mo-
nitored carefully. Woundinfection is an indication for antibiotic therapy, 
guided by woundculture results and surgical evacuation of a draining 
hematoma in the presence of woundinfection is mandatory. Minor 
woundhealing problems do not form an indication for antibiotic therapy. 
Patients who are discharged from the hospital with an unhealed wound 
or after a difficult reconvalescence period should recicve adjuntive out-
patient care. 
Riskfactors associated with joint sepsis in knee replacement were de-
scribed in chapter VI. Reumatoid arthritis was the most important risk-
factor (RR=5.0) that was identified in the pre- and peroperative period. 
When patients developed a woundinfection or had antibiotics prescribed 
for woundproblems, they ran a very high risk for joint sepsis (RR=17.2 
and 20.8). The risk was also increased in the presence skin necrosis 
(RR=14.7) and wound dehiscence (RR=4.5) especially in combination 
with another woundhealing problem such as erythema or drainage. An 
increased risk was also found in patients from whom a woundculture 
(RR=10.7) or bloodculture (RR=3.9) was taken and in patients who left 
hospital with an unhealed wound (RR=20.3) or with a painfull and lim-
ited knee function (RR=7.0). Reoperation after the index arthroplasty 
was another important risk factor since 3 additional patients of 24 (12.5%) 
developed joint sepsis after reoperation (RR=4.7). 
The use of gentamicin bone cement might be beneficial for high risk pa-
tients with reumatoid arthritis (and probably also diabetes and previous 
surgery), and perhaps also for knee patients without riskfactors since the 
infection rate is approximatly fourfold that of the hip replacements. Fur-
ther trials are needed to evaluate this. Patients with high risk woundpro-
blems should receive adequate antibiotic therapy. This is not indicated in 
the presence of a single minor woundproblem, hematoma or drainage. 
Significant skin defects should be closed. Patients, discharged with an un-
healed wound or painfull limited knee function should undergo frequent 
outpatient visits. 
The relation of wound and urine cultures and later joint sepsis after 
replacement surgery was analysed in chapter VII. In 26 patients with 
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joint sepsis (17 hip replacements and 9 knee replacements) S. aureus 
(42%), S. epidermidis (12%), gram-negative bacteria (24%) and anaerobics 
(4%) were identified as causative agents and cefuroxime adequately co-
vered this spectrum. 
Later joint sepsis was preceded by woundinfection in 12 of 26 patients. 
When S.aureus was cultured from the wound after hip replacement in 
the postoperative period the risk of joint sepsis was 24 times increased, 
with gram-negative bacteria 17 times and with other species 10 times, 
when compared with patients without a woundculture. S. epidermidis was 
not related to joint sepsis. In knee replacement S. aureus and S. epidermidis 
were not related to joint sepsis, but isolation of gram-negative and other 
organisms increased the risk 17 and 15 times, respectively. 
Perioperative joint cultures were positive in 26 out of 622 (4.2%) cases 
but not one of the 26 patients with a positive culture developed later 
joint sepsis. Joint sepsis was related to the 140 of 939 (15%) posidve va-
cuum-drain cultures, but the woundculture was more reliable in pre-
dicting the risk of joint sepsis and the eventual causative agent. Periop-
erative joint cultures and postoperative draincultures are therefore not 
indicated in primary joint replacement. 
Postoperative urinary tract infection occurred in 15% of the patients 
and was related to urinary catheters and the period the catheter was in 
situ. There was an increased risk for joint sepsis in the presence of a pri-
mary tract-infection, but this could not be explained by early postopera-
tive hematogenous bacterial seeding to the joint. Five patients devel-
oped septicaemia with a catheter in situ more than 72 hours and 
removal is recommended before the third day. 
The use of additional antibiotics, prescribed after the routine cefurox-
ime prophylaxis is described in chapter VII. No relevant differences 
were observed, between the groups with a single dose or three doses 
perioperative cefuroxime with respect to the total amount, type, indica-
tion and duration of therapy of the prescribed additional antibiotics. 
The amount of antibiotics was expressed in 'Defined Daily Doses' 
(DDD). 
Additional antibiotics were used in 21% of patients after hip and 31% 
after knee replacement. In total 11.4 DDD per 100 bed days of antibi-
otics were prescribed in hip replacement and 15.7 DDD per 100 bed 
days in knee replacement. For woundproblems 3.8 and 6.9 DDD per 
100 bed days were given in respectively hip and knee replacement. For 
distant infections, such as in the urinary tract, 6.5 DDD per 100 bed 
days were administered in both the hip and the knee group. Duration of 
antibiotic therapy varied only with indication. Most often prescribed 
were penicillins (43-50%), sulfonamides (18%), cefalosporines (10-16%) 
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and nitrofurantoine (8-13%), and drug use was related to the kind of 
infections. 
In this study the efficacy of a single perioperative dose of cefuroxime 
was evaluated in hip and knee replacement surgery, using a three dose 
regimen as control. The incidence of joint sepsis in hip replacement was 
0.64% and in knee replacement 2.45%, respectively. 
No significant differences were found between the one dose group and 
the three dose group with respect to postoperative woundproblems, dis-
tant infections and usage of antibiotics after prophylaxis. 
The equal efficacy of the single perioperative dose cefuroxime, com-
pared with the three dose regimen, could not be confirmed due to the 
low numbers of joint sepsis. A longer follow-up period, with probably 
more cases of joint sepsis diagnosed, may provide more conclusive data. 
We were able to identify a number of important riskfactors for joint sep-
sis from the prospective data of the dose defining study. Instigation of 
additional prophylactic and/or therapeutic treatment is advised in high 
risk patients, in order to reduce the incidence of joint sepsis. 
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Chapter Χ 
Samenvatting 
Prothese-infectie blijft, ondanks een afname van de incidentie in de laat­
ste decaden van 10% tot 1 à 3%, één van de meest gevreesde compli-
caties na gewrichtsvervanging met een endoprothese. In hoofdstuk II 
blijkt uit een overzicht van de recente literatuur, dat de meeste 
prothese-gerelateerde infecties ontstaan tijdens de operatie door con-
taminatie met bacterie dragende deeltjes vanuit de lucht. Deze lucht-
contaminatie ontstaat door het strooien van huidschilfers door personen 
in de operatiekamer. Een klein deel van de infecties ontstaat door 
hematogene uitzaaing van bacteriën. Glycocalyx, een slijmlaag die 
geproduceerd wordt door bacteriën, speelt een grote rol in de Patho-
genese van infecties, vooral in aanwezigheid van biomaterialen. 
Schone-lucht systemen in combinatie met perioperatieve systemische 
antibiotica reduceren het aantal prothese infecties tot enkele per 
duizend. Het gebruik van antibiotica-houdend botcement wordt gead-
viseerd bij risico-patiënten, maar verdere evaluatie van dit cement is 
nodig. 
Lichamelijk onderzoek van de patient, laboratoriumtesten zoals de 
bezinking en het C-reactieve proteïne, seriële röntgenfoto's, isotopen 
scans en gewrichts-aspiraties kunnen waardevol zijn bij het stellen van 
de diagnose van prothese-gerelateerde infecties, maar leveren nooit het 
definitieve bewijs voor infectie. De uiteindelijk diagnose kan slechts 
verkregen worden uit meerdere biopsie-kweken van de interface 
gedurende de revisie operatie. Een peroperatieve vriescoupe van inter-
face met acute ontsteking (meer dan 5 leucocyten per veld, 500x) of ern-
stige chronische ontsteking (meer dan 50 lymfocyten) is sterk suggestief 
voor infectie. 
De éénmalige perioperatieve antibiotica prophylaxe wordt in toene-
mende mate toegepast in de orthopaedic. Omdat er geen studies be-
kend waren over de effectiviteit van de éénmalige dosis prophylaxe bij 
gewrichtsvervangende operaties is een prospectieve gerandomiseerde 
studie verricht, waarin heup- en knie-arthroplastieken werden gestrati-
ficeerd. Patienten in de experimentele arm ontvingen een éénmalige 
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dosis Cefuroxim en de controle groep een driemalige dosis (24 uur). Alle 
operaties werden uitgevoerd in zogenaamde conventioneel geven-
tileerde operatiekamers. De heup- en knieprothesen werden na de trial 
apart geanalyseerd omdat bleek dat het patientenmateriaal en de inci-
dentie van diepe infectie duidelijk verschilde tussen deze groepen. 
In hoofdstuk III werden de resultaten van 2651 heupvervangingen 
geanalyseerd, waarvan 1327 in de één dosis groep en 1324 in de drie 
dosis groep. De groepen waren goed vergelijkbaar. 
Er werden tussen de één en drie dosis groep geen verschillen gevonden 
met betrekking tot postoperatieve wondstoornissen, urineweginfecties, 
andere infecties op afstand en het gebruik van antibiotica na de prophy-
laxe. 
Na een gemiddelde follow-up van 13 maanden werd bij 17 patiënten 
(0.64%) diepe infectie vastgesteld; bij 11 in de één dosis groep (0.83%, 
95% betrouwbaarheidsinterval 0.33-1.32%) en bij 6 in de drie dosis 
groep (0.45%, 95% betrouwbaarheidsinterval 0.08-0.81%). Dit verschil 
is niet significant (eenzijdige chi-kwadraat toets, ρ > 0.05). 
Het geschatte verschil tussen de beide dosis groepen was 0.38% (95% 
betrouwbaarheidsinterval 0-0.9%). De gelijkwaardige effectiviteit van de 
éénmalige dosis Cefuroxim, in vergelijking met de drie dosis prophylaxe, 
kan daarom nog niet worden bevestigd. De huidige aantallen diepe 
infectie zijn te klein om definitieve conclusies te trekken. Een langere 
follow-up met waarschijnlijk meer diepe infecties kan mogelijk meer 
duidelijk verschaffen. Vooralsnog wordt een driemalige dosis gead-
viseerd. 
Hoofdstuk IV beschrijft de resultaten van de trial voor 362 totale knie 
operaties, waarvan 175 plaatsvonden met een één dosis prophylaxe en 
187 met een drie dosis prophylaxe. De groepen waren goed vergelijk-
baar. Er werden tussen de één en drie dosis groep geen verschillen 
gevonden met betrekking tot 'kleine' postoperatieve wondstoornissen, 
urineweginfectie, andere infecties op afstand en het gebruik van antibi-
otica na de prophylaxe. Wel waren er meer wondinfecties in de drie 
dosis groep. 
Na een gemiddelde follow-up van 12 maanden werd bij 9 patiënten 
(2.45%) diepe infectie vastgesteld; bij drie in de één dosis groep (1.71%, 
95% betrouwbaarheidsinterval 0.09-3.33%) en bij 6 in de drie dosis 
groep (3.2%, 95% betrouwbaarheidsinterval 0.63-5.77%). Dit verschil is 
niet significant (eenzijdige chi-kwadraat toets, ρ > 0.05). De steekproef 
voor de kniegroep is te klein om definitieve uitspraken te doen over de 
gelijkwaardige effectiviteit van de éénmalige dosis. 
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Met behulp van de prospectief verzamelde gegevens uit de dosis studie 
waren wij in staat om een analyse uit te voeren naar risicofactoren voor 
diepe infectie bij heup- en knie-arthroplastieken. 
Bij analyse van de heup-arthroplastieken (hoofdstuk V) bleek dat patiën-
ten met diabetes, mislukte fractuur Osteosynthese en steriliteitsonder-
breking tijdens de operatie, respectievelijk 3.7 , 5.4 en 3.4 maal zoveel 
kans op infectie hadden dan patiënten zonder deze factoren. 
In de postoperatieve periode gaf wondinfectie zelfs 62.2 maal meer kans 
op diepe infectie. Patienten van wie een wond- of bloedkweek werd 
genomen, hadden 11.6 en 7.3 maal meer kans en patiënten met een 
positieve postoperatieve urinekweek hadden 4.9 maal meer kans op 
diepe infectie. Wanneer een patient het ziekenhuis verliet met een niet-
genezen wond of na een moeilijke revalidatieperiode was het risico 22.2 
en 5.2 maal verhoogd. Reoperatie in verband met mechanische proble-
men was ook een belangijke risicofactor; 4 van 64 patiënten 
ontwikkelden nog diepe infectie na deze tweede operatie (9.5 maal meer 
kans). 
Voor patiënten met een verhoogd risico wordt het gebruik van genta-
micine botcement aanbevolen als extra prophylaxe tegen infectie. 
Patienten met diabetes dienen perioperatief goed ingesteld te worden. 
Wondinfectie is een indicatie voor antibiotische therapie, op geleide van 
de wondkweek. Bij wondstoornissen zonder wondinfectie is antibioti-
sche therapie niet geïndiceerd. Bij patiënten met wondinfectie en een 
drainerend hematoom is chirurgische evacuatie van het hematoom 
aangewezen. Patienten die het ziekenhuis verlaten met een niet-genezen 
wond of na een moeilijke revalidatieperiode dienen extra poliklinische 
zorg te ontvangen. 
Bij de analyse van de knie-arthroplastieken (hoofdstuk VI) bleek dat 
reumatoide arthritis de belangrijkste risicofactor was voor diepe infectie 
in de pre- en peroperatieve periode, die resulteerde in een 5.0 maal ver-
hoogde kans. 
Patienten met een wondinfectie en patiënten die antibiotica kregen in 
verband met wondproblemen hadden een 17.2 en 20.8 maal verhoogde 
kans op diepe infectie. Het risico was ook duidelijk verhoogd bij wond-
randnecrose (14.7 maal) en wonddehiscentie (4.5 maal), vooral in com-
binatie met andere wondstoornissen zoals roodheid en drainage. Er was 
ook een verhoogd risico voor patiënten van wie wondkweken (10.7 
maal) of bloedkweken (3.9 maal) werden genomen en voor patiënten 
met een niet-genezen wond (20.3 maal) of een pijnlijke en in functie 
beperkte knie (7.0 maal) bij ontslag uit het ziekenhuis. Daarnaast was 
reoperatie in verband met mechanische problemen ook een belangrijke 
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risicofactor; 3 van 24 patiënten ontwikkelden nog diepe infectie na deze-
tweede operatie (4.7 maal verhoogde kans). 
Het gebruik van gentamicine botcement zou het aantal infecties bij risi-
co patiënten met reumatoidc arthritis (en waarschijnlijk ook met diabe-
tes en eerdere operaties) kunnen reduceren. Het dient zelfs overwogen 
te worden bij patiënten zonder risicofactoren, omdat de diepe infectie 
incidentic vier keer zo hoog is als bij heup-arthroplastieken uitgevoerd 
in dezelfde ziekenhuizen. Verdere trials met gentamicine botcement 
zijn nodig om dit te onderzoeken. 
Naast wondinfectie is ook wondrandnecrose en wondranddehiscentie in 
combinatie met andere wondstoomissen een indicatie voor antibiotische 
therapie. Bij een enkelvoudige wondstoornis, hematoom of drainage is 
antibiotische therapie niet geïndiceerd. Grotere huiddefecten moeten 
gesloten worden om diepe infectie te voorkomen. Patienten die het zie-
kenhuis verlaten met een niet-genezen wond of een pijnlijke en in func-
tie beperkte knie dienen nauwkeurig gevolgd te worden. 
De relatie van wond- en urinekweken met latere diepe infectie bij de 
heup- en knie-arthroplastiek werd in hoofdstuk VII geanalyseerd. Bij 26 
patiënten met diepe infectie werden S. aureus (42%), S. epidermidu (12%), 
gram-negatieven (24%) en anaerobe bacteriën (4%) als verwekkers ge-
kweekt en Cefuroxim dekte dit spectrum goed. 
Diepe infectie werd bij 12 van de 26 patiënten door postoperatieve 
wondinfectie voorafgegaan. Als bij de heup-arthroplastiek S. aureus werd 
gekweekt van de postoperatieve wond dan was de kans op diepe infectie 
24 keer verhoogd, bij gram-negatieven 17 keer en bij andere bacteriën 
10 keer, in vergelijking met patiënten zonder wondkweken. Er was geen 
verband met S. epidermidis. Bij de knie-arthroplastiek was geen relatie 
met S. aureus en 5. epidermidu, maar na isolatie van gram-negatieve of 
andere micro-organismen was de kans op diepe infectie respectievelijk 
17 en 15 maal verhoogd. 
Peroperatievc gewrichtskweken waren bij 26 van de 622 (4.2%) patiën-
ten positief, maar niet één patient met een positieve kweek ontwikkelde 
diepe infectie. Diepe infectie was wel gerelateerd aan positieve drain-
kweken (140 van 939, 15%), maar de wondkweek bleek betrouwbaarder 
in het voorspellen van de kans op diepe infectie en een eventuele ver-
wekker van diepe infectie. Peroperative gewrichtskweken en drainkwe-
ken behoeven daarom niet routinematig verricht te worden bij primaire 
arthroplastieken. 
Postoperatieve urineweg infecties kwamen voor bij 15% van de patiën-
ten en er was een duidelijke relatie met urinecathelers en ook met de 
duur van cathetergebruik. Bij heup-arthroplastieken bestond een posi-
tieve relatie tussen postoperatieve urineweg infecties en diepe infectie, 
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maar dit kon niet door vroeg postoperatieve hematogene uitzaaiing ver-
klaard worden. Omdat bij vijf patiënten urosepsis ontstond nadat een 
urinecatheter langer dan 72 uur in situ was, wordt verwijdering van de 
catheter voor de derde dag aanbevolen. 
Het gebruik van antibiotica na de routinematige Cefuroxim prophylaxe, 
werd in hoofdstuk VII beschreven. Er was geen belangrijk verschil tus-
sen de één en drie dosis groep met betrekking tot de hoeveelheid, het 
type, de indicatie en de duur van de gebruikte antibiotica. De hoeveel-
heid antibioticum werd uitgedrukt in zogenaamde 'Defined Daily 
Doses' (DDD). 
Additionele antibiotica werden gebruikt in 21% van de patiënten na 
een heup-arthroplastick en in 31% na een knie-arthroplastiek. In totaal 
werden 11.4 DDD's per 10O bed dagen antibioticum gegeven na een 
heuparthroplastiek en 15.7 DDD's per 100 bed dagen na een knie-
arthroplastiek. Voor wondproblemen werden respectievelijk 3.8 en 6.9 
DDD's per 100 bed dagen antibioticum toegediend na een heup- en 
knie-arthroplastiek. Voor infectie op afstand werden 6.5 DDD's per 100 
bed dagen antibioticum \oorgeschreven na beide operaties. De duur 
van de therapie varieerde alleen met de indicatie. 
Pénicillines (43-50%), sulfonamides (18%), cefalosporincs (10-16%) en 
nitrofurantoine (8-13%) werden het meest voorgeschreven en het anti-
bioticum gebruik was gerelateerd aan het type infectie. 
In deze studie werd de eifectiviteit van een éénmalige perioperatieve 
dosis Cefuroxim onderzocht bij heup- en knie-arthroplastiekcn, met een 
driemalige dosering als controle. De incidentie van diepe infectie bij 
heup-arthroplastieken was 0.64% en bij knie-arthroplastieken 2.45%. 
Er werden, geen significante verschillen gevonden tussen de één dosis 
groep en de drie dosis groep met betrekking tot wondinfectics, wond-
stoomissen, infecties op afstand en het gebruik van antibiotica na de 
prophylaxe. 
De gelijkwaardige effectiviteit van de éénmalige perioperatieve dosis 
Cefuroxim in vergelijking met de driemalige dosering, kon niet bevestigd 
worden door het lage aantal patiënten met diepe infectie. Een langere 
follow-up periode, waarin waarschijnlijk nog meer patiënten met diepe 
infectie gevonden zullen worden, kan in de toekomst meer duidelijkheid 
verschaffen. 
Met de prospectief verzamelde gegevens uit de dosis studie was het 
mogelijk om een aantal belangrijke risicofactoren voor diepe infectie te 
identificeren. Extra prophylactische en/of therapeutische maatregelen 
worden aanbevolen voor patiënten met risicofactoren om de infectie 
incidentie te reduceren. 
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Supplement Ia: General summary of the data of 
the dose-defìning study on hip replacement 
1 dose 3 doses total (%) 
ENTRY, EXCLUSIONS, WITHDRAWALS 
exclusions 
inclusions 
withdrawals 
ANALYSED 
Hospital stay (days) 
preoperative 
overall 
PREOPERATIVE DATA hip 
Age (years) 
0-50 
51-60 
61-70 
71-80 
>81 
Sex 
male 
female 
Quctelet index (kg/m ) 
missing 
<25 
25-30 
>=30 
Physical condition 
good 
moderate 
poor 
141 
1399 
72 
1327 
35 
26 3 
137 
1397 
73 
1324 
27 
24 1 
278 
2796 
145 
2651 
. 
9 04 
5 19 
66 
178 
421 
502 
160 
287 
1040 
216 
422 
526 
163 
1102 
206 
19 
62 
178 
439 
487 
158 
266 
1058 
220 
418 
507 
179 
1123 
184 
17 
128 
356 
860 
989 
318 
553 
2098 
436 
840 
1033 
342 
2225 
390 
36 
4 83 
13 43 
32 44 
37 31 
12 00 
20 86 
79 14 
16 45 
31 69 
38 97 
12 90 
83 93 
14 71 
1 36 
121 
1 dose 3 doses total (%) 
58 
191 
86 
29 
42 
90 
15 
6 
129 
9 
13 
13 
54 
171 
87 
26 
58 
83 
5 
7 
121 
8 
20 
8 
112 
362 
173 
55 
100 
173 
20 
13 
250 
17 
33 
21 
4.22 
13.66 
6.53 
2.07 
3.77 
6.53 
0.75 
0.49 
9.34 
0.64 
1.24 
0.79 
Concurrent discases: 
ens 
cardiovascular 
respiratory tract 
gastro-intestinal 
diabetes 
rheumatoid arthritis 
prostatism 
prolaps/pessarium 
other 
Preoperative infections: 
pulmonary 
skin 
other 
Use of steroids: 36 33 69 2.60 
Type of arthroplasty: 
hemiarthroplasty 
total hip 
Type of surgery: 
primary 
revision 
Side: 
left 
right 
Diagnosis hip: 
idiopathic arthrosis 
post-traumatic arthrosis 
secondary arthrosis 
rheumatoid arthritis 
fracture 
other 
Previous operations hip: 
osteotomy 
prosthesis 
osteosynthesis fracture 
other 
86 
1241 
1301 
26 
649 
678 
919 
14 
91 
88 
176 
39 
42 
26 
33 
11 
81 
1243 
1284 
40 
611 
713 
934 
7 
106 
80 
158 
39 
56 
40 
30 
16 
167 
2484 
2585 
66 
1260 
1391 
1853 
21 
197 
168 
334 
78 
98 
66 
63 
27 
6.30 
93.70 
97.51 
2.49 
47.53 
52.47 
69.90 
0.79 
7.43 
6.34 
12.60 
2.94 
3.70 
2.49 
2.38 
1.02 
122 
1 dose 3 doses total (%) 
PEROPERATIVE DATA hip 
Surgeon: 
staff 
resident 
Acetabular prosthesis: 
no 
cemented 
cementless 
Femoral prosthesis: 
cemented 
cementless 
Approach hip: 
(antero)lalcral 
posterolateral 
Degree of difficulty operation: 
normal 
difficult 
very difficult 
1245 
82 
89 
874 
364 
1117 
210 
439 
888 
1112 
196 
19 
1242 
82 
86 
877 
361 
1099 
225 
422 
902 
1090 
206 
28 
2487 
164 
175 
1751 
725 
2216 
435 
861 
1790 
2202 
402 
47 
93.81 
6.19 
6.60 
66.05 
27.35 
83.59 
16.41 
32.48 
67.52 
83.06 
15.16 
1.77 
Breakdown of sterility: 75 82 157 5.92 
Duration of operation (minutes): 
missing 
< 60 
60-120 
120-180 
>180 
Blood loss (ml): 
missing 
< 500 
500-1000 
1000-1500 
>1500 
Drains used: 
missing 
1 
2 
3 or 4 
28 
360 
807 
125 
7 
55 
609 
481 
128 
554 
3 
68 
959 
297 
18 
352 
811 
134 
9 
37 
625 
462 
133 
67 
4 
62 
981 
277 
46 
712 
1618 
259 
16 
92 
1234 
943 
261 
121 
7 
130 
1940 
574 
1.74 
26.86 
61.03 
9.77 
0.60 
3.47 
46.55 
35.57 
9.85 
4.56 
0.26 
4.90 
73.18 
21.65 
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Wound nnse: 
no 
povidone iodine 
ab-solution 
POSTOPERATIVE DATA hip 
Haematoma: 
light 
moderate 
severe 
Minor woundhcaling problems: 
erythema <= 1 cm 
pus suture 
dehiscence 
blister 
wound edge necrosis 
Wound drainage: 
serous 
purulent 
blood 
Drainage drain wound: 
serous 
purulent 
Wound infection (erythema > 1 
Urine catheter (intermittent): 
once 
twice 
3 times or more 
Urine catheter a demeure: 
< 24 hours 
24-48 hours 
24-72 hours 
> 72 hours 
Drain fluid production: 
< 250 ml 
250-500 ml 
500-750 ml 
> 750 ml 
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Day drain removal: 
l-3rd day 
4th day 
5th day 
> 5th day 
Anticoagulation medication: 
coumanne 
coumanne + heparin 
coumanne + (reo)macrodex 
other 
Situation at discharge: 
wound not healed 
temperature elevated 
painful/limited function 
difficult reconvalescence 
Preoperative sediment (> 5 leucos): 
no 
yes 
COMPLICATIONS: 
orthopaedic (conservative) 
reoperation mechanical 
genera] complication clean 
genera] complication not clean 
invasive diagnostics 
clean general surgery 
not clean surgery 
other elective surgery 
death in hospital 
CULTURES hip 
Wound cultures: 
positive 
negative 
Operative cultures: 
positive 
negative 
Drain culture: 
positive 
negative 
dose 3 doses total (%) 
Urine preoperative: 
positive 
clinica] diagnosis 
negative 
Urine postoperative: 
positive 
clinical diagnosis 
negative 
Pulmonary tract: 
positive 
clinical diagnosis 
negative 
Skin: 
positive 
clinical diagnosis 
Blood: 
positive 
negative. 
Other: 
positive 
clinical diagnosis 
negative 
29 
2 
114 
198 
3 
142 
11 
7 
9 
12 
19 
5 
42 
2 
4 
2 
32 
0 
129 
191 
3 
132 
13 
7 
10 
8 
18 
4 
30 
2 
1 
0 
61 
2 
243 
389 
6 
274 
24 
14 
19 
20 
37 
9 
72 
4 
5 
2 
2.30 
0.08 
9.17 
14.67 
0.23 
10.34 
0.91 
0.53 
0.72 
0.75 
1.40 
0.34 
2.72 
0.15 
0.19 
0.08 
ADDITIONAL ANTIBIOTICS (POSTOPERATIVE) hip 
Wound 
Urine preoperative 
Urine postoperative 
Pulmonarv tract 
Skin 
Other infections 
Temperature cci 
Other reasons 
FOLLOW-UP hip 
Mean follow-up (days) 
Mechanical reoperations 
(Joint sepsis after reoperation 
Joint sepsis 
48 
21 
158 
8 
6 
7 
18 
35 
414 
33 
3 
11 
40 
20 
153 
16 
8 
5 
18 
23 
421 
31 
1 
6 
88 
41 
313 
24 
14 
12 
36 
58 
64 
4 
17 
3.32 
1.55 
11.81 
0.91 
0.53 
0.45 
1.36 
2.19 
2.41 
0.15) 
0.64 
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Supplement Ib: General summary of the data of 
the dose-defining study on knee replacement 
1 dose 3 doses total (%) 
ENTRY, EXCLUSIONS, WITHDRAWALS: 
exclusions 33 25 58 12.7 
inclusions 
withdrawals 17 18 35 8.8 
ANALYSED 
Hospital stay (days): 
preoperative 
overall 
PREOPERATIVE DATA knee 
Age (years): 
0-50 
51-60 
61-70 
71-80 
>80 
Sex: 
male 
female 
Quetelet index (kg/m2): 
missing 
<25 
25-30 
>=30 
Physical condition: 
good 
moderate 
poor 
192 
175 
3.15 
32.13 
205 
187 
4.07 
30.0 
397 
362 
. 
6 
15 
55 
77 
22 
23 
152 
27 
51 
58 
39 
139 
36 
0 
7 
18 
55 
88 
19 
23 
164 
28 
51 
61 
47 
148 
38 
1 
13 
33 
110 
165 
41 
46 
316 
55 
102 
119 
86 
287 
74 
1 
3.59 
9.12 
30.39 
45.58 
11.33 
12.71 
87.29 
15.19 
28.18 
32.87 
23.76 
79.28 
20.44 
0.28 
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1 dose 3 doses total (%) 
Concurrent diseases: 
ens 
cardiovascular 
respiratory tract 
gastro-intestinal 
diabetes 
rheumatoid arthritis 
prostatism 
prolaps/pessarium 
other 
Preoperative infections: 
pulmonary 
skin 
other 
2 
9 
6 
5 
9 
.3 
1 
1 
7 
0 
1 
0 
3 
24 
6 
2 
8 
55 
1 
2 
13 
2 
1 
2 
5 
33 
12 
7 
17 
108 
2 
3 
20 
2 
2 
2 
1.38 
9.12 
3.31 
1.93 
4.70 
29.83 
0.55 
0.83 
5.52 
0.55 
0.55 
0.55 
Use of steroids: 17 17 34 9.39 
Type of surgery: 
primary 
revision 
Side: 
left 
right 
Diagnosis knee: 
idiopathic arthrosis 
post-traumatic arthrosis 
rheumatoid arthritis 
other 
Previous operations knee: 
arthrotomy 
osteotomy 
prosthesis 
menisectomy 
other 
173 
2 
80 
95 
118 
4 
52 
1 
8 
8 
2 
3 
12 
182 
5 
89 
98 
117 
9 
55 
6 
14 
16 
5 
6 
6 
355 
7 
169 
193 
235 
13 
107 
7 
22 
24 
7 
9 
18 
98.07 
1.93 
46.69 
53.31 
64.92 
3.59 
29.56 
1.93 
6.08 
6.63 
1.93 
2.49 
4.97 
PERIOPERATIVE "DATA b e e 
Surgeon: 
staff 
resident 
167 
8 
177 
10 
344 
18 
95.03 
4.97 
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Type of fixation knee prosthesis: 
cemented 
non-cemented 
Type of prosthesis knee: 
non-constrained 
semi-constrained 
Degree of difficulty operation: 
norma] 
difficult 
very difficult 
Breakdown of sterility: 
Duration of operation: 
missing 
<60 
61-120 
121-180 
>180 
Blood loss (ml): 
missing 
<500 
500-1000 
1000-1500 
>1500 
Drains used: 
1 
2 
3 o r 4 
Wound rinse: 
no 
povidone iodine 
ab-solution 
POSTOPERATIVE DATA knee 
Haematoma: 
light 
moderate 
severe 
1 dose 3 doses total (%) 
Minor woundhcaling problems: 
erythema <= 1 cm 
pus suture 
dehiscence 
blister 
wound edge necrosis 
Wound drainage: 
serous 
purulent 
blood 
Drainage drain wound (serous): 
Wound infection (erythema > 1 cm): 
Urine catheter (intermittent): 
once 
twice 
3 times or more 
Urine catheter a demeure: 
< 24 hours 
24-48 hours 
24-72 hours 
> 72 hours 
Drain fluid production: 
missing 
< 250 ml 
250-500 ml 
500-750 ml 
> 1000 ml 
Day drain removal: 
l-3rd day 
4th day 
5th day 
> 5th day 
Anticoagulation medication: 
coumarine 
coumarine + heparin 
coumarine + (reo)macrodex 
other 
33 
16 
0 
12 
2 
6 
23 
1 
6 
6 
4 
7 
4 
1 
14 
14 
4 
23 
5 
11 
60 
39 
60 
156 
14 
4 
1 
119 
35 
8 
13 
35 
19 
2 
14 
1 
6 
28 
3 
7 
5 
9 
9 
3 
5 
9 
20 
13 
18 
7 
16 
73 
39 
52 
169 
15 
1 
2 
129 
38 
9 
11 
68 
35 
2 
26 
3 
12 
51 
4 
13 
11 
13 
16 
7 
6 
23 
34 
17 
41 
12 
27 
133 
78 
111 
325 
29 
5 
3 
248 
73 
17 
24 
18.78 
9.67 
0.55 
7.18 
0.83 
3.31 
14.09 
1.10 
3.59 
3.04 
3.59 
4.42 
1.93 
1.66 
6.35 
9.39 
4.70 
11.33 
3.31 
7.46 
36.74 
21.55 
30.94 
89.78 
8.01 
1.38 
0.83 
68.51 
20.17 
4.70 
6.63 
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1 dose 3 doses total (%) 
Situation at discharge: 
wound not healed 
temperature elevated 
painful/limited function 
difficult reconvalcscence 
Preoperative sediment (> 5 leucos): 
no 
yes 
COMPLICATIONS: 
orthopaedic (conservative) 
reoperation mechanical 
general complication clean 
general complication not clean 
invasive diagnostics 
clean general surgery 
not clean surgery 
other elective surgery 
death in hospital 
CULTURES knee 
Wound cultures: 
positive 
negative 
Operative cultures: 
positive 
negative 
Drain culture: 
positive 
negative 
Urine preoperative: 
positive 
negative 
Urine postoperative: 
positive 
clinical diagnosis 
negative 
Pulmonary tract: 
clinical diagnosis 
negative 
6 
3 
13 
19 
120 
20 
4 
0 
6 
0 
0 
2 
0 
5 
1 
10 
6 
0 
32 
12 
53 
6 
9 
32 
0 
13 
0 
3 
7 
3 
14 
23 
113 
32 
5 
4 
2 
3 
1 
2 
1 
5 
0 
8 
11 
2 
43 
6 
62 
5 
13 
34 
1 
24 
1 
4 
13 
6 
27 
42 
233 
52 
9 
4 
8 
3 
1 
4 
1 
10 
1 
18 
17 
2 
75 
18 
115 
11 
22 
66 
1 
37 
1 
7 
3.59 
1.66 
7.46 
11.60 
64.36 
14.36 
2.49 
1.10 
2.21 
0.83 
0.28 
1.10 
0.28 
2.76 
0.28 
4.97 
4.70 
0.55 
20.72 
4.97 
31.77 
3.04 
6.08 
18.23 
0.28 
10.22 
0.28 
1.93 
131 
1 dose 3 doses total (%) 
Skin: 
positive 1 0 1 0.28 
clinical diagnosis 1 4 5 1.38 
Blood: 
positive 0 2 2 0.55 
negative 10 12 22 6.08 
Other: 
positive 1 1 2 0.55 
ADDITIONAL ANTIBIOTICS (POSTOPERATIVE) knee 
Wound 
Urine preoperative 
Urine postoperative 
Pulmonary tract 
Skin 
Other infections 
Temperature eci 
Other reasons 
11 
3 
25 
0 
1 
1 
8 
3 
15 
3 
31 
1 
1 
2 
7 
2 
26 
6 
56 
1 
2 
3 
15 
5 
7.18 
1.66 
15.47 
0.28 
0.55 
0.83 
4.14 
1.38 
FOLLOW-UP knee 
Mean follow-up (days) 
Mechanical reoperations 
(Joint sepsis after reoperation 
Joint sepsis 
392 
8 
2 
3 
375 
18 
1 
6 
-
26 
3 
9 
7.18 
0.83) 
2.49 
132 
Supplement IIa: General summary of the risk fac­
tors (univariate analysis - 2651 hip replacements) 
PREOPERATIVE RISK FACTORS hip 
Sex 
Age (years) 
Cefuroxime dose 
Quetelet index 
(kg/m2) 
Physical condition 
Preop. hospital stay 
(days) 
Preop. infections 
Preop. urine sediment 
(>5 leucocytes/field) 
Use of steroids 
Diabetes 
male 
female 
0-64 
>=64 
one 
three 
missing 
0-30 
> 3 0 
good 
moderate 
poor 
0 
>=1 
yes 
no 
yes 
no 
-
yes 
no 
yes 
no 
η 
553 
2098 
762 
1889 
1327 
1324 
436 
1873 
342 
2225 
390 
36 
132 
2504 
71 
2580 
358 
1690 
603 
69 
2582 
100 
2551 
infections 
η % 
3 
14 
3 
14 
11 
6 
3 
10 
4 
14 
3 
0 
2 
15 
0 
17 
2 
13 
2 
_ 
17 
2 
15 
0.54 
0.67 
0.39 
0.74 
0.83 
0.45 
0.69 
0.53 
1.17 
0.63 
0.77 
0.00 
1.52 
0.60 
0.00 
0.66 
0.56 
0.77 
0.33 
0.00 
0.66 
2.00 
0.59 
ρ value 
0.74 
0.31 
0.23 
0.39 
0.85 
0.20 
0.95 
0.50 
0.50 
0.08 
133 
PREOPbRAIIVL· RISK FACTORS hip 
Diagnosis 
Previous surgery 
oth 
arthrosis 
rheum arthr 
fracture 
other 
_ 
prosthesis 
fracture osteosynth 
1er (80% osteotomy) 
2071 
168 
334 
78 
2397 
66 
63 
125 
infections 
η % ρ value 
12 
1 
4 
14 
1 
2 
0 
0 58 
0 60 
1 20 
0 00 
0 58 
1 52 
3 17 
0 00 
0 52 
0 05 
PERIOPERA 11 VE RISK l· ACTORS hip 
infections 
ρ value 
Approach 
Use bone cement 
Breakdown of sterility 
(90% hole in glove) 
Operation 
difficully 
Operation time 
(minutes) 
Blood loss 
(milliliters) 
Surgeon 
Wound nnse 
(antero)lateral 
posterolateral 
yes 
no 
yes 
no 
normal 
difficult 
very difficult 
missing 
0-150 
> 150 
missing 
1-500 
501-1000 
> 1000 
staff 
resident 
. 
povidone iodine 
ab-solution 
861 
1790 
422 
2229 
157 
2494 
2202 
402 
47 
46 
2535 
70 
92 
1234 
943 
382 
2487 
162 
1998 
214 
439 
6 
11 
1 
16 
3 
14 
14 
3 
0 
0 
16 
1 
0 
7 
7 
3 
17 
0 
12 
2 
3 
0 70 
061 
0 24 
0 72 
1 91 
0 56 
0 64 
0 76 
0 00 
0 00 
0 63 
143 
0 00 
0 57 
0 74 
0 79 
0 68 
0 00 
0 60 
0 93 
0 68 
0 80 
0 26 
0 04 
0 83 
061 
081 
0 29 
0 84 
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POSTOPERATIVE RISK FACTORS hip 
infections 
η 
11 
1 
3 
2 
15 
2 
2 
% 
0.52 
0.37 
1.66 
2.78 
0.65 
0.59 
0.80 
ρ value 
Haematoma no 
light 
moderate 
severe 
Minor wound problems no 
yes 
erythema < 1 cm 
dehiscence 
blister 
wound edge necrosis 
Wound drainage no 
serous 
pus 
blood 
2126 
272 
181 
72 
2315 
336 
247 
30 
34 
45 
2307 
295 
20 
29 
0.30 
1.36 
20.00 
6.90 
0.03 
0.80 
0.000 
Drainage drain wound 
Wound infection 
Antibiotics (wound) 
yes 
no 
yes 
no 
yes 
no 
374 
2277 
56 
2595 
88 
2563 
5 
12 
9 
8 
8 
9 
1.34 
0.53 
16.07 
0.31 
9.76 
0.35 
0.07 
0.00 
0.00 
OTHER POSTOPERATIVE 
RISK FACTORS hip 
infections 
η % ρ value 
Urinary tract 
catheter 
(hours) 
Day drain removal 
(days) 
Wound healed 
(at hospital discharge) 
Temperature normal 
(at hospital discharge) 
none 
< 2 4 
24-48 
48-72 
>72 
1-3 
> 3 
yes 
no 
yes 
no 
1222 
466 
433 
169 
361 
2516 
135 
2613 
38 
2622 
29 
5 
4 
3 
0 
3 
15 
2 
13 
4 
16 
1 
0.41 
0.86 
0.69 
0.00 
1.39 
0.60 
1.48 
0.50 
10.53 
0.61 
3.45 
0.23 
0.21 
0.00 
0.06 
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OTHER POSTOPERATIVE infections 
RISK FACTORS hip η η % ρ value 
Painless function 
(at hospital discharge) 
Quick reconvalescence 
(at hospital discharge) 
Orthop. complications 
Non-orthop. complication # 
Non-orthop. surgery 
Wound culture 
Drain culture 
Urine preop. 
Urine postop. 
Skin infections 
Blood culture 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
neg 
pos 
neg 
pos 
neg 
pos 
neg 
pos 
pos 
neg 
pos 
2556 
95 
2479 
172 
94 
2540 
92 
2559 
26 
2625 
2524 
50 
77 
1845 
684 
122 
2345 
243 
63 
1982 
274 
395 
2594 
57 
2570 
72 
9 
15 
2 
12 
5 
0 
17 
5 
12 
0 
17 
11 
1 
5 
9 
3 
5 
15 
1 
1 
8 
9 
13 
4 
13 
3 
1 
0.59 
2.11 
0.48 
2.91 
0.00 
0.67 
5.43 
0.47 
0.00 
0.65 
0.44 
2.00 
6.49 
0.49 
0.44 
4.10 
0.64 
0.41 
1.59 
0.40 
2.28 
0.50 
7.02 
0.51 
4.71 
11.11 
0.07 
0.00 
0.43 
0.00 
0.68 
0.00 
0.00 
0.58 
0.00 
0.00 
0.00 
(# = including five patients with skin infections of whom four had joint sepsis,there­
fore not considered significant in risk analysis, see also skin infection) 
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Supplement IIb: General summary of the risk fac­
tors (univariate analysis - 362 knee replacements) 
PREOPERATIVE RISK FACTORS knee infections 
η η % ρ value 
Sex 
Age (years) 
Cefuroxime dose 
Quetelet index 
(kg/m') 
Physical condition 
Preop hospital stay 
(days) 
Preop infections 
Preop urine sediment 
(>5 leucocytes/field) 
Use of steroids 
Diabetes 
Diagnosis 
male 
female 
0-64 
>=64 
one 
three 
missing 
0-30 
> 3 0 
good 
moderate 
poor 
0/1 
>=2 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
arthrosis 
rheum arthr. 
other 
46 
316 
75 
287 
175 
187 
55 
221 
86 
287 
75 
1 
239 
123 
6 
356 
77 
49 
227 
34 
328 
17 
345 
248 
107 
7 
2 
7 
0 
19 
3 
6 
2 
5 
2 
5 
4 
5 
4 
0 
9 
0 
3 
6 
1 
8 
1 
8 
3 
6 
0 
4 35 
2 22 
0 00 
3 14 
1 71 
321 
3 64 
2 26 
2.33 
1 77 
5 40 
2 16 
3 25 
0 00 
2.35 
0 00 
5 77 
2.58 
2 94 
2 44 
5 88 
2.32 
1 29 
5 94 
0.00 
0 39 
0.12 
0 36 
0 83 
0 19 
0 50 
0 98 
0 12 
0 86 
0 36 
0 05 
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PREOPERATIVE RISK FACTORS knee infections 
% ρ value 
Previous surgery 
-
prosthesis 
osteotomy 
other 
282 
7 
24 
48 
2.13 
14.29 
4.17 
2.04 
0.21 
PERIOPERATIVE RISK FACTORS knee infections 
% ρ value 
Use bone cement 
Breakdown 
(90% hole i 
Operation 
difficulty 
of sterility 
η glove) 
Operation time 
(minutes) 
Blood loss 
(milliliters) 
Surgeon 
yes 
no 
yes 
no 
normal 
difficult 
very difficult 
missing 
0-150 
> 150 
missing 
1-500 
> 5 0 0 
staff 
resident 
275 
87 
15 
347 
300 
56 
6 
3 
346 
13 
170 
169 
23 
335 
18 
8 
1 
0 
9 
6 
3 
0 
0 
8 
1 
4 
5 
0 
9 
0 
2.91 
1.14 
0.00 
2.59 
2.00 
4.83 
0.00 
0.00 
1.43 
7.69 
2.35 
2.96 
0.00 
2.62 
0.00 
0.60 
0.53 
0.31 
0.46 
0.69 
0.49 
POSTOPERATIVE RISK FACTORS knee infections 
Hacmatoma 
Minor woundhealing 
problems 
yes 
no 
yes 
no 
Wound drainage 
erythema < 1 cm 
pus suture 
dehiscence 
blister 
skin necrosis 
no 
serous 
pus 
blood 
95 
267 
68 
294 
35 
2 
26 
3 
12 
294 
51 
4 
13 
% 
4.21 
1.87 
5.88 
1.70 
2.86 
7.69 
25.00 
5 
2 
1 
1 
1.70 
3.92 
25.00 
7.69 
ρ value 
0.21 
0.05 
0.01 
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POSTOPERATIVE RISK tACTORS knee infections 
Drainage vacuum-drain wound yes 
no 
Wound infection 
Antibiotics (wound) 
yes 
no 
yes 
no 
11 
351 
13 
349 
26 
336 
% ρ value 
0 00 
2 56 
23 08 
1 72 
19 23 
1 17 
0 59 
0 00 
0 00 
О I HER POSTOPERATIVE 
RISK FACTORS knee 
infections 
% 
ρ value 
Lnnary tract 
catheter 
(hours) 
Day drain removal 
(days) 
Wound healed 
(at hospital discharge) 
Temperature normal 
(at hospital discharge) 
Painless function 
(at hospital discharge) 
Quick rcconvalescence 
(at hospital discharge) 
Orthop complications 
Non-orthop compi 
Non-orthop reop 
Wound culture 
none 
< 2 4 
24-48 
48-72 
>72 
1-3 
> 3 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
. 
neg 
pos 
219 
44 
34 
17 
41 
325 
37 
349 
13 
356 
13 
335 
27 
320 
42 
9 
353 
11 
351 
357 
5 
327 
17 
18 
3 10 
2 27 
0 00 
0 00 
2 44 
2 77 
0 00 
1 43 
30 77 
2 25 
16 67 
1 49 
1481 
1 56 
9 52 
0 00 
2 35 
9 09 
2 28 
12 52 
0 00 
1 53 
5 88 
16 67 
0 80 
0 30 
0 00 
0 02 
0 00 
0 00 
0 63 
0 15 
0 72 
0 00 
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OTHER POSTOPERATIVE infections 
RISK FACTORS knee η η % ρ value 
Drain culture - 228 5 2.18 0.60 
neg 115 4 3.48 
pos 18 0 0.00 
Urine preoperative - 329 7 2.13 0.11 
neg 22 2 9.09 
pos 11 0 0.00 
Urine postoperative - 258 6 2.33 0.95 
 
 
_ 
 
 
_ 
neg 
pos 
_ 
pos 
_ 
neg 
pos 
 
 
 
 
 
 
67 
37 
356 
6 
338 
22 
2 
2 
1 
8 
1 
7 
2 
0 
18 
13 
3  
2.99 
2.70 
2.25 
16.67 
2.07 
9.52 
0.00 
Skin infections -   2  0.02 
Blood culture 
0.22 
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Supplement Ilia: Preoperative diagnosis and 
postoperative woundhealing of patients diag­
nosed with joint sepsis 
preoperative data postoperative data 
no 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
age 
a 
63 
65 
75 
73 
75 
72 
71 
74 
80 
74 
73 
78 
70 
55 
93 
66 
75 
sex 
b 
f 
f 
m 
f 
f 
m 
m 
m 
dose 
proph 
с 
1 
3 
1 
3 
1 
3 
1 
1 
1 
3 
1 
1 
1 
1 
1 
3 
3 
diagn 
d 
Tos 
о 
О 
О 
f 
fos 
О 
О 
о 
о 
о 
О 
fcup 
О 
f 
га 
о 
type 
repl 
e 
th 
th 
th 
th 
th 
th 
th 
th 
th 
th 
th 
th 
threv 
th 
hh 
th 
th 
cement 
f 
a-/f-
a+/r+ 
a+/f+ 
a+/r+ 
a+/r+ 
a+/f+ 
a+/r+ 
a+/f+ 
a+/f+ 
a+/f+ 
a+/r+ 
a + / f + 
a-/f+ 
a-/f+ 
f+ 
a + / f + 
a + / f + 
haema-
toma 
g 
. 
+ + + 
+ + 
-
-
-
-
+ + 
-
+ + + 
+ 
-
-
. 
+ + + 
. 
-
minor 
w p 
h 
eryt 
-
-
-
-
-
-
-
-
-
-
-
-
eryt 
deh 
-
-
drain­
age 
1 
-
ser 
bl 
-
pus 
-
ser 
pus 
ser 
pus 
-
pus 
-
-
Ы 
scr 
. 
wound 
inf 
J 
. 
inf 
inf 
-
inf 
-
mf 
inf 
inf 
mf 
. 
inf 
-
. 
-
mf 
. 
a) age at index operation 
b) m = male, f = female 
c) 1 = one dose of penoperative cefuroxime, 3 = three doses of penoperative cefuroxime 
d) fos = failed osteosynthesis, о = osteoarthrosis, fcup = failed cup arthroplasty, ra = rheumatoid 
arthntis, ftka = failed total knee replacement, ost = osteotomy 
e) th = total hip replacement, hh = hemi hip replacement, threv = revision total hip, tk = total 
knee replacement, tkrev = revision total knee replacement 
f) + = cement, - = cemendess, a = acetabular component, f = femoral component 
g) - = none, + = light, ++ = moderate, + + + = severe 
h) er(yt) = erythema < 1cm, d(eh) = dehiscence, ρ = pus suture, b = blister, n(e) = necrosis 
i) ser = serous drainage, bl = blood, pus = purulent drainage 
j) inf = wound infecüon (erythema > 1 cm) 
141 
preoperative data postoperative data 
no 
18 
19 
20 
21 
22 
23 
24 
25 
26 
age 
a 
79 
85 
74 
18 
72 
85 
70 
71 
73 
sex 
b 
m 
m 
f 
dose 
proph 
с 
3 
3 
3 
3 
1 
3 
1 
1 
3 
didgn 
d 
0 
ra 
ftka 
ra 
о 
ra 
га/ost 
ra 
ra 
type 
repl 
e 
tk 
tk 
tkrcv 
tk 
tk 
tk 
tk 
tk 
tk 
cement 
f 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
. 
+ 
hacma-
toma 
g 
_ 
+ 
-
+ + + 
+ + 
-
. 
. 
+ + + 
minor 
w p 
h 
er/ne -
-
-
-
deh 
-
p/ne 
-
d/b/n 
drain­
age 
1 
_ 
. 
-
pus 
sereus 
. 
ser/Ы 
. 
Ы 
wound 
inf 
J 
_ 
. 
inf 
inf 
-
-
inf 
-
-
a) age at index operation 
b) m = male, f = female 
c) 1 = one dose of penoperative cefuroximc, 3 = three doses of penoperative cefuroximc 
d) fos = failed osteosynthesis, о = osteoarthrosis, fcup = failed cup arthroplasty, ra = rheumatoid 
arthntis, ftka = failed total knee replacement, ost = osteotomy 
e) th = total hip replacement, hh = hemi hip replacement, tlirev = revision total hip, tk = total 
knee replacement, tkrev = revision total knee replacement 
1) + = cement, - = cementless, a - acetabular component, Г = femoral component 
g) - - none, + = light, ++ = moderate, +++ = severe 
h) er(yt) - erythema < 1cm, d(eh) = dehiscence, ρ = pus suture, b = blister, n(e) = necrosis 
i) ser = serous chaînage, bl = blood, pus = purulent drainage 
j) ml = wound infection (erythema > 1 cm) 
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Supplement HIB: Follow-up data of patients with 
joint sepsis 
1. 
2 
3. 
4 
5 
6 
7 
8. 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
2 1 . 
22 
23 
24 
25 
26 
pain 
m 
. 
-
-
r 
r/w 
r/w 
r/w 
r/w 
r/w 
r/w 
r/w 
-
r/w 
r/w 
-
-
r 
r/w 
r/w 
r/w 
r/w 
-
r/w 
r/w 
r/w 
months 
>ok 
η 
5 
6 
6 
2 
10 
signs 
inf 
о 
sinus 
drain 
drain 
sinus 
tend 
sinus 
sinus 
cry/fe 
sinus 
sinus 
sinus 
-
-
drain 
sinus 
sinus 
drain 
eryth 
cryth 
sinus 
dr/er 
sinus 
sinus 
er/fe 
sinus 
months 
>ok 
Ρ 
11 
1 
1 
1 
5 
1 
1 
1 
1 
11 
1 
-
-
1 
1 
18 
1 
5 
1 
3 
4 
3 
1 
10 
1 
X-
ray 
4 
η 
η 
η 
У 
η 
η 
у 
У 
η 
y 
У 
η 
У 
у 
η 
η 
у 
У 
-
-
-
у 
E S R 
increased 
г 
У 
-
У 
у 
У 
у 
У 
у 
У 
у 
у 
у 
у 
у 
у 
У 
У 
у 
у 
у 
m) г = in rest, w = on weight-beanng 
η) months pain developed after operation 
o) signs inf = signs of infection, er(ylh) = erythema of the wound, tend = tenderness of 
the wound, dr = drainage, fe = fever, 
p) number of months infection signs developed after operation 
q) y = yes (X-ray suspect for infection), η = no 
r) ESR = erythrocyte sedimentation rate, y = yes (increased 20 mm above 
pcropcrative value or > 35 mm first hour) 
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Supplement IIIc: Cultures postoperative wound, 
vacuum-drain, postoperative urine, blood and 
joint at reoperation of patients diagnosed with 
joint sepsis 
no 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
WOUND 
POSTOP 
. 
• 
Pr mirabilis 
Ρ aeruginosa 
-
S aureus 
streptococ D 
S vmdans 
-
-
S aureus 
S aureus 
-
. 
E coli 
Pr mirabilis 
-
-
S aureus 
" 
neg 
-
-
Peptococcus 
Bacillus 
Difteroid rods 
. 
Enterobacter 
. 
-
VACUUM-DRAIN 
POSTOP 
. 
-
Pr mirabilis 
Ps aeruginosa 
neg 
-
Gram neg rods 
S aureus 
streptococ D 
-
S epidermidis 
-
-
neg 
neg 
Enterobacter 
-
" 
-
neg 
neg 
neg 
. 
-
-
-
URINE 
POSI OP 
E coli 
Ρ aeruginosa 
streptococ D 
-
Ps aeruginosa 
E coli 
Ps aeruginosa 
E coli 
Pr mirabilis 
-
-
-
-
-
E coli 
Pr mirabilis 
E coli 
streptococ D 
Pr mirabilis 
-
Pseudomonas 
-
streptococ D 
E cob 
-
-
neg 
-
-
E cob 
-
-
BLOOD 
SEPSIS 
neg 
" 
-
-
-
neg 
• 
-
-
-
S aureus 
-
-
-
-
-
-
neg 
-
-
-
neg 
-
-
J O I N T 
S aureus 
S aureus 
Pr mirabilis 
S epidermidis 
E coli 
S aureus 
S aureus 
S aureus* 
Enterobacter 
-
-
neg 
negative 
Enterobacter 
S aureus 
S aureus 
Peptococcus 
neg 
S epidermidis 
S epidermidis 
S aureus 
S aureus 
Enterobacter 
E coli 
S aureus 
S aureus 
(neg = negative culture, - = culture not done, * = from aspiration culture) 
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Supplement Hid: Treatment of patients with joint 
sepsis 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
IG 
17 
18 
19 
20 
21 
22 
23 
24 
25 
2b 
SURGICAL 
1 REA 1 ΜΕΝ Γ 
s 
D 
D 
Ό 
Lx Acet 
D 
D / R P 
D / R P / R i / R P 
D + R P 
-
D 
-
-
R P 
R P 
D 
D 
I) 
D / R P 
R P / R i 
D / R P / A m 
D / R P / R i 
D / R P 
D 
D 
D 
R P 
ANTIBIOTIC 
TREAT Ml· Ν Γ 
t 
loc 
syst 
syst 
loci 
loc 
loc 
loc 
loc 
+ syst 
[cement) 
+ syst 
+ syst 
+ syst 
chronic ab 
loc + syst 
chronic ab 
chronic ab 
loc 
loc 
syst 
loc 
loc 
loc 
loc 
loc 
loc 
loc 
syst 
loc 
syst 
loc 
+ syst 
+ syst 
•+ syst 
+ syst 
+ syst 
+ syst 
+ syst 
+ syst 
+ syst 
+ syst 
+ syst 
O L T C O M E 
u 
p i s 
p i s 
p i s 
p i s 
p i s 
res arthr 
res arthr 
res arthr 
p i s 
p i s 
p i s 
p i s 
res arthr 
res arthr 
p i s 
p i s 
p i s 
res arthr 
new ρ ι s 
amputation 
new ρ ι s 
arthrodesis 
p i s 
arthrodesis 
p i s 
arthrodesis 
M J M B F R 
OPl· RATIONS 
V 
2 
1 
1 
1 
3 
3 
8 
3 
-
3 
-
-
2 
2 
1 
2 
2 
8 
b 
5 
6 
4 
1 
5 
1 
2 
INFECTION F-LP 
C I J R H ) MOISI HS 
w 
no 
yes 
yes 
no 
no, died 
' , died 
no 
? 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
no 
J 
>cs 
yes 
yes 
yes 
no, died 
f 
no, died 
yes 
X 
16 
18 
19 
4 
1 
1 
2 
-
2 T 
7 
27 
12 
3 
1 
16 
17 
1 
1 
8 
25 
12 
10 
1 
1 
1 
9 
s) D = debndcment, RP = removal prosthesis, Ri = reimplantation, 
Am= amputation, Ex Acet = Exchange acctabalum 
t) loc = local antibiotic treatment with gentamicin beads or μΓ stated) gentamicin 
cement, syst = systemic antibiotics 
u) ρ ι s = prosthesis in situ, res arthr = resection arthroplasty, new ρ ι s = new pros-
lliesis in situ 
w) died = sepsis-rtlatcd' 
x) f-up =rollow-up after last operation 
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Stellingen 
behorende bij het proefschrift 
'Joint sepsis after prophylaxis 
with one or three doses 
of cefuroximc in hip and knee 
replacement' 
Ate B. Wymenga 
Nijmegen 3 mei 1991 
I. 
Wondinfectie na een heupvervangende operatie is de enige wond-
stoornis, waarvoor antibiotische therapie geïndiceerd is. Alle andere 
stoornissen in de wondgenezing behoeVen geen antibiotische thera-
pie. 
II. 
Hematoomvorming in combinatie met wondinfectie na een heup- of 
knie-arthroplastiek is een indicatie voor chirurgische evacuatie van 
het hematoom. 
III. 
Het verhoogde risico voor prothese-infectie van patiënten met een 
urineweginfectie na een heupvervangende operatie, kan niet ver-
klaard worden door hematogene infectie vanuit de urinewegen. 
IV. 
Er is geen relatie tussen het gebruik van een blaascatheter na een 
heup- of knie-arthroplastiek en infectie van de endoprothese. 
V. 
Tijdens een gewrichtsvervangende operatie dient de lucht in de ope-
ratiekamer minder dan 10 bacterie-dragende deeltjes per kubieke 
meter te bevatten. 
(W. Whyte et al, J. Hosp. Inf. 4:133-139,1983) 
VI. 
Evenals ons wagenpark dienen ook luchtverversingssystemen van 
operatiekamers een Algemene Periodieke Keuring te ondergaan. 
VIL 
Het zou de trial rapportage ten goede komen indien onderzoekers 
minder geobsedeerd waren door significantie testen en zich meer zou-
den concentreren op het schatten van de mogelijke omvang van het 
behandelingsefFect, uitgedrukt in het 95% betrouwbaarheidsinterval. 
(S.J. Pocock, Clinical Trials, a practical approach, 1988) 
VIH. 
De tijd heelt veel wonden, maar meestal niet die van endoprothese 
infecties. 
DC. 
De mededeling van sommige orthopaeden dat zij bij prothese implan-
taten nooit infecties zien, dient met enige s(c)epsis beoordeeld te wor-
den. 
X. 
De classificatie van enkelfracturen volgens Weber is niet geschikt om 
te beslissen of een enkelfractuur conservatief dan wel operatief be-
handeld moet worden, omdat binnen de type B-fracturen letsels val-
len die een verschillende behandeling behoeven. 
(CA. Cedell, Acta Orthop. Scand. 56:101-102,1985) 
XI. 
De bepaling van de leucocyten bij patiënten met verdenking op acute 
appendicitis draagt niet bij tot de diagnose als de klachten korter 
duren dan 12 uur of langer dan 48 uur. 
(Persoonlijke mededeling A.A.P. project Comae B.M.E.) 
XII. 
Uit infectie-profylactisch oogpunt dienen er meer vrouwen tot ortho-
paedisch chirurg te worden opgeleid, omdat vrouwen beduidend min-
der bacterie-dragende huidschilfers strooien dan mannen. 
(J. Hill et al, Lancet: 1131-1133,1974) 
XIII. 
Een nadeel van het gebruik van een tekstverwerker met standaard 
operatieverslagen en ontslagbrieven is, dat er tussen de regels niets 
meer te lezen valt. 
Nijmegen, 3 mei 1991 
Ate В. Wymenga 



